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The current demand for more environmentally benign processes requires the 
investigation of alternative renewable resources in different industry sectors to become 
independent from fossil fuels. Lignin, as a major polymer present in nature, contains 
significant amounts of aromatic building blocks and thus, is considered a valuable 
renewable feedstock for the future supply of aromatics. For that reason, the 
depolymerization and valorization of this commodity in biorefineries via various chemical 
and enzymatic approaches is of high importance. Several enzymes are known to act on 
lignin, but β-etherases together with glutathione lyases catalyze the selective cleavage 
of β-O-4 aryl ether bonds present in lignin in a highly stereoselective manner. These 
enzymes, belonging to the glutathione S-transferase superfamily, catalyze a reductive, 
glutathione-dependent ether bond cleavage. 
In this thesis, a whole-cell catalyst combining β-etherases and glutathione lyase was 
studied in order to overcome the enzymes’ glutathione dependence, which is regarded 
as a major limitation for their application in the production of aromatics from lignin 
polymer and its oligomers. Therefore, the whole-cell catalyst was investigated for 
efficient cleavage of the β-O-4 aryl ether bond in a lignin model substrate with 
intracellular GSH regeneration. This revealed that up to 5 mM of this substrate could be 
converted without addition of external GSH or carbon source. The applicability of the 
whole-cell process was successfully demonstrated in the kinetic resolution of the racemic 
lignin model substrate to provide enantiopure compounds. 
Understanding the catalytic mechanism of an enzyme is one of the crucial requirements 
for its successful application. In that matter, a thorough analysis of the active sites of β-
etherases LigE and LigF from Sphingobium sp. SYK-6 is presented, expanding our 
knowledge on the impact of different active-site residues on catalytic efficiency. By 
introducing mutations into the active sites of LigE and LigF, residues important for GSH-
activation and catalysis have been identified. Additionally, multiple LigF mutants with 
significantly improved activity were obtained, representing an excellent starting point for 
further protein engineering.  
Moreover, the substrate scope of β-etherases was expanded to non-lignin-derived, 
bisphenol A-related compounds in this thesis, demonstrating the potential of these 
enzymes for the degradation of other, man-made structures. 
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1.1 Current societal challenges 
The 21st century is defined by many social, economic and environmental challenges that 
humankind has to solve. Among many others, the biggest concerns are caused by 
increasing global population, poverty alleviation, environmental degradation, species 
extinction, and climate change. The problem of climate change is no longer just a 
scientific interest, but it progressively affects economics, sociology, law, national and 
local politics, and health 1–3. In order to prevent the irreversible damage on the planet 
Earth, as reported by IPCC (The Intergovernmental Panel on Climate Change), some 
governments (including Germany) have made commitments to reduce greenhouse gas 
emissions to limit its destructive effects. To meet these commitments, aggressive policy 
action and a rapid shift away from fossil fuel use is necessary. For example, the German 
government recently introduced a major framework called “Climate Action Law” and the 
policy programme “Climate Action Programme 2030” that focus on climate action 
measures such as expansion of renewable resources, support for e-mobility, and the 
phaseout of coal-fired power. In order to achieve this courageous goal, alternative 
sources of gas, fuel and other chemicals derived from fossil fuel sources have to be 
developed. One of the promising alternatives is lignocellulose. Lignocellulosic material 
can be fully renewed/regrown on a very low time-scale, has often been considered a 
waste product, and avoids the controversy of the “food versus fuel” argument as seen in 
the first generation of biofuels. This makes lignocellulose a great candidate to become a 
valuable feedstock for transformation into desired products. 
 
1.2 Lignin as a part of lignocellulose 
Lignocellulosic biomass, an abundant and renewable resource, is a sophisticated and 
complex structural material of plant cell walls. Lignocellulose as a supramolecule 
consists of three main classes of biopolymers – cellulose, hemicellulose and lignin 4–6 – 
the combination of which provide structural stability and rigidity to the plant cell 7,8. 
Cellulose, the most abundant polymer in the nature, is a polysaccharide made of β-1,4-
linked ᴅ-glucose units and it accounts for 30-50 % of the dry weight of lignocellulose 
(depending on the biomass source). Currently industry’s most desired biopolymer, it is 
used in pulp and paper production and as a part of the biotechnological process for 




bioethanol, methane and even hydrogen 9.  
Hemicellulose possesses a complex carbohydrate structure comprised of various 
polysaccharides, principally xylans (pentose) and mannans (hexose), which can be 
solubilized and extracted in various conditions (temperature, pH, moisture content) 4. 
The function of hemicellulose in lignocellulosic biomass is to connect lignin and cellulose 
fibres (Fig. 1.1).  
 
 
Fig. 1.1: Schematic representation of the location and structure of lignin in lignocellulosic material. Adapted 
from Zakzeski et al.10. 
 
Lignin, an irregular, three dimensional amorphous heteropolymer, is one of the most 
abundant polymers in nature 7,11. 15-30 % of the dry weight of lignocellulose is comprised 
of lignin and its main function in the plant cell wall is to provide structural support, 
impermeability as well as resistance against oxidative stress and microbial attack 10. All 
of these properties are directly connected with its structural features. Lignin consists of 
phenylpropanoid arylalcohol subunits held together by a minimum of 12 different 
described bonds 12. The highly aromatic and functionalized matrix, together with the 
enormous quantities produced annually, make lignin an attractive raw material for the 
manufacturing of biofuels and fine as well as specialty chemicals. Although it has huge 
potential and offers attractive features, real industrial applications of lignin are still scarce 
due to its problematic processing caused by lignin’s renowned recalcitrance and the 
variety of covalent inter-unit linkages through which its aromatic monomers are 
connected 13.  
Lignin, currently mostly produced by pulp and paper industry as a by-product, is 
considered as a waste material and burned for the generation of heat and energy 10. 
However, both lignin and lignocellulose are appealing feedstocks in biorefineries. In 
order to ensure environmentally-friendly, carbon efficient and renewable procedures in 
which biomass is converted into biofuel or chemicals, the understanding and controlling 





1.3 Lignin structure 
Methoxylated hydroxycinnamyl alcohol building blocks are the major structural units of 
lignin. As opposed to cellulose with defined monomeric units linked by regular β-1,4-
glycosidic bonds, lignin monomeric units (monolignols) are connected via a variety of 
non-enzymatic, radical coupling reactions that generate a mixture of interunit covalent 
bonds 14,15. Generally, lignin is formed by radical polymerization of guaiacyl (G) units from 
precursor coniferyl alcohol, syringyl (S) units from precursor sinapyl alcohol, and p-
hydroxyphenyl (H) units from precursor p-coumaryl alcohol 16,17 (Fig. 1.2). Depending on 
the biomass source, isolation method and environmental conditions, proportions 
between G:S:H units may vary. However, softwood lignin contains mostly G units and 
very low levels of H units, hardwood lignin contains similar levels of G and S units (and 
traces of H units), while grasses contain all three units 18. In Fig. 1.2, the most common 
interunit linkages found in lignin are shown in a representative structure. Interunit 
linkages had been identified on low molecular weight products of lignin, monomers, 
dimers and oligomers, using GC-MS, LC-MS and NMR spectroscopy. 
The most abundant linkage in lignin is the arylglycerol-β-aryl ether (β-O-4) bond. It 
corresponds to 40-60 % of all interunit linkages present in softwood as well as hardwood 
14,19,20. Recently, quantities of the β-O-4 units were measured directly in the cell wall using 
the two-dimensional NMR technique HSQC, which confirmed the predominant status of 
the β-O-4 linkage and its importance for lignin depolymerization 21.  
The resinol linkage (β-β) is the core of resinol structures (pinoresinol, syringaresinol, 
episyringaresinol, lariciresinol, and dimethoxylariciresinol) 22, which were identified and 
isolated either chemically or enzymatically from hardwood lignin 22. It was shown that 
hardwood lignin comprises larger amounts of resinol bonds than softwood and that maize 
lignin completely lacks resinol linkages in its structure 23.  
Other lignin bonds, including the phenylcoumaran bond (β-5), biphenyl bond (5-5), 
dibenzodioxocin bond (α-β-O-4-4) and diphenylether bond, represent additional 
interlinkages that commonly prevail in the lignin structure 19,24,25. A less common 
structure, the flavonoid tricin, has been recently confirmed to be present in the lignin 
structure of wheat straw 26,27 (Fig. 1.2). The valuable anticancer and antiaging properties 






Fig. 1.2: Structure of lignin and its precursors. (A) Monolignols used in lignin synthesis in nature. (B) 
Representative structure of a lignin polymer with common linkage types highlighted in bold. (C) Flavonoid 
tricin. 
 
1.4 Lignin isolation 
As lignin covers 25-30 % of all renewable carbon in nature, numerous methods for the 
isolation of this polymer from its lignocellulosic matrix have been described. When lignin 
is isolated, different goals may be targeted and therefore different methods can be used. 
The general objectives for lignin isolations are: analysis (designed to determine lignin 
purity, native structure, or contend), removal (performed by the pulp and paper industry, 
designed to remove as much lignin from lignocellulose as possible), and fractionation 
(practised by biorefinery, designed for further conversion of lignin into biofuels/bio-based 
chemicals). 
Klason lignin is one of the most broadly employed techniques used for quantifying lignin 
contend in biomass. Lignocellulosic feedstock is extracted by benzene and ethanol, then 
72 % H2SO4 is added and the reaction is conducted at 20-30˚C for 1-4 h 29–31. The result 
of this time and effort dependent process is acid-insoluble or ‘true’ lignin. Klason lignin is 
considered to be the most direct and the most reliable method for quantitative lignin 
analysis and is used as the standard method for lignin determination 32. 




lignin is employed. Solubility in organic solvents has been used for decades to extract 
lignin from biomass 33,34. A variety of solvents can be used for lignin extraction such as 
2-methoxyethanol, acetone, and dimethyl sulfoxide. However, due to its optimal 
Hildebrand solubility parameter (σ), dioxane is predominantly applied. The most 
commonly used method for lignin structure analysis is Björkman lignin. Described by 
Björkman in 1956 35, the wood flour was exposed to extensive milling process in Lampén 
and vibrational ball mill in presence of toluene. Afterwards, milled wood lignin was 
purified from the aqueous p-dioxane. However, this lignin may contain some 
carbohydrate material, it is considered to be appropriate standard method resulting in 
lignin with low structural changes, and is used in structural and compositional studies 36. 
Until now, most of the lignin production has been connected with pulp and paper 
manufacturing – historically the largest biomass refining industry. The pulp and paper 
industry’s desired product is the cellulose pulp that is commonly obtained by either the 
kraft process or the lignosulfonate process 37,38. During the kraft lignin process, wood 
biomass is treated with extensive amounts of aqueous sodium hydroxide and sodium 
sulfide at temperatures between 170-180˚C, allowing solubilization of most of the present 
lignin. While the result of such a process is a lignin-rich mixture called black liquor 39,40, 
most of it is not likely to serve as a source of lignin for biorefinery operations. Instead, 
the vast majority of concentrated black liquor is burned as a fuel to generate part of the 
industry’s energy 17,41,42. The reason for limited lignin valorization from black liquor are 
the structural changes in the lignin polymer that occur as a result of the kraft process. 
Compared to untreated lignin, kraft lignin usually contains more biphenyl units due to 
their resistance against heat and alkaline conditions during kraft process, contrary to 
other types of bonds that are degraded 43–46. In addition, new types of functional groups 
and linkages are introduced during the pulping process, such as stilbenes 47 (Fig. 1.3).  
Additionally to the kraft process, the pulp and paper industry uses a sulfite pulping, 
though on a smaller scale 39,48. In the sulfite process, wood is usually treated with calcium 
or magnesium sulfite at 130-150˚C for several hours, allowing a sulfurous acid process 
to form benzylium cations. These cations attract sulfite ions and force the formation of 
lignosulfonic acid. In contrast to the kraft lignin, lignosulfonates are not largely burned as 
a source of energy, but are commonly used for further refinery 39. The improved 
properties of the lignosufonates compared to kraft lignin (water solubility) empower 
further utilization of this feedstock, even though structural changes compared to the 






Fig. 1.3: Lignin model structure depicting features of kraft lignin (A) and ligninosulfonate lignin (B). Adapted 
from Zakzeski et al.10. 
 
As the availability of fossil fuels has its endpoint and is not renewable on any human time 
scale, different alternatives to fossil fuels, especially biogas, biodiesel and bioethanol, 
are in current demand. This, however, redefines the role of biomass and its derivatives 
in terms of availability, efficiency and the product spectra achieved from this raw material. 
Isolation of lignin, as it is performed in biorefinery, allows separation of the commodities 
of cellulose and hemicellulose as sources of fermentable sugars, while an isolated, 
structurally (relatively) unchanged lignin stream is open to further utilization into biobased 
chemicals. 
Broadly used in biorefineries, the Organosolv process is a relatively general term 
describing the treatment of biomass with a broad range of organic solvents 40. First 
described and patented by Kleinert & Tayenthal 267 for the fractionation of spruce, 
multiple variations of the process have been described by now 40,49–51. Nonetheless, a 
significant majority of the organosolv procedures involve aqueous ethanol (or methanol) 
52 as an essential organic solvent in combination with mineral acid as a catalyst 50,51. 
Generally, the organosolv process consists of several steps, including hydrolysis of the 
hemicellulosic fraction, dissolution of lignin in the organosolv liquor and production of the 
cellulose in the form of pulp (after which the lignin can be recovered by precipitation or 
solvent evaporation) 53. 
The organosolv process originated in the pulp and paper industry. However, it has 
transitioned into the more sophisticated biorefinery industry, the goal of which is to 
produce high quality lignin for further chemical production and simultaneous separation 
of the cellulose and hemicellulose. One of several currently applied processes in 




cellulosic pulp and lignin directly in one processing step 54. The principle is based on the 
separation of the three main components in a biphasic system combining water and bio-
based 2-methyltetrahydrofuran (2-MeTHF) as solvents as well as oxalic acid as a 
catalyst. Each part of the biomass is separated directly into the individual phases: the 
aqueous phase containing dissolved monomeric sugars from hemicellulose, the organic 
phase containing the extracted lignin fraction and the solid phase composed of the 
insoluble cellulose fraction 53,55 (Fig. 1.4). The ability to use a bio-based solvent, to 
recover the solvents and the catalyst, to separate the biomass in a single process step 
with a biomass loading of up to 100-150 g/L in the batch process and up to 400 g/L in 
repetitive batch, makes the OrganoCat® process not only ecologically but also 
economically feasible 53. 
 
 
Fig. 1.4: The principle of the OrganoCat® process for the fractionation of lignocellulosic material to provide 
directly processible streams of hemicellulose, cellulose pulp, and lignin. Adapted from Grande et al. 53. 
 
1.5 Lignin-degrading enzymes 
As the industry of biorefineries is growing, methods for the valorization of produced high 
purity lignin is in current demand. The main thermo-chemical strategies for lignin 
depolymerization include pyrolysis, cracking or hydrolysis, hydrogenolysis, catalytic 
reduction, and catalytic oxidation 56. These methods do not result in a selective lignin 
breakdown, but yield complex mixtures of degradation products. However, a selective 
cleavage of carbon-carbon and carbon-oxygen bonds in lignin is required for a more 
controlled and less complex product mixture. Enzymes that have evolved to 
depolymerize lignin may provide the solution for its successful, efficient and 
environmentally-friendly valorization. Enzymes capable of modifying the lignin structure 
have already been reported in the 1980’s and over the years, various enzyme types and 





1.5.1 Laccases (EC 1.10.3.2) 
Laccases are polyphenol oxidoreductases belonging to the family of multi-copper 
oxidases (MCOs) found in plants, fungi, and bacteria. Although laccases are mostly 
extracellular enzymes, some wood-rotting fungi also produce intracellular laccases. They 
usually contain four copper ions, though atypical laccases with a reduced number of 
copper ions have been characterized 59. The copper ions are divided into three types: a 
blue type-1 (T1) mononuclear copper center and a trinuclear copper cluster consisting 
of one type-2 (T2) or normal copper center and two type-3 (T3) or coupled binuclear 
copper centers. Type I copper is located in the T1 site of the enzyme and is responsible 
for the characteristic blue colour and start of the oxidation process in the laccase 
mechanism. The T2 copper, together with two ions of T3 copper, are located in a highly 
conserved trinuclear cluster 60. Laccases are generally able to degrade phenolic 
substrates 61. By combining them with natural mediators (acetovanillone, p-coumaric 
acid, ferulic acid, sinapic acid, syringaldehyde, acetosyringone, vanillin) or synthetic 
mediators (TEMPO (2,2,6,6-tetramethylpiperidine-1-oxyl), HBT (1-hydroxy-
benzotriazole), ABTS (2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid), violuric 
acid), their substrate scope is extended to large, non-phenolic molecules, including lignin 
(Fig. 1.5) 62,63. 
 
 
Fig. 1.5: Structural representation of laccase-mediator system, used in oxidation of variety of non-phenolic 
substrates. 
 
Laccases catalyze a four single-electron substrate oxidation reaction and are fully 
reduced by O2 through two consecutive two-electron transfer steps as shown in Fig. 1.6 
64,65. The first step of catalysis is the oxidation of the substrate by Cu2+ cations, forming 
a fully reduced enzyme. Reduction of dioxygen takes place in two steps via the formation 
of bound oxygen intermediates. The O2 molecule binds to the T2-T3 site, resulting in the 
creation of a peroxide intermediate. The peroxide intermediate breaks down to an oxi-
radical intermediate and undergoes a two-electron reductive cleavage of the oxygen-
oxygen bond, releasing a water molecule and the resting enzyme in the substrate-






Fig. 1.6: Catalytic mechanism of multicopper laccases oxidizing substrate (green) to free radicals (red). 
 
Laccases exist in a variety of structures; most of them are monomeric, but homodimeric, 
heterodimeric, and multimeric forms of laccases have been described 65,66. The 
molecular weight of laccases depends on the source and ranges from 50 to 140 kDa. 
Structurally, laccases bear a cupredoxin-like fold arranged in a Greek-key β-barrel 
consisting of two β-sheets 67,68. Due to their ability to detoxify a range of pollutants, 
laccases have been used in a variety of industrial and biotechnological applications 
(paper and pulp industry, textile industry, petrochemical industry, food industry, or 
cosmetic industry) 69. 
 
1.5.2 Lignin peroxidases (LiP, EC 1.11.1.14) 
LiPs, heme-containing glycoproteins of 38-46 kDa size, catalyze the H2O2-dependent 
oxidative depolymerization of lignin. These extracellular proteins are produced mostly by 
white-rot and brown-rot fungi, however some have been found in bacteria 
(actinomycetes, α-proteobacteria, and γ-proteobacteria) 4,70. The high redox potential of 
LiPs caused by the heme iron allows oxidation of the aromatic non-phenolic structures 
of lignin 57,71. Lignin polymer can only be degraded by LiPs with the help of natural or 




active site. The radical reaction mechanism of LiPs is similar to the mechanism of 
classical peroxidases (Fig. 1.7). One molecule of H2O2 oxidizes the resting state enzyme 
(with ferric heme) by removing two electrons and forming the most reactive intermediate, 
compound I. Compound I contains an oxo-porphyrin-radical (Fe4+= O•) complex. 
Subsequently, it is reduced by one electron from a substrate/mediator (typically veratryl 
alcohol (VA)) generating compound II (Fe4+= O, oxo-porphyrin complex). Compound II 
can be further reduced by another substrate/mediator molecule, returning the enzyme to 
its resting state. In the absence of substrate/mediator, a catalytically inactive form of the 
enzyme, compound lll, is formed. Compound lll is then converted to the resting enzyme 
by autooxidation or by oxidation with a VA radical 57,72.  
 
 
Fig. 1.7: Catalytic mechanism of lignin peroxidase oxidizing a substrate veratryl alcohol (VA, green) to free 
radicals (red). 
 
Structurally, LiPs are composed of two domains (proximal and distal domain), in between 
which the heme is located. LiPs contain four disulfide bridges, two Ca2+ binding sites 
(one per each domain) and two glycosylation sites. Heterologous recombinant 
expression of the LiPs has been demonstrated in E. coli 73 and in the eukaryotic host 
Pichia pastoris 72. Despite the fact that the LiPs are able to catalyze cleavage of a carbon-




polymerization occurring due to the preferred radical coupling reaction with small 
phenolic products 74.  
 
1.5.3 Manganese peroxidases (MnP, EC 1.11.1.13) 
The most commonly produced peroxidases active on lignin are H2O2-dependent MnPs, 
which are found predominately in basidiomycetes (white-rot fungi, soil fungi), though they 
are produced by some bacteria and algae as well 57,75,76. These extracellular, 
glycosylated heme-containing proteins, with a size of 40-50 kDa, are able to 
depolymerize and (re)polymerize a large number of phenolic substrates. MnPs are using 
the unique one-electron Mn2+-dependent mechanism in which generated Mn3+ acts as 
diffusible redox-mediator, allowing for oxidation of variety of phenolic substrates like 
phenols, amines, dyes, as well as phenolic lignin model compounds. In contrast to the 
LiPs’ mediator assisted mechanism, MnPs are not able to oxidize recalcitrant, non-
phenolic compounds 77–79. The catalytic cycle of MnPs shown in Fig. 1.8 is initiated by 
binding of H2O2 to the native ferric enzyme and formation of compound I, which is again 
an oxo-porphyrin-radical (Fe4+= O•) species. Subsequent reduction proceeds through a 
monochelated Mn2+, that acts as one-electron donor and is oxidized to Mn3+, creating 
compound II (Fe4+= O, oxo-porphyrin intermediate). The reduction of compound II 
proceeds in a similar way and another Mn3+ is formed from Mn2+, re-forming the native 
enzyme in the resting state 78,80–82. 
 
 





LiPs and MnPs show similar structure: they are globular proteins formed by α-helices 
predominantly in two domains, with a central cavity containing the heme group. LiPs and 
MnPs stability depend on disulfide bonds: LiP contains four disulfide bridges, whereas 
MnP contains an additional bridge and two cation-binding sites that can accommodate a 
number of different metal ions.  
 
1.5.4 Versatile peroxidases (VP, EC 1.11.1.16) 
VPs are high redox potential, heme-containing enzymes widely studied for their unique 
characteristics. They are monomeric glycoproteins with a molecular weight of 
approximately 40-50 kDa and are exclusively expressed in white-rot fungi 83. VP possess 
the ability to oxidize an extensive range of substrates while sharing structural and 
catalytic characteristics with LiPs and MnPs. Often referred to as ‘hybrid’ peroxidases, 
VPs are able to oxidize high-potential non-phenolic compounds like LiPs (Mn2+-
independent), but also are able to catalyze Mn2+-mediated oxidations like MnPs. This 
catalytic versatility, together with no requirement for redox mediators, represents an 
attractive feature for oxidation of a variety of phenolic and non-phenolic aromatic 
compounds (including lignin). The catalytic cycle of VPs (Fig. 1.9) is initiated by binding 
of hydrogen peroxide to the ferric state of the heme, forming compound I, an oxo-
porphyrin-radical (Fe4+= O•) with significant oxidizing ability. Compound I is reduced to 
compound II, either via one-electron from a substrate/mediator or through a 
monochelated Mn2+, that acts as one-electron donor and is oxidized to Mn3+. The 
reduction of compound II continues in a comparable fashion either by another 
substrate/mediator molecule or by reduction of Mn2+ to Mn3+, re-forming the native state 






Fig. 1.9: Catalytic mechanism of versatile peroxidases via oxidation of a non-phenolic substrate veratryl 
alcohol (VA, green) forming free radicals (red) following the orange route (analog to LiPs mechanism), or via 
oxidation of Mn2+ (green) to Mn3+ (red) following the blue route (in analogy to the MnP mechanism). 
 
VPs contain four conserved disulfide bridges, two structural Ca2+ sites, a heme pocket 
and a Mn2+-binding site 84,85. A high redox potential and the presence of different catalytic 
sites connected to the heme pocket are responsible for the promiscuity of these 
enzymes.  
 
1.5.4 Dye-decolourizing peroxidases (DyP, EC 1.11.1.19) 
The most recent group of heme peroxidases catalyzing H2O2-dependent oxidation of 
various molecules is named according to its unique ability to oxidize synthetic high-redox 
potential dyes of the anthraquinone type 86,87. Among others, DyPs demonstrated 
oxidization of 2,2-azino-bis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), 
carotenoids, phenolic (DMP, guaiacol) and non-phenolic (VA) lignin models 88. DyPs are 
mostly present in bacteria (actinobacteria and proteobacteria), but have been reported 
in fungi and higher eukaryotes as well 89. Compared to the previously described lignin-
modifying enzymes, DyPs show no structural homology to classic fungal heme 
peroxidases (LiP, MnP and VP). On the other hand, their reaction scope is similar to the 
typical peroxidases, LiPs, MnPs, and VPs, as they promote lignin degradation with the 
help of redox mediators. The catalytic mechanism of DyPs is suggested to be similar to 
that of LiPs including the resting state as well as transient compound I and compound II. 
The catalytic process typically requires two single-electron oxidations. In the first step, a 
resting ferric enzyme reacts with hydrogen peroxide forming the oxo-porphyrin-radical 




II (Fe4+= O, oxo-porphyrin-intermediate). Compound II undergoes a second reduction by 
one electron to restore the resting state of the peroxidase. In contrast to other heme 
peroxidases, our knowledge on the DyP mechanism is still limited 90. Structurally, DyPs 
are rather different from the other peroxidases. Instead of distal histidine typical for most 
of the peroxidase, DyPs use an aspartame in their active site as acid-base catalyst. From 
the analyzed DyPs, it has been shown that they consist of two domains, each containing 
a ferredoxin-like fold built by predominantly antiparallel β-sheets 89,91,92, which is different 
from the α-helical fold of the other peroxidases. Heterologous expression of the DyPs 
from bacteria is commonly performed in E. coli cells, and the ability of DyPs to oxidize 
not only high redox substrates but also synthetic dyes represents a huge potential in 
biotechnological application of waste water treatment 93. 
 
1.5.6 Glutathione S-transferases (GST; EC 2.5.1.18) 
GSTs form a protein superfamily that plays an important role in cell detoxification. A 
shared character of all GSTs is their ability to catalyze conjugation of the tripeptide 
glutathione (GSH) to a wide range of hydrophobic substrates, and thus boost their 
excretion from cells. In nature, GSTs have been found in both eukaryotes and 
prokaryotes, and have been divided into four main families: cytosolic GSTs, 
mitochondrial GSTs, microsomal GSTs and bacterial fosfomycin-resistance proteins 94. 
Each of the families have their classification system into classes named after greek 
letters. The amino acid sequences of the GST superfamily are extremely diverse and a 
large part of the sequences available in protein databases have not yet specified 
functions 94. Structurally, GSTs often function as dimers; each monomer consists of a 
conserved N-terminal thioredoxin domain containing the GSH-binding site together with 
a more versatile C-terminal α-helical domain containing the binding site for the GSH 
acceptor. 
 
1.5.6.1 GSH-dependent lignin degradation pathway 
In 1989, Masai et al. 95 discovered an enzyme that was able to catalyze reductive 
cleavage of the β-O-4 aryl ether bond in lignin model compounds with a different 
mechanism when compared to the previously mentioned LiPs, MnPs, VPs, DyPs and 
laccases. Whereas these enzymes use an oxidative and non-selective radical-based 
mechanism when degrading lignin, the glutathione-dependent lignin degradation 
pathway is highly selective and follows a non-radical mechanism 96. The first detailed 
studies on the GSH-dependent lignin degradation pathway were described for the 




three consecutive steps catalyzed by three sets of proteins. The first step of the cascade 
is represented by an NAD+-dependent oxidation of the alcohol group at α carbon of the 
lignin substrate, forming the corresponding keto group. It involves four alcohol 
dehydrogenases, namely LigD, LigO, LigL, and LigN, which bear defined 
stereopreferences for the configuration at the α carbon atom of the lignin model 
substrate. While LigD and LigO display (R)-stereopreference, LigL and LigN possess 
affinity towards the opposite enantiomer, and exhibit (S)-stereopreference 101,102. The 
produced ketone-intermediate is subsequently exposed to β-O-4 aryl ether cleavage 
catalyzed by highly enantioselective GSH-dependent β-etherases following an SN2-type 
mechanism with inversion of stereoconfiguration at the β carbon 103,104. From the three 
β-etherases that were described in Sphingobium sp.SYK-6, two, LigE and LigP, perform 
cleavage of ether bonds in substrates with (R)-configured β carbon, while the third, LigF, 
converts the corresponding (S)-enantiomers. The formed products, chiral glutathione 
adducts, are subsequently converted by GSH-dependent glutathione lyases catalyzing 
thioether cleavage and forming oxidized glutathione (GSSG) 104,105. The complete 
outcome is a reductive cleavage of the β-O-4 aryl ether bond. Only one glutathione lyase, 
LigG, exhibiting high enantioselectivity for conversion of the (R)-configured thioether 103 
was originally identified in Sphingobium sp. SYK-6, though low activity towards the 
corresponding (S)-enantiomer was described 105.  
 
 
Fig. 1.10: Biochemical pathway of Sphingobium sp. SYK-6 for β-O-4 aryl ether cleavage [GVL: β-guaiacyl-
α-veratrylglycerol, GVG: β- guaiacyl-α-veratrylglycerone, GS-VG: β-glutathionyl-α-veratrylglycerone, VG: β-
deoxy-α-veratrylglycerone, GSH: reduced glutathione, GSSG: oxidized glutathione]. 
 
Alcohol dehydrogenases, β-etherases, and glutathione lyases in Sphingobium sp. SYK-
6 are all intracellular enzymes, which means that they probably do not pursue polymeric 




the only β-etherase that is secreted extracellularly and is GSH-independent has been 
described in an ascomycete of the genus Chaetomium 106. In recent years, significant 
focus was given on the discovery of the new β-etherases and glutathione lyases in public 
databases. A variety of β-etherases was found and described in Sphingobium or 
Novosphingobium species 105,107–110 while recently, novel β-etherases from Erythrobacter 
and Altererythrobacter species were identified and characterized 111. 
As previously described, heterogeneity, hydrophobicity and complex structure of lignin 
make its use and analysis in chemical or biochemical experiments rather challenging. 
Due to these issues, various lignin model compounds, oligomers with a defined structure, 
were developed. The benefit of these molecules is not only their representation of 
specific bonds found in lignin, but also more straightforward analysis with standard 
analytical methods. Since the β-O-4 aryl ether linkage is the most abundant bond in 
native lignin, many model compounds representing this link have been described and 






Fig. 1.11: Lignin-like model compounds commonly used to mimic the β-O-4 aryl ether bond found in lignin. 
[GGE: guaiacylglycerol-β-guaiacyl ether 110; MPHPV: (2-methoxyphenoxy) hydroxypropiovanillone 108; GVG: 
β-guaiacyl-α-veratrylglycerone 110; 2,6-MP-VG: β-(2,6-methoxyphenoxy)-α-veratrylglycerone 110; 3,5-MP-
VG: β-(3,5-methoxyphenoxy)-α- veratrylglycerone 110; GβG: guaiacyl-β-guaiacyl ether 107; GβS: guaiacyl-β-
syringyl ether 107; SβG: syringyl-β-guaiacyl ether 107; SβS: syringyl-β-syringyl ether 107; FPHPV: β-(1-formyl-
3- methoxyphenoxy)-γ-hydroxypropioveratrone 112; GVE: β-guaiacyl-α-veratrylethanone 110; MUAV: α-O-(β-




From all of the above-mentioned enzymes responsible for the GSH-dependent lignin 
degradation pathway, β-etherases have been studied the most. Besides the enzymes 
from Sphingobium sp. SYK-6, further bacterial, GSH-dependent etherases have been 
identified and biochemically characterized. Despite originating mostly from bacteria of 
the genus Novosphingobium, sequence similarities vary significantly. Sequence 
identities among LigE-type β-etherases vary between 56 % and 85 %, whereas LigF-
type homologs share between 36 % and 96 % sequence identity, though the LigF 
homologs, based on the phylogenetic analyses, are split into two related but distinct 
subclades 109,111. The special type of heterodimeric β-etherases was described in N. 
aromaticivorans, Novosphingobium sp. PP1Y and Sphingobium xenophagum by Kontur 
et al. 109 with sequence identities varying between 52 % and 74 %. On the other hand, 




recently been described in Erythrobacter, Altererythrobacter and gammaproteobacteria 
with sequence identities among LigE- and LigF-type enzymes of 53 % and 54 %, 
respectively 111. All studied β-etherases convert their substrates with absolute 
stereospecificity 107,108,110. While all LigE-type homologs exhibit the same (R)-selectivity 
as LigE, all characterized members of the LigF subtype exhibit strict (S)-selectivity. The 
heterodimeric β-etherases, found in N. aromaticivorans, Novo sp. PP1Y and 
Sphingobium xenophagum, contrarily display stereoselectivity as the LigE-type 
homologs, even though their sequences suggest they are phylogenetically related to 
LigF-type enzymes 109. Despite the fact that LigE- and LigF-type enzymes exhibit 
complementary stereoselectivities, their biochemical properties are rather similar. All 
described β-etherases possess pH optima in the alkaline pH range which supports 
deprotonation of the glutathione thiolate (pKa 9,65) for nucleophilic attack on the β 
carbon of the substrate. Yet, some β-etherases are able to retain their activity down to 
pH 5 110. The temperature optimum of β-etherases is usually around 20 to 30 °C, with 
some enzymes displaying a temperature optimum of even 40 °C 108. Some were even 
able to retain activity at temperatures up to 60 °C 110, which together with their 
stereoselectivity gives them potential for practical applications in the kinetic resolution of 
desired chemicals 113 or lignin depolymerization within biorefineries. Crystal structures of 
β-etherases from Sphingobium sp. SYK-6, namely LigE and LigF were solved, which 
allows for a deeper understanding and characterization of the enzymes 112. LigE and 
LigF, like other members of glutathione S-transferases, carry a N-terminal thioredoxin 
domain, consisting of four β strains and three α helices, connected via a small linker to 
the C-terminal helical domain. The position of the active site is located in between these 
domains, and while the active site of LigE forms a surface-exposed cleft, the active site 






Fig. 1.12: Crystal structure of β-etherases LigE (A: dimer, B: monomer) and LigF (C: dimer, D: monomer). 
The co-crystallized cofactor GSH is visualized as green sticks and balls while the thioredoxin domain is 
shown in red and the helical domain is shown in blue. 
 
The dimer interface of LigE is only formed by the C-terminal helical domain, whereas 
both thioredoxin and the helical domain contribute to the dimer formation in LigF. These 
structural differences are in agreement with the different classes of the GST superfamily 
they belong to. LigE belongs to the GSTFuA class, whereas classification of LigF is not 
yet clear due to its unique dimer interface 112,114. Based on the crystal structures of β-
etherases LigE and LigF with cofactor GSH bound to their active sites, it was possible to 
target potential amino acid residues important for catalysis. In both cases, a conserved 
serine residue (Ser21 in LigE and Ser13 in LigF) seems to play a role in catalysis since 
a major decrease in activity is observed when the residues are mutated 112. Recently 
described heterodimeric β-etherases named BaeAB, suggest the importance of the 
Asn12 residue for the GSH activation necessary for the catalysis 115. Based on the 
computational analysis of the LigF by Prates et al. 116, both hydrogen bonding residues, 





1.5.6.3 Glutathione lyases 
The last reaction step of the GSH-dependent lignin degradation pathway is performed 
by glutathione lyases. The further investigations showed that all β-etherase-containing 
strains also possess one or more glutathione lyases 105,109, suggesting that these 
enzymes usually work in close cooperation. Glutathione lyases catalyze the elimination 
of glutathione from the conjugate generated by the action of the β-etherases and thus 
allowing complete oxidation of the glutathione and the release of the final product. The 
only exception so far is represented by the glutathione lyase from the proteobacterium 
Thiobacillus denitrificans. Analysis of the genome of T. denitrificans revealed no 
presence of β-etherases genes, raising questions about the natural function of LigG-TD 
105. Interestingly, neither of the studied glutathione lyases displays absolute 
stereospecificity but rather a stereopreference, indicating the ability of glutathione lyases 
to convert both enantiomeric forms of the glutathione adduct, although conversion of one 
of the two enantiomers is always preferred 105,108. So far, two glutathione lyases have 
been successfully crystalized, LigG from Sphingobium sp. SYK-6 117,118 and NaGSTNu 
from Novosphingobium aromaticivorans 109. Both, as members of the GST superfamily, 
possess a N-teminal thioredoxin domain and C-terminal helical domain. Regardless of 
their similar function, the enzymes are rather different structurally. LigG belongs to the 
Omega class of GSTs and exhibits a clear (R)-preference while NaGSTNu belongs to the 
Nu-class, which is less selective with slight (S)-preference 105,108,109. In the structure of 
LigG, the active site forms a surface-exposed cleft, while the active site of NaGSTNu is 
located in a tunnel-like structure (Fig. 1.13). Interestingly, these structural properties 
together with the stereopreferences correspond to the respective characteristics of 
described β-etherases; LigG as well as LigE possess a surface-exposed active site and 
show (R)-selectivity/preference while both NaGSTNu and LigF contain the active site in a 
tunnel-like structure with an obvious (S)-selectivity/preference. This suggests that the 
shape of the active site plays a role in binding/accommodating the respective substrate 






Fig. 1.13: Crystal structures of glutathione lyases LigG, co-crystallized with GSH (A: dimer, B: monomer), 
and NaGSTNu, co-crystalled with GSH (C: dimer, D: monomer). The co-crystallized cofactor GSH is 
visualized as green sticks and balls, while the thioredoxin domain is shown in red and the helical domain is 
shown in blue. 
 
The crystal structure of LigG in complex with the substrate analog β-glutathionyl-
acetoveratrone (GS-AV) was determined and analyzed by Pereira et al. 118. Structural 
analysis of the positioning of GS-AV in the enzyme’s active site allowed identification of 
amino acid residues important for catalysis. The position of the aromatic Tyr113 is 
important for interaction with the aromatic ring of the substrate as mutagenesis of this 
residue resulted in a drastic loss of activity. Based on the crystal structure, Pereira et al. 
118 postulated a two-step mechanism for LigG catalysis. In the first step, the substrate 
analog, β-glutathionyl-acetoveratrone (GS-AV) is bound to the enzyme assisted by the 
interaction with Tyr113. The residue Cys15 simultaneously performs a nucleophilic 
attack on the carbon of the thioether bond of the substrate, resulting in formation of an 
enzyme-glutathione intermediate (via formation of a disulfide bridge) and release of the 
monolignan acetoveratrone (AV). In the second step, free GSH enters the active site and 
cleaves the enzyme-glutathione intermediate with formation and release of GSSG, 




A different, single step mechanism was proposed by Kontur et al. 109 for Nu class 
glutathione lyases, such as NaGSTNu from N. aromaticivorans. Based on the crystal 
structure of NaGSTNu, it was postulated that the substrate β-glutathionyl-
hydroxypropiovanillone (GS-HPV) and GSH bind to the enzyme at the same time. The 
thiol group of GSH is activated by hydrogen bonds with Thr51 and Asn53 (part of the 
Thr-Pro-Asn motif conserved within Nu class GSTs) and nucleophilically attacks the 
thioether-carbon of the substrate to form GSSG, while hydroxypropiovanillone HPV is 
released.  
 
1.5.6.4 Application of β-etherases and glutathione lyases in lignin 
depolymerization 
β-Etherases and glutathione lyases are primarily characterized on lignin model 
structures, which allows a deeper understanding of the enzymes’ characteristics. For 
possible industrial applications, however, natural, polymeric lignin is the desired starting 
material for the production of aromatic monomers. As discussed previously, the pre-
treatment method by which the lignin is isolated has a serious impact on the distribution 
of carbon-carbon and carbon-oxygen bonds and hence, the efficiency of lignin 
depolymerization along with the type of released aromatics. 
A first report for an in vitro biocascade combining LigD (Cα dehydrogenase), LigF (β-
etherase) and LigG (glutathione lyase) from Sphingobium sp. SYK-6 for 
depolymerization of kraft lignin was described by Reiter et al. 119. Combination of these 
enzymes in a one-pot reaction, together with the NADH-dependent glutathione 
reductase from Allochromatium vinosum (AvGR) for efficient NAD and GSH regeneration 
(Fig. 1.14), resulted in very low yields (~2 wt %) of different aromatics, mostly vanillin. 
The reason for this low efficiency may be a low residual content of the aryl ether linkages 
in reprocessed kraft lignin as well as the fact that the employed enzymes, due to their 
stereospecificity, were only able to cleave the (αR βS)-configured β-O-4 aryl ether bonds, 







Fig. 1.14: Enzyme cascade for β-O-4 aryl ether bond cleavage. [LigD: Cα dehydrogenase, LigF: β-etherase, 
and LigG: glutathione lyase (all from Sphingobium sp. SYK-6), AvGR: glutathione reductase from A. 
vinosum]. Adapted from Reiter et al. 119. 
 
This obstacle was overcome by Ohta et al. 120 when respective enzymes from 
Novosphingobium sp. MBES04 were combined, namely two stereocomplementary Cα-
dehydrogenases (SDR3 and SDR5), two β-etherases with opposite stereoselectivity 
(GST4 and GST5) and a glutathione lyase (GST3) with a relatively low stereoselectivity. 
Depolymerization of milled wood lignin (MWL) from either softwood or hardwood sources 
using those enzymes in a one-pot system resulted in improved product yields (up to 6,6 
wt %) of mostly guaiacyl-hydroxypropanone (GHP) and syringyl-hydroxypropanone 
(SHP) 120. Improvement of the monomeric product yield may be explained by 
enantiocomplementary enzymes used in the process as well as by the structural 
properties of the milled wood lignin, which is reported to possess a lower degree of 
polymerization and facilitates easier substrate access to the enzyme’s active site121.  
A very similar one-pot lignin depolymerization was performed by Gall et al. 27, applying 
LigD and LigN (enantiocomplementary Cα-dehydrogenases from Sphingobium sp. SYK-
6), LigE and LigF (enantiocomplementary β-etherases from Sphingobium sp. SYK-6), 
the less selective glutathione lyase NaGSTNu from N. aromaticivorans and the 
glutathione reductase AvGR from A. vinosum. The mentioned cascade was tested to 
depolymerize a hybrid poplar (HP) lignin (enriched in syringyl units) as well as the 




fractions of lignin were exposed to the enzymatic conversion. For lignin with an average 
MW of 1390 the highest monomeric product yield of up to 12.5 wt % was obtained, which 
was mostly composed of GHP and SHP 27. The yield of retrieved monomeric products 
decreased with increasing size of the lignin oligomer, which can be explained by a lower 
solubility of the higher MW lignin fractions and the dimensional difficulties of the substrate 
to access the enzyme s’ active sites.  
Recently, a different approach was described by Picart et al. 122 in order to achieve 
oxidation of the α-hydroxyl groups in β-O-4 aryl ether linkages of lignin, which is 
necessary for subsequent cleavage of the ether bonds by β-etherase activity. Instead of 
stereocomplementary Cα dehydrogenases, a laccase-mediator system (LMS) was used. 
After unselective and cofactor-independent lignin oxidation by laccase lcc2 M3 from T. 
versicolor and violuric acid as mediator, cleavage of the β-O-4 aryl ether bonds was 
performed by β-etherases LigE from Sphingobium sp. SYK-6 and LigF-NA from N. 
aromaticivorans, along with glutathione lyase LigG-TD from T. denitrificans for 
glutathione removal. Using beech wood OrganoCat®  lignin as a substrate, 12.5 wt % of 
a soluble lignin oil consisting of various low-molecular weight aromatics, particularly 
vanillin and coniferyaldehyde, was obtained. Due to the different required reaction 
conditions of laccase and GSH-dependent enzymes, this process was performed as a 
two-pot cascade with lignin oxidation as the first step followed by ether bond cleavage 
as the second step. A brief summary of all described lignin depolymerization strategies 





Fig. 1.15: Summary of enzymatic lignin depolymerization using β-etherases and glutathione lyases. 
 
1.6 Protein engineering 
Native enzymes are naturally optimized to catalyze chemical reactions within living 
organisms, which defines their optimal conditions. Mostly aqueous environment, neutral 




may often represent obstacles in practical and industrial use. Therefore, most of the 
times, properties of native enzymes, such as activity, thermostability, selectivity, 
substrate concentration tolerance and solvent tolerance need to be adapted to fit the 
desired reaction conditions of a biocatalytic process. The structure and function of an 
enzyme are encoded in its amino acid sequence and therefore, modification of the 
sequence can lead to improved enzyme characteristics. Several methods have been 
described so far to effectively introduce mutations into the DNA sequence of an enzyme 
with the goal of developing improved enzyme variants suitable for industrial 
requirements. The DNA sequence of an enzyme can be exposed to several rounds of ‘in 
vitro’ evolution until the desired characteristic is met. There are two main strategies of 
enzyme engineering: directed evolution and rational design. 
 
1.6.1 Random mutagenesis and directed evolution 
The definition of random mutagenesis lies in its name. Mutations are introduced into the 
DNA sequence (exchange of nucleotides) which can result in amino acid exchanges. 
When introducing random mutations into an enzyme-encoding gene, a mutant library is 
obtained that needs to be screened for the enzyme property of interest. Performing 
sequential cycles of random mutagenesis, in which the best enzyme variant from one 
cycle is taken as a template for the following cycle, is called directed evolution (Fig. 1.16). 
The pioneer of directed evolution, Francis Arnold (Nobel Laureate in 2018), was able to 
use only three rounds of random mutagenesis on the protease subtilisin E to remarkably 
improve its ability to function in a high concentration of DMF compared to the wild type 
enzyme 123. Currently, several methods of directed evolution are commonly used: error-
prone PCR, mutator strains or gene shuffling are just a few. The most popular technique 
is the error-prone PCR, which uses polymerases with a fairly high error rate (up to 2 %) 
together with unequal nucleotide concentrations and addition of manganese ions to 
increase the error rate of amplification of the wild-type sequence 124. Among the biggest 
advantages of directed evolution is the ability to introduce mutations without deeper 
knowledge of the structure or mechanism of the enzyme of interest as well as the ability 
to run multiple sequential mutagenesis and screening cycles until the targeted enzyme 
improvement is met. On the other hand, a major obstacle of this method is the need for 
a fast, sensitive and reliable screening assay to identify improved mutants before the 






Fig. 1.16: General representation of directed evolution using high-throughput screening. 1: Random 
mutations are introduced to the whole gene or a gene fragment. 2: A bacterial cell is transformed with the 
mutated DNA. 3: Cell culture is grown on solid media, where individual cells (individual mutants) can be 
separated. 4: Screening of the generated mutant library to identify improved variants. 5: Improved variants 
are isolated and analyzed. 6: Selected mutants are characterized for desired properties. If an optimal mutant 
has been obtained, the enzyme evolution is finished and the process is completed (7). If not, the best variants 
of the previous mutagenesis round are used as a template for the next round, starting with random 
mutagenesis again (1), until the goal is met. 
 
1.6.2 Rational design and semi-rational design 
Contrary to directed evolution, rational design requires structural information about the 
enzyme to be engineered as well as detailed knowledge on its function and mechanism 
to ensure satisfactory results. In recent years, increased knowledge of protein structures 
due to protein NMR or X-ray crystallography made the rational design approach more 
and more popular among scientist. Together with computational analyses to predict the 
properties of each amino acid residue in the enzyme, it is possible to “spot” the residue 
or set of residues that may be important for an enzyme’s thermostability, substrate 
specificity or enantioselectivity 126. This approach represents an efficiency improvement, 
as only few mutants are generated by rational design, and no screening method is 




site directed mutagenesis, such as QuikChange or the Q5 protocol. 
However, even with structural insights for an , it is difficult to predict the effect of an amino 
acid exchange with absolute certainty. Therefore, to overcome this problem a hybrid 
concept between rational design and random mutagenesis, called semi-rational design, 
has been developed. In this concept, one or more specific residues are targeted and 
randomly replaced by all (or multiple) amino acids. Although the choice of the position 
remains rational, the choice of the amino acids to be inserted is rather random. Site-
saturation mutagenesis (SSM) represents one of the semi-rational approaches. In SSM, 
mutations are introduced into the DNA by using specific degenerated codons. Use of the 
degenerated “NNN” codon (N can be represented by all four nucleotides: A, T, G, and 
C) will allow for all 64 codons, and implements all 20 amino acids on this position. 
However, in this setting the screening of 192 random variants (4x4x4x3: four different 
nucleotides, three different positions in the codon, and an oversampling factor of three) 
is required to achieve 95 % theoretical library coverage 127. The number of random 
mutants necessary to be screened increases dramatically if two residues are mutated at 
the same time (12 288 mutants). Therefore, smart libraries have been developed taking 
advantage of the repetition of the genetic code. By changing the degenerated codon to 
“NNS” (S coding for G or C) the number of codons is reduced to 32 while still covering 
all 20 amino acid residues. With this alteration, the number of random mutants to be 
screened decreases to 96 (4x4x2x3) for one mutated residue 125. This concept of smart 
libraries was further advanced by using the “NDT” codon (D coding for A, G, or T), where 
the number of possible codons is reduced to 12 and the number of random mutants to 
be screened is reduced to only 36 (4x3x1x3) with a single mutated residue 128. With this 
approach, however, “only” 12 different amino acids, containing representatives of 
aromatic, aliphatic, non-polar, polar, negatively and positively charged amino acid 
residues, are allowed on the selected position. On the other hand, it allows multiple 
residues to be mutated at the same time while keeping the number of mutants to be 
screened comparably low. 
Semi-rational design accelerates the process of laboratory evolution of an enzyme and 
provides more in-depth characterization of the mutated position. In this matter, various 
smart library strategies to improve the enzyme’s efficiency, substrate acceptance, 
enantioselectivity, or thermostability have been described 127–129. 
Every protein engineering approach has its benefits and its requirements. While random 
mutagenesis requires a quick and efficient screening method, the improvement of 
enzyme properties can be achieved even without structural knowledge of the enzyme. 




and functional understanding of the enzyme, but put significantly less effort on the 






1.7 Aim of the project 
The main focus of this thesis was a thorough investigation of β-etherases and glutathione 
lyases for efficient cleavage of β-O-4 aryl ether bonds to expand our knowledge on these 
enzymes for future practical applications.  
As one of the drawbacks of these enzymes for practical application is their dependency 
on the relatively expensive cofactor glutathione, one aim of this thesis was to explore the 
possibility of intracellular provision and regeneration of glutathione by the E. coli 
metabolism. Since glutathione is produced as antioxidative agent by living cells, we 
wanted to investigate whether this can be utilized to supply the required glutathione 
cofactor for efficient intracellular β-O-4-aryl-ether-bond cleave in a lignin model substrate 
catalyzed by β-etherases and glutathione lyases. This concept was further applied to the 
kinetic resolution of a lignin model substrate on semi-preparative scale in order to afford 
enantiopure compounds.  
Despite the fact that β-etherases are known for more than 30 years now, their catalytic 
mechanism has not been fully resolved yet. Based on the knowledge gained over the 
years, it is assumed that they follow an SN2-like mechanism. In order to expand our 
knowledge on the catalytic mechanism of β-etherases, the second aim of this thesis was 
to study the impact of active site residues on LigE and LigF catalysis. This was 
approached by mutational studies of both enzymes, based on the previously published 
crystal structures, in combination with kinetic measurements. 
Moreover, a third aim of this thesis was to investigate the potential ability of β-etherases 
to cleave also aryl ether bonds in non lignin-related substrates, which would significantly 
expand their biocatalytic applicability beyond lignin depolymerization. 
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All chemicals were of analytical grade or higher and were purchased from either Sigma-
Aldrich Chemie (Steinheim, Germany), VWR Chemicals (Darmstadt, Germany), Thermo 
Fisher Scientific (Waltham, USA), AppliChem (Darmstadt, Germany), Alfa Aesar 
(Karlsruhe, Germany), Acros Organics (Geel, Belgium) or Carl Roth (Karlsruhe, 
Germany) unless stated otherwise.  
 
2.1.2 Equipment, software and kits 
 
Tab. 2.1: Equipment used in this study. 
Equipment Supplier 
Chromatography systems 
ÄKTA Pure protein purification system GE Healthcare Bio-Science (Pittsburgh, USA) 
ÄKTA Start protein purification system GE Healthcare Bio-Science (Pittsburgh, USA) 
HisTrapTM FF column Agilent Technologies, Inc (Santa Clara, USA) 
HisTrapTM HF column Agilent Technologies, Inc (Santa Clara, USA) 
Nexera XR HPLC System 
- LC-20AD XR 
- Sil-20 AC XR 
- SPD-M20A 
- CTO-20 AC 
- CBM-20A 
Shimadzu Deutschland GmbH (Duisburg, DE) 
Nucleosil® 100-5 C18 column (4.6 x 250 mm) Macherey-Nagel (Düren, DE) 
Chiralcel OD-RH column (4.6 × 150 mm) Daicel Corporation (Illkirch, FR) 
UV-Vis analytic systems 
CARY 60 Bio UV-Vis Agilent Technologies, Inc (Santa Clara, USA) 
CLARIOstar microtiter plate reader BMG LABTECH GmbH (Ortenberg, DE) 
NanoPhotometer NP80 Implen (Munich, DE) 
Centrifuge 
Heraeus Fresco 21 microcentrifuge Thermo Fisher Scientific (Waltham, USA) 
Heraeus Multifuge X3R centrifuge Thermo Fisher Scientific (Waltham, USA) 
Mega Star 3.0 R centrifuge VWR (Radnor, USA) 
Micro Star 17 centrifuge VWR (Radnor, USA) 
Incubator 
INCU-Line Incubator VWR (Radnor, USA) 
MaxQ 8000 shaker Thermo Fisher Scientific (Waltham, USA) 
Minitron Infors HT Infors AG (Bottmingen, CH) 
ThermoMixer C Eppendorf AH (Hamburg, DE) 
VWR Incubating microplate shaker VWR (Radnor, USA) 
Electrophoresis 
FastGene blue/green GelPic LED Box NIPPON Genetics Europe (Düren, DE) 
Mini PROTEAN SDS-PAGE system Biorad (Hercules, USA-CA) 
Owl EasyCast B1A Mini Gel-electrophoresis systems Thermo Fisher Scientific (Waltham, USA) 
MS 300V power supply Major Science (Saratoga, USA) 




Entris 224i-1S precision balances Sartorius AG (Göttingen, DE) 
Entris 3202i-1S precision balances Sartorius AG (Göttingen, DE) 
PCR devices 
PeqSTAR thermocycler VWR (Radnor, USA) 
Vacuum systems 
Rotavapor® R-300 BÜCHI Labortechnik Gmbh (Essen, DE) 
RZ6 high vacuum pump Vacuubrand (Wertheim, DE) 
Other devices 
Arium® pro ultrapure water system Sartorius AG (Göttingen, DE) 
Eppendorf Research® plus pipettes Eppendorf AH (Hamburg, DE) 
Fisherbrand™Model 120 Sonic dismembrator Thermo Fisher Scientific (Waltham, USA) 
Sonorex Digitec BANDELIN electronic Gmbh & Co. KG (Berlin, DE) 
Vortex-Genie2 Scientific Industries Inc (Bohemia, USA) 
Analytical devices used in cooperation 
Bruker Avance AVII 600 NMR spectrometer Bruker Corporation (Billerica, USA) 
LC MS 
- UHPLC system Ultimate3000RS 
- Kinetex C18 column (1,7µm 100A, 150x2,1mm) 
- Maxis HD UHR-TOF 
- Apollo II Elektrospray source 
 
Thermo Fisher Scientific (Waltham, USA) 
Phenomenex (Torrance, USA-CS) 
Bruker Corporation (Billerica, USA-MA) 
Bruker Corporation (Billerica, USA-MA) 
MCS-ITC calorimeter MicroCal (Northampton, USA) 
Propol Digital Automatic Polarimeter Dr. Kernchen (Seelze, DE) 
 
Tab. 2.2: Software used in this study. 
Software Supplier 
BioEdit 7.2 Tom Hall, Ibis Therapeutics (Carlsbad, USA) 
BLASTP NCBI (North Bethesda, USA) 
ChemDraw Professional 16.0 Perkin Elmer (Waltham, USA) 
Clone Manager 9.1 Scientific & Educational Software (Westminster, USA) 
LabSolution 5.51 Shimadzu Deutschland GmbH (Duisburg, DE) 
MestRenova LITE  Mestrelab Research, S.L. (Santiago de Compostela, ES) 
MS Office  Microsoft Corporation ® (Redmond, USA) 
OriginPro 2019b 9.65 OriginLab Corporation (Northampton, USA) 
TopSpin 4.0.3 Bruker BioSpin GmbH (Ettlingen, DE) 
UNICORN 5.31 GE Healthcare Bio-Science (Pittsburgh, USA) 
Yasara YASARA Biosciences GmbH (Vienna, AT) 
 
Tab. 2.3: Kits used in this study. 
Kit Supplier 
NucleoSpin® Gel and PCR Clean-up Kit Macherey-Nagel (Düren, DE) 
NucleoSpin® Plasmid Purification Kit Macherey-Nagel (Düren, DE) 
QIAquick® Gel Extraction Kit Quiagen (Hilden, DE) 
E.Z.N.A.® Plasmid Mini Kit I Omega Bio-tek, Inc. (Norcross, USA) 
E.Z.N.A.® MicroElute DNA CleanUp Kit Omega Bio-tek, Inc. (Norcross, USA) 
E.Z.N.A.® MicroElute Gel Extraction Kit Omega Bio-tek, Inc. (Norcross, USA) 
B-PER™ Bacterial Protein Extraction Reagent Thermo Fisher Scientific (Waltham, USA) 
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2.1.3 Bacterial strains, plasmids and oligonucleotides 
 
Tab. 2.4: Bacterial strains used in this study. 
Strain Characterization Supplier 
E. coli DH5α F- Φ80lacZΔM15 Δ(lacZYA-argF)U169 recA1 
endA1 hsdR17(rk
-, mk
+) phoA supE44 thi-1 
gyrA96 relA1 λ- 
Thermo Fisher Scientific (Waltham, USA) 
E. coli BL21 (DE3) F- ompT hsdSB (rB
-, mB
-) gal dcm (DE3) Thermo Fisher Scientific (Waltham, USA) 
E. coli BL21 Gold (DE3) F- ompT hsdSB (rB
-, mB
-) gal dcm+ Tetr λ(DE3) 
endA Hte 
Agilent Technologies (Santa Clara, USA) 
E. coli C43 (DE3) F- ompT hsdSB (rB
-, mB
-) gal dcm (DE3) Lucigen Corporation (Middleton, USA) 
 
Escherichia coli DH5α was used for general cloning and plasmid DNA isolation, while E. 
coli BL21 (DE3), E. coli BL21 Gold (DE3) and E. coli C43 (DE3) were used for expression 
of the enzymes and the whole-cell biocatalytic reactions.  
 
2.1.3.1 Strain constructs of the whole-cell experiments 
The genes encoding LigF-NA, LigE and LigG-TD were previously cloned into vector pET-
28a(+). To combine both etherase-encoding genes on a pETDuet-1 vector, the ligE gene 
was amplified by PCR using forward primer pET28a_NdeI_to_NcoI_fwd to introduce a 
NcoI restriction site and reverse primer pET28a_universal_rev (see Tab. 2.6). The 
resulting PCR product was digested with restriction enzymes NcoI and HindIII. The gene 
encoding LigF-NA was amplified by PCR using pET28a_universal_fwd and 
pET28a_universal_rev primers (Tab. 2.6) and the resulting PCR product was digested 
with NdeI and XhoI. Empty pETDuet-1 vector was first cut using restriction enzymes NcoI 
and HindIII, and the digested PCR product harboring the ligE gene was ligated into the 
first multiple cloning site (MCS). The resulting vector pETDuet-1_ligE was confirmed by 
sequencing. In a second step, vector pETDuet-1_ligE was digested with NdeI and XhoI 
and the digested PCR product harboring the LigF-NA gene was ligated into the second 
multiple cloning site. The resulting vector pETDuet-1_ligE_ligF-NA was again confirmed 
by sequencing. Furthermore, the gene encoding LigG-TD was amplified by PCR using 
pET28a_universal_fwd and pET28a_universal_rev primers (Tab. 2.6). The resulting 
PCR product was digested with NdeI and HindIII and ligated into empty pIT2 vector, 
which was cut with the same restriction enzymes. The resulting vector pIT2_ligG-TD was 
confirmed by sequencing. For co-expression of both -etherases and the glutathione 
lyase, chemically competent E. coli BL21 (DE3) and E. coli C43 (DE3) strains were 
transformed with pETDuet-1_ligE_ligF-NA and pIT2_ligG-TD, resulting in strains E. coli 
BL21 (DE3) (pETDuet-1_ligE_ ligF-NA) (pIT2_ligG-TD) and E. coli C43 (DE3) (pETDuet-
1_ligE_ ligF-NA) (pIT2_ligG-TD). 
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For co-expression of only one etherase and the glutathione lyase in E. coli, vector 
pIT2_ligG-TD together with pET-28a(+)_ligE or pET-28a(+)_ligF-NA was introduced into 
chemically competent E.coli C43 (DE3) cells, resulting in E.coli C43 (DE3) 
(pET28a(+)_ligE) (pIT2_ligG-TD) and E.coli C43 (DE3) (pET28a(+)_ligF-NA) (pIT2_ligG-
TD) strains.  
 
Tab. 2.5: Plasmids used in this study. 
Plasmid Characterization Antibiotic resistance 
(working concentration *)  
Source 
pET-28a(+) T7 promoter, T7 terminator,  
lacI coding sequence 
Kanamycin (50 μg/mL) Merck Group (Darmstadt, DE) 
pETDuet-1 T7 promoter, T7 terminator,  
lacI coding sequence 
Ampicillin (100 μg/mL) Merck Group (Darmstadt, DE) 
pIT2-MCS trc promoter, rrnB terminator 
 
Tetracycline (10 μg/mL**) Kovach et al. 268 
*All of the antibiotics were prepared as stock solutions with 1000 times higher concentration.  
**Tetracycline stock solution was prepared with 70 % ethanol. 
 
Tab. 2.6: Oligonucleotides used in this study. The oligonucleotides were synthesized by Sigma-Aldrich 
Chemie (Steinheim, Germany). 




pET28a_universal_fwd GTGAGCGGATAACAATTCCC 20 63.2 
pET28a_universal_rev CTAGTTATTGCTCAGCGGTG 20 60.1 
T7-fwd TAATACGACTCACTATAGGG 20 53.2 
T7-term CTAGTTATTGCTCAGCGGT 19 54.5 
pETUp ATGCGTCCGGCGTAGA 16 54.3 
DuetDown1 GATTATGCGGCCGTGTACAA 20 57.3 
DuetUp2 TTGTACACGGCCGCATAATC 20 57.3 
M13-rev GAGCGGATAACAATTTCACACAGG 24 61.0 
Altering oligonucleotides 
pET28a_NdeI_to_NcoI_fwd GCAGCCCCATGGCACGCAATAATACCATC 29 79.5 
Quikchange® oligonucleotides 
LigE-Y23A_fwd CATATTTGGTACGCCAAACAGCCGGGCTAATGGTACAACCG 41 83.6 
LigE-Y23A_rev CGGTTGTACCATTAGCCCGGCTGTTTGGCGTACCAAATATG 41 83.6 
LigE-W107A_fwd CACGGACCAACTGCGGTTGAAGCCAGCCAATTATCCAGGAATT 43 86.5 
LigE-W107A_rev AATTCCTGGATAATTGGCTGGCTTCAACCGCAGTTGGTACGTG 43 86.5 
LigE-F115A_fwd CCGCAGTTGGTCCGTGGGCTCGTTGTTATATCCTGGA 37 85.1 
LigE-F115A_rev TCCAGGATATAACAACGAGCCCACGGACCAACTGCGG 37 85.1 
LigE-Y122A_fwd GCGGCAGGCTCAGATCATGAGCATCCAGGATATAACAACGA 41 84.8 
LigE-Y122A_rev TCGTTGTTATATCCTGGATGCTCATGATCTGAGCCTGCCGC 41 84.8 
LigE-F142A_fwd CGCTGACCTCCCAGAGCCCACTGTTCACGGC 31 85.8 
LigE-F142A_rev GCCGTGAACAGTGGGCTCTGGGAGGTCAGCG 31 85.8 
LigE-W197A_fwd GCAACGCTTGCGGTCGCCAGAAAAACTGCCAGTG 34 86.4 
LigE-W197A_rev CACTGGCAGTTTTTCTGGCGACCGCAAGCGTTGC 34 86.4 
LigE-Y23F_fwd TATTTGGTACGCCAAACAAACGGGCTAATGGTACAAC 37 77.8 
LigE-Y23F_rev GTTGTACCATTAGCCCGTTTGTTTGGCGTACCAAATA 37 77.8 
LigE-Y122F_fwd GGCAGGCTCAGATCATGAAAATCCAGGATATAACAAC 37 76.9 
LigE-Y122F_rev GTTGTTATATCCTGGATTTTCATGATCTGAGCCTGCC 37 76.9 
LigE-R138A_fwd TCCCAGAAACCACTGTTCAGCGCTCCAACGAACATAATC 39 82.7 
LigE-R138A_rev GATTATGTTCGTTGGAGCGCTGAACAGTGGTTTCTGGGA 39 82.7 
LigF-F7A_fwd CTATTTGCACCCGGACCAGCGCTATACAGTTTCAGGGTC 39 82.3 
LigF-F7A_rev GACCCTGAAACTGTATAGCGCTGGTCCGGGTGCAAATAG 39 82.3 
LigF-N12A_fwd GCGGTTTCAGGCTAGCTGCACCCGGACCAAAGC 33 85.3 
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LigF-N12A_rev GCTTTGGTCCGGGTGCAGCTAGCCTGAAACCGC 33 85.3 
LigF-C107A_fwd TGGTGCTAACGCACCAAGCGAAATATTCATCAACCCATTTGG 42 84.2 
LigF-C107A_rev CCAAATGGGTTGATGAATATTTCGCTTGGTGCGTTAGCACCA 42 84.2 
LigF-W108A_fwd ATGGTGCTAACGCACGCACAGAAATATTCATCAACCCATTTGGT 44 83.6 
LigF-W108A_rev ACCAAATGGGTTGATGAATATTTCTGTGCGTGCGTTAGCACCAT 44 83.6 
LigF-V110A_fwd ATATTTCTGTTGGTGCGCTAGCACCATTGGTTGGG 35 80.3 
LigF-V110A_rev CCCAACCAATGGTGCTAGCGCACCAACAGAAATAT 35 80.3 
LigF-S111A_fwd CCAAATGCCCAACCAATGGTAGCAACGCACCAACAGAAATATTCATCAAC 50 85.9 
LigF-S111A_rev GTTGATGAATATTTCTGTTGGTGCGTTGCTACCATTGGTTGGGCATTTGG 50 85.9 
LigF-W115A_fwd ATTGCTTTAATACCAAATGCAGCACCAATGGTGCTAACGACACAACAG 48 84.5 
LigF-W115A_rev CTGTTGGTGCGTTAGCACCATTGGTGCTGCATTTGGTATTAAAGCAAT 48 84.5 
LigF-I119A_fwd CATTTTCTGGGCAATTGCTTTAGCACCAAATGCCCAACCAATGGT 45 85.6 
LigF-I119A_rev ACCATTGGTTGGGCATTTGGTGCTAAAGCAATTGCCCAGAAAATG 45 85.6 
LigF-I122A_fwd GCCATTTCAGCTGCTGTTCAGCGATCGGAACGTTTTTATTG 41 83.6 
LigF-I122A_rev CAATAAAAACGTTCCGATCGCTGAACAGCAGCTGAAATGGC 41 83.6 
LigF-P142A_fwd GCTCATTTTCTGGGCAGCTGCTTTAATACCAAATGCCCAACCAATGG 47 85.6 
LigF-P142A_rev CCATTGGTTGGGCATTTGGTATTAAAGCAGCTGCCCAGAAAATGAGC 47 85.6 
LigF-Q144A_fwd CGACGCCATTTCAGCTGAGCTTCCGGGATCGGAACGTTT 39 87.8 
LigF-Q144A_rev AAACGTTCCGATCCCGGAAGCTCAGCTGAAAYGGCGTCG 39 87.8 
LigF-K147A_fwd TACGTGCACGACGCCAAGCCAGCTGCTGTTCCGGG 35 90.0 
LigF-K147A_rev CCCGGAACAGCAGCTGGCTTGGCGTCGTGCACGTA 35 90.0 
LigF-W148A_fwd TGCACGACGCGCTTTCAGCTGCTGTTCCGGG 31 88.1 
LigF-W148A_rev CCCGGAACAGCAGCTGAAAGCGCGTCGTGCA 31 88.1 
LigF-I199A_fwd GACGCTGCAGACCATTTGCAGCGGCAAAATTACAAATATCGGC 43 85.9 
LigF-I199A_rev GCCGATATTTGTAATTTTGCCGCTGCAAATGGTCTGCAGCGTC 43 85.9 
LigF-Q39A_fwd AATCTTTTTGAACCAATCGCTATGAGCCTCAAATTTGCTCGGATCCACAAA 51 83.8 
LigF-Q39A_rev TTTGTGGATCCGAGCAAATTTGAGGCTCATAGCGATTGGTTCAAAAAGATT 51 83.8 
LigF-W115R_fwd TTAATACCAAATGCCCTACCAATGGTGCTAACGCAC 36 77.7 
LigF-W115R_rev GTGCGTTAGCACCATTGGTAGGGCATTTGGTATTAA 36 77.7 
LigF-W115N_fwd ATTGCTTTAATACCAAATGCGTTACCAATGGTGCTAACGCACCAACAG 48 82.7 
LigF-W115N_rev CTGTTGGTGCGTTAGCACCATTGGTAACGCATTTGGTATTAAAGCAAT 48 82.7 
LigF-W115D_fwd ATTGCTTTAATACCAAATGCGTCACCAATGGTGCTAACGCACCAACAG 48 84.5 
LigF-W115D_rev CTGTTGGTGCGTTAGCACCATTGGTGACGCATTTGGTATTAAAGCAAT 48 84.5 
LigF-W115C_fwd TTTAATACCAAATGCACAACCAATGGTGCTAACGCACC 38 79.6 
LigF-W115C_rev GGTGCGTTAGCACCATTGGTTGTGCATTTGGTATTAAA 38 79.6 
LigF-W115Q_fwd GCTTTAATACCAAATGCCTGACCAATGGTGCTAACGCACCAA 42 82.6 
LigF-W115Q_rev TTGGTGCGTTAGCACCATTGGTCAGGCATTTGGTATTAAAGC 42 82.6 
LigF-W115E_fwd GCTTTAATACCAAATGCCTCACCAATGGTGCTAACGCACCAA 42 82.6 
LigF-W115E_rev TTGGTGCGTTAGCACCATTGGTGAGGCATTTGGTATTAAAGC 42 82.6 
LigF-W115G_fwd TTAATACCAAATGCCCCACCAATGGTGCTAACGCAC 36 80.7 
LigF-W115G_rev GTGCGTTAGCACCATTGGTGGGGCATTTGGTATTAA 36 80.7 
LigF-W115H_fwd AATTGCTTTAATACCAAATGCATGACCAATGGTGCTAACGCACCAACAGA 51 78.5 
LigF-W115H_rev TCTGTTGGTGCGTTAGCACCATTGGTCATGCATTTGGTATTAAAGCAATT 51 78.5 
LigF-W115I_fwd AATTGCTTTAATACCAAATGCTATACCAATGGTGCTAACGCACCAACAGA 51 82.0 
LigF-W115I_rev TCTGTTGGTGCGTTAGCACCATTGGTATAGCATTTGGTATTAAAGCAATT 51 82.0 
LigF-W115L_fwd GCTTTAATACCAAATGCCAGACCAATGGTGCTAACGCACCAA 42 82.6 
LigF-W115L_rev TTGGTGCGTTAGCACCATTGGTCTGGCATTTGGTATTAAAGC 42 82.6 
LigF-W115K_fwd GCTTTAATACCAAATGCCTTACCAATGGTGCTAACGCACCAA 42 80.7 
LigF-W115K_rev TTGGTGCGTTAGCACCATTGGTAAGGCATTTGGTATTAAAGC 42 80.7 
LigF-W115M_fwd GCTTTAATACCAAATGCCATACCAATGGTGCTAACGCACCAA 42 81.2 
LigF-W115M_rev TTGGTGCGTTAGCACCATTGGTATGGCATTTGGTATTAAAGC 42 81.2 
LigF-W115F_fwd TGCTTTAATACCAAATGCAAAACCAATGGTGCTAACGCACCAAC 44 82.2 
LigF-W115F_rev GTTGGTGCGTTAGCACCATTGGTTTTGCATTTGGTATTAAAGCA 44 82.2 
LigF-W115P_fwd CTTTAATACCAAATGCCGGACCAATGGTGCTAACGCACCA 40 83.1 
LigF-W115P_rev TGGTGCGTTAGCACCATTGGTCCGGCATTTGGTATTAAAG 40 83.1 
LigF-W115S_fwd GCTTTAATACCAAATGCACTACCAATGGTGCTAACGCACCAA 42 80.5 
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LigF-W115S_rev TTGGTGCGTTAGCACCATTGGTAGTGCATTTGGTATTAAAGC 42 80.5 
LigF-W115T_fwd TGGTGCGTTAGCACCATTGGTACGGCATTTGGTATTAAAG 40 80.9 
LigF-W115T_rev CTTTAATACCAAATGCCGTACCAATGGTGCTAACGCACCA 40 80.9 
LigF-W115Y_fwd GCTTTAATACCAAATGCGTAACCAATGGTGCTAACGCACCAA 42 81.2 
LigF-W115Y_rev TTGGTGCGTTAGCACCATTGGTTACGCATTTGGTATTAAAGC 42 81.2 
LigF-W115V_fwd GCTTTAATACCAAATGCCACACCAATGGTGCTAACGCACCAA 42 83.1 
LigF-W115V_rev TTGGTGCGTTAGCACCATTGGTGTGGCATTTGGTATTAAAGC 42 83.1 
LigF-A11F_fwd GCCAGCGGTTTCAGGCTATTAAAACCCGGACCAAAGCTATACA 43 78.9 
LigF-A11F_rev TGTATAGCTTTGGTCCGGGTTTTAATAGCCTGAAACCGCTGGC 43 78.9 
LigF-S13A_fwd GTTGCCAGCGGTTTCAGTGCATTTGCACCCGGACCAAAGC 40 89.4 
LigF-S13A_rev GCTTTGGTCCGGGTGCAAATGCACTGAAACCGCTGGCAAC 40 89.4 
LigF-N12A, S13A_fwd GTTGCCAGCGGTTTCAGGGCAGCTGCACCCGGACCAAAGCTAT 43 90.3 
LigF-N12A, S13A_rev ATACGTTTGGTCCGGGTGCAGCTGCCCTGAAACCGCTGGCAAC 43 90.3 
Site saturation oligonucleotides 
LigF-P142X_fwd (NNS) GACGCCATTTCAGCTGCTGTTCSNNGATCGGAACGTTTTTATTGATG 47 85.2 
LigF-P142X_rev (NNS) CATCAATAAAAACGTTCCGATCNNSGAACAGCAGCTGAAATGGCGTC 47 85.2 
LigF-S13X_fwd (NNS) GTTGCCAGCGGTTTCAGSNNATTTGCACCCGGACCAAAGC 40 78.9 
LigF-S13X_rev (NNS) GCTTTGGTCCGGGTGCAAATNNSCTGAAACCGCTGGCAAC 40 78.9 
LigF-N12X_fwd (NNS) CCAGCGGTTTCAGGCTSNNTGCACCCGGACCAAAGCTAT 39 78.6 
LigF-N12X_rev (NNS) ATAGCTTTGGTCCGGGTGCANNSAGCCTGAAACCGCTGG 39 78.6 
LigE-S21X_fwd (NNS) CGCCAAACATACGGSNNAATGGTACAACCGCTTTCCAGCTGCA 43 78.9 
LigE-S21X_rev (NNS) TGCAGCTGGAAAGCGGTTGTACCATTNNSCCGTATGTTTGGCG 43 78.9 
 
2.1.4 Commercial enzymes, enzyme kits and dyes. 
 
Tab. 2.7: Commercial enzymes, enzyme kits and dyes used in this study. 
Enzyme/kit Source Supplier 
Ncol-HF Nocardia carolina New England Biolabs (Ipswich, USA) 
HindIII-HF Haemophilus influenzae Rd New England Biolabs (Ipswich, USA) 
EcoRI Escherichia coli RY13 New England Biolabs (Ipswich, USA) 
NdeI-HF Neisseria denitrificans New England Biolabs (Ipswich, USA) 
Xhol-HF Xanthomonas holcicola New England Biolabs (Ipswich, USA) 
EcoRV plasmid J62 pLG74 New England Biolabs (Ipswich, USA) 
DpnI Diplococcus pneumoniae G41 New England Biolabs (Ipswich, USA) 
CutSmart buffer  New England Biolabs (Ipswich, USA) 
T4 DNA Ligase  Bacteriophage T4 New England Biolabs (Ipswich, USA) 
T4 DNA Ligase buffer  New England Biolabs (Ipswich, USA) 
DreamTaq DNA Polymerase Thermus aquaticus Thermo Fisher Scientific (Waltham, USA) 
PfuTurbo DNA polymerase Pyrococcus furiosus Agilent Technologies, (Santa Clara, USA) 
Phusion© polymerase Pyrococcus furiosus New England Biolabs (Ipswich, USA) 
PfuUltra II Hotstart Master Mix (2x) Pyrococcus furiosus Agilent Technologies, (Santa Clara, USA) 
Green Go Taq® Flexi Buffer (10x)  Promega (Madison, USA) 
Midori Green Direct  NIPPON Genetics Europe (Düren, DE) 
HDGreenTM DNA Stain  INTAS (Göttingen, DE) 
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2.1.5 β-etherases and glutathione lyases 
 
Tab. 2.8: β-etherases and glutathione lyases used in the presented study. 
Enzyme Source NCBI number 
LigE Sphingobium paucimobilis SYK-6 WP_014075192.1 
LigE-NS Novosphingobium sp. PP1Y WP_013832481.1 
LigE-NA Novosphingobium aromaticivorans DSM1244 WP_011446047.1 
LigP Sphingobium paucimobilis SYK-6 WP_014077574.1 
LigF Sphingobium paucimobilis SYK-6 WP_014075191.1 
LigF-NS Novosphingobium sp. PP1Y WP_013832480.1 
LigF-NA Novosphingobium aromaticivorans DSM1244 WP_041551020.1 
LigG Sphingobium paucimobilis SYK-6 WP_041392591.1 
LigG-NS Novosphingobium sp. PP1Y WP_041558818.1 
LigG-TD Thiobacillus denitrificans ATCC 25259 WP_011311562.1 
 
2.1.6 Growth media and buffer solutions 
 
Tab. 2.9: Growth media and buffer solutions used in this study with their components. 
Growth medium/buffer solution Component Preparation 
Lysogeny broth (LB media) - 10 g/L tryptone 
- 5 g/L yeast extract 
- 10 g/L sodium chloride 
-mixed with MilliQ water up to 
desired volume, autoclaved 
Lysogen broth agar (LB agar) - 10 g/L tryptone 
- 5 g/L yeast extract 
- 10 g/L sodium chloride 
- 15 g/L agar-agar 
-mixed with MilliQ water up to 
desired volume, autoclaved, 
(possibly added antibiotic) poured 
to the Petri dish 
Terrific broth (TB media) - 12 g/L tryptone 
- 24 g/L yeast extract 
- 5 g/L glycerol 
-mixed with MilliQ water up to  
90 % v/v volume, autoclaved, 
filled up with 10x TB salts 
Terrific broth salts – 10x concentrated 
(TB salts) 
- 23.1 g/L KH2PO4 
- 125.4 g/L K2HPO4 
-mixed with MilliQ water up to 
desired volume, autoclaved 
Super optimal broth with catabolite 
repression  
(SOC media) 
- 20 g/L tryptone 
- 5 g/L yeast extract 
- 0.5 g/L sodium chloride 
- 0.186 g/L potassium chloride 
 
- 10 mM magnesium chloride 
- 10 mM magnesium sulfate 
- 20 mM glucose 
-solution containing tryptone, 
yeast extract, sodium chloride, 
potassium chloride mixed with 
MilliQ water up to desired volume, 
autoclaved 
 
-solution of 2 M glucose (sterilized 
by filtration) 
-solutions of 2 M magnesium 
sulfate and 2 M magnesium 
chloride, autoclaved 
 
-add glucose (1:100), magnesium 
sulfate (1:200) and magnesium 
chloride (1:200) to the main broth 
IMAC* binding buffer - 20 mM KH2PO4 
- 500 mM sodium chloride 
- 20 mM imidazole 
-mixed with MilliQ water up to 
desired volume, pH adjusted by 
HCl to 7.4, filtered, degassed 
IMAC elution buffer - 20 mM KH2PO4 
- 500 mM sodium chloride 
- 500 mM imidazole 
-mixed with MilliQ water up to 
desired volume, pH adjusted by 
HCl to 7.4, filtered, degassed 
IMAC pre-elution buffer ** - 20 mM KH2PO4 
- 500 mM sodium chloride 
- 125 mM imidazole 
-mixed with MilliQ water up to 
desired volume, pH adjusted by 
HCl to 7.4, filtered, degassed 
Protein storage buffer - 20 mM TRIS-base 
- 20 % v/v glycerol 
-mixed with MilliQ water up to 
desired volume, pH adjusted by 
HCl to 7.5, autoclaved 
Tris-acetate-EDTA buffer (TAE buffer) - 4.84 g/L TRIS-base 
- 1.142 mL/L acetic/glacial acid 
- 2 mL/L of 0.5 mM EDTA 
-mixed with MilliQ water up to 
desired volume 
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SDS PAGE-running buffer - 3.03 g/L TRIS-base 
- 14.44 g/L glycine 
- 1.0 g/L sodium dodecyl sulfate (SDS) 
-mixed with MilliQ water up to 
desired volume 
SDS PAGE-sample buffer  
4x concentrated 
- 80 mg/L SDS 
- 40 % v/v glycerol 
- 20 % v/v mercaptoethanol 
- 4 mg/L bromophenol blue 
- 100 mM TRIS-HCl, pH 6.8 
-mixed SDS with TRIS-HCl,  
added rest of the components 
SDS PAGE-gel staining solution - 30 % v/v ethanol 
- 10 % v/v acetic/glacial acid 
- 2.5 g/L Coomassie Brilliant Blue R-250® 
-mixed with MilliQ water up to 
desired volume 
SDS PAGE-gel destaining solution - 30 % v/v ethanol 
- 10 % v/v acetic/glacial acid 
-mixed with MilliQ water up to 
desired volume 
RF 1 buffer - 30 mM KCH3CO2 
- 50 mM MnCl2 
- 100 mM RbCl 
- 10 mM CaCl2 
- 15 % v/v glycerol, pH 5.8 
-mixed with MilliQ water up to 
desired volume 
-pH adjusted with acetic/glacial 
acid 
-sterilized by filtration 
RF 2 buffer - 10 mM MOPS 
- 75 mM CaCl2 
- 10 mM RbCl2 
- 15 % v/v glycerol, pH 6.8 
-mixed with MilliQ water up to 
desired volume 
-pH adjusted with NaOH 
-sterilized by filtration 
* IMAC= immobilized metal affinity chromatography 




2.2.1 Synthesis of model substrates 
Several substrates used for the analysis and description of the biocatalysts were 
synthesized after modified protocols form Picart et al. 110. The three-step synthesis 
included bromination of an acetophenone derivate, followed by SN2 reaction with phenol 
compound, forming the keto-ether bond, and finished by the hydroxy-methylation of the 
keto-ether compound using paraformaldehyde. General scheme of synthesis is shown 
in Fig. 2.1 and the shortcuts, abbreviations and the full names of the compounds are 
listed in Tab. 2.10. NMR analyses of synthesized compounds are shown in chapter 7.5. 
 
 
Fig. 2.1: General scheme of substrates synthesis. 
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Compound full name 
A 3,4-DM-ON 3,4-dimethoxyacetophenon 
B 2-BR-3,4-DM-ON 2-bromo-1-(3,4-dimethoxyphenyl)-ethan-1-one 
C VN-3,4-ON 4-(2-(3,4-dimethoxyphenyl)-2-oxoethoxy)-3-methoxybenzaldehyde 
3 VN-VG β-vanillinyl-α-veratrylglycerone 
2 2,6-MP-3,4-ON β-(2,6-dimethoxyphenoxy)-α-(3,4-dimethoxyphenyl)-ethan-1-on 
1 rac-2,6-MP-VG β-(2,6-dimethoxyphenoxy)-α-veratrylglycerone 
 
2.2.1.1 Synthesis of 2-bromo-1-(3,4-dimethoxyphenyl)-ethan-1-one (B) 
A dry and argon-flushed three-necked flask equipped with a magnetic stirrer, a reflux 
condenser, an argon inlet and a septum were charged with 5.0 g of A (1.0 eq., 28 mmol), 
8.0 g of p-toluenesulfonic acid monohydrate (1.5 eq., 42 mmol) and 400 mL of dry 
acetonitrile (dried overnight with activated molecular sieve with 3 Å pore size). After all 
the substrates were dissolved, a solution of 6.0 g of N-bromosuccinimide (NBS) (1.2 eq., 
33.6 mmol) in 100 mL of dry acetonitrile was added. The reaction mixture was stirred for 
2 h at 100 °C and upon completion cooled to room temperature. The solvent was 
evaporated under reduced pressure, the residue dissolved in dichloromethane and 
washed with distilled water. The organic phase was dried over MgSO4, filtered and 
evaporated under reduced pressure. The product was purified by column 
chromatography (dichloromethane/ethyl acetate, 100:1) yielding the product B as white 
solid with yield of 70 % (5.0 g). 
 
 
1H NMR (400 MHz, CCl3D): δ [ppm] = 7.60 (dd, 3J = 8.4 HZ, 5J = 2.0 Hz, 1H), 7.54 (d, 
5J = 2.0 Hz, 1H), 6.92 (d, 3J = 8.2 Hz, 1H), 4.40 (s, 2H), 3.96 (s, 3H), 3.95 (s, 3H) 
13C NMR (100 MHz, CCl3D): δ [ppm] = 190.2, 154.3, 149.6, 127.0, 124.0, 111.1, 110.1, 
56.3, 56.1, 30.6  
 
2.2.1.2 Synthesis of β-keto ethers (2, C) 
5.0 g of B (1.0 eq.0, 19.3 mmol), 3.0 g of anhydrous Na2CO3 (1.5 eq., 29.0 mmol) and 
the corresponding phenol compound (for synthesis of 2; 2,6-methoxyphenol, for 
synthesis of C; vanillin) (1.5 eq., 29 mmol) were dissolved in 50 mL of acetone. The 
reaction mixture was stirred at room temperature for 72 hours. After filtration and washing 
with dichloromethane, the solution was evaporated under reduced pressure. The residue 
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was re-dissolved in dichloromethane and washed with distilled water and brine. The 
organic phase was dried over MgSO4, filtered and evaporated under reduced pressure. 
The product was purified by column chromatography.  
Synthesis of 2 
The crude product was purified by column chromatography with gradient from pure 
dichloromethane to dichloromethane:ethyl acetate of 4:1. The product 2 was isolated 
with a yield of 59.4 % (3.8 g). 
 
 
1H NMR (600 MHz, CCl3D): δ [ppm] = 7.71 (dd, 3J = 8.5 Hz, 5J = 2.0 Hz, 1H), 7.51 (d, 
5J = 2.0 Hz, 1H), 7.05 (d, 3J = 8.2 Hz, 1H), 7.01 (t, 4.40 3J = 8.5 Hz, 1H), 6.69 (d, 3J = 
8.4 Hz, 2H), 5.07 (s, 2H), 3.86 (s, 3H), 3.85 (s, 3H), 3.74 (s, 6H) 
13C NMR (150 MHz, CCl3D): δ [ppm] = 193.3, 153.4, 153.0, 148.0, 135.8, 127.6, 124.2, 
122.8, 111.0, 110.3, 105.6, 74.6, 55.7, 55.6, 55.3 
* the compound 2 was used as a precursor for the synthesis of the substrate 1, but was 
also used as a substrate for the enzymes’ analysis 
Synthesis of C 
The crude product was purified by column chromatography with gradient from pure 
dichloromethane to dichloromethane:ethyl acetate of 4:1. The product C was isolated 
with a yield of 87.2 % (5.6 g). 
 
 
1H NMR (600 MHz, DMSO): δ [ppm] = 9.83 (s, 1H), 7.71 (dd, 3J = 8.4 Hz, 5J = 2.0 Hz, 
1H), 7.51 (d, 5J = 2.0 Hz, 1H), 7.48 (dd, 3J = 8.5 Hz, 5J = 1.9 Hz, 1H), 7.42 (d, 5J = 2.0 
Hz, 1H), 7.13 (d, 3J = 8.2 Hz, 1H), 7.05 (d, 3J = 8.5 Hz, 1H), 5.69 (s, 2H), 3.86 (s, 3H), 
3.85 (s, 3H), 3.80 (s, 3H) 
13C NMR (150 MHz, DMSO): δ [ppm] = 192.3, 191.5, 153.4, 153.0, 149.0,148.9, 130.1, 
127.2, 125.2, 122.8, 112.5, 110.9, 110.3, 110.0, 70.6, 55.7, 55.6, 55.3 
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2.2.1.3 Hydroxy methylation of β-keto-ethers (1, 3) 
Synthesis of 1 
3.0 g of 2 (1.0 eq., 9 mmol), 1.9 mL of paraformaldehyde (10.0 eq., 90 mmol), and 9.54 
g of anhydrous Na2CO3 (1.0 eq.) were dissolved in 30 mL of dry dichloromethane. The 
mixture was stirred at room temperature for 20 h. When the reaction was over, distilled 
water was added to the reaction and the aqueous phase was extracted with 
dichloromethane. The organic phase was washed with brine. The combined organic 
layers were dried over MgSO4, filtered and evaporated under reduced pressure. The 
product was purified by column chromatography (dichloromethane:ethyl acetate, 100:1) 
yielding the product 1 as slightly brown oil with yield of 76.1 % (2.5 g). 
 
 
1H NMR (600 MHz, DMSO): δ [ppm] = 7.72 (dd, 3J = 8.5 Hz, 5J = 2.1 Hz, 1H), 7.51 (d, 3J 
= 2.1 Hz, 1H), 7.07 (d, 3J = 8.5 Hz, 1H), 6.98 (t, 3J = 8.3 Hz, 1H), 6.65 (d, 3J = 8.3 Hz, 
2H), 5.20 (m, 1H), 4.70 (m, 1H), 3.85 (s, 3H), 3.80 (s, 3H), 3.77 (m, 2H), 3.64 (s, 3H) 
13C NMR (150 MHz, DMSO): δ [ppm] = 195.4, 153.1, 152.5, 148.5, 136.0, 128.9, 123.7, 
123.5, 110.8, 105.6, 83.5, 62.2, 55.86, 55.8, 55.5 
Synthesis of 3 
3.0 g of C (1.0 eq., 9 mmol), 1.9 mL of paraformaldehyde (10.0 eq., 90 mmol), and 4.77 
g of anhydrous Na2CO3 (0.5 eq.) were dissolved in 30 mL of isopropyl alcohol. The 
mixture was stirred at 45˚C for 20 h. When the reaction was over, distilled water was 
added to the reaction and the aqueous phase was extracted with dichloromethane. The 
organic phase was washed with brine. The combined organic layers were dried over 
MgSO4, filtered and evaporated under reduced pressure. The crude product was 
repeatedly purified by column chromatography with gradient from pure dichloromethane 
to dichloromethane:ethyl acetate of 1:1 yielding the product 3 as slightly yellow-white 
solid with yield of 62.3 % (2.0 g).  
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1H NMR (600 MHz, DMSO): δ [ppm] = 9.81 (s, 1H), 7.81 (dd, 3J = 8.4 Hz, 5J = 2.0 Hz, 
1H), 7.52 (d, 5J = 2.0 Hz, 1H), 7.44 (m, 5J = 1.9 Hz, 1H), 7.42 (m, 1H), 7.13 (d, 3J = 8.5 
Hz, 1H), 6.90 (d, 3J = 8.8 Hz, 1H), 5.95 (m, 1H), 5.28 (t, 3J = 5.7 Hz, 1H), 3.95 (m, 2H), 
3.85 (s, 3H), 3.84 (s, 3H), 3.81 (s, 3H) 
13C NMR (150 MHz, DMSO): δ [ppm] = 194.3, 191.5, 153.7, 152.4, 149.0,148.9, 130.1, 
127.2, 125.2, 123.6, 113.0, 110.9, 110.8, 110.2, 81.2, 63.0, 55.7, 55.6, 55.0 
 
2.2.1.4 Enzymatic synthesis of glutathione adducts 
In order to prepare the model substrates for glutathione lyases, the enzymatical reactions 
were performed. Racemic model substrates 11 and 12 were enzymatically synthesized 
in reactions where compound 1 or compound 2 were used as substrates. Reactions were 
performed in 5 mL volume and consisted of 0.2 mM of corresponding substrate (final 
DMSO concentration 5 % v/v), 1.0 mM of GSH, 100 mM glycine buffer pH 9.5 and the 
50 μg of enzymes LigE and LigF-NS. After the completion of the enzymatic reaction, the 
volume of the reaction was mixed with 5 mL of water and 5 mL of ethyl acetate (EtOAc) 
forming two immiscible solvent phases system. The mixture was transformed into the 
extraction funnel and the organic phase was separated and the solvent was evaporated 
under reduced pressure.  
For preparation of the (R)-11 and (S)-11 substrates, the reaction was modified and 0.4 
mM of 1 was used as well as only LigE (for preparation of (S)-11) or only LigF-NS (for 
preparation of (R)-11) were employed in the reactions. In these cases, after the 50 % of 
the substrate 1 was converted to the desired enantiomeric product, the extraction step 
was omitted and the received mixture was used as a starting point for the 
characterization of glutathione lyases (fresh GSH had to be added with the new enzyme). 
All of the substrates prepared for the characterization of glutathione lyases with their 
structures, shortcuts, abbreviations and full names are summarized in the Tab. 2.11.  
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Tab. 2.11: Structures, names, abbreviations and shortcuts of substrates enzymatically synthesized for the 
characterization of glutathione lyases. 
Compound structure  Shortcut  Abbreviation  Compound full name 
 
 11  GS-VG  β-glutathionyl-α-
veratrylglycerone 
 
 (R)-11  (R)-GS-VG  (R)-β-glutathionyl-α-
veratrylglycerone 
 
 (S)-11  (S)-GS-VG  (S)-β-glutathionyl-α-
veratrylglycerone 
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2.2.1.5 Other substrates used in this thesis 
Several other dimeric lignin-like model substrates were used in this thesis. Structures of 
these together with their shortcuts, abbreviations and full names are listed in Tab. 2.12. 
These substrates were synthesized by Dr. Hauke Voß and were kindly provided for the 
presented research. The protocols for synthesis of these molecules are precisely 
described in his doctoral thesis 269.  
 
Tab. 2.12: Structures, names, abbreviations and shortcuts of substrates synthesized by Dr. Voß. 
Compound structure  Shortcut  Abbreviation  Compound full name 
 
 4  rac-MTP-VG  β-(2-methoxytiophenoxy)- 
-α-veratrylglycerone 
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2.2.1.6 Non lignin-related model substrates 
Non-lignin model substrates containing aryl ether bonds, which were used in this thesis, 
were provided by Prof. Dr. Dieter E. Kaufmann from the Institute of Organic Chemistry 
at TU Clausthal, Germany. These manmade compounds together with their names and 
shortcuts are shown in Tab. 2.13. 
 
Tab. 2.13: Structures, names, and shortcuts of non-lignin-based substrates tested in this thesis. 
Non-lignin substrate structure  Shortcut  Compound full name 
 




















 33  4,4'-(propane-2,2-diyl)bis 
(methoxybenzene) 
 
 34  5,5'-(propane-2,2-diyl)bis 
(1,3-dibromo-2-ethoxybenzene) 
 
2.2.2 Molecular and microbiological methods 
 
2.2.2.1 Gene synthesis 
All of the genes used in presented work were synthesized by Eurofins (Ebersberg, 
Germany) with codon optimized sequences for heterologous expression in E. coli strains. 
The genes contained restriction enzymes 5’-NdeI and 3’-HindIII allowing simple 
restriction and subsequent subcloning into the pET-28a(+) plasmid. 
 
2.2.2.2 Restriction digest and ligation 
Restriction enzymes or restriction endonucleases type II recognize and bind to specific 
sequences of DNA. Each restriction enzyme recognizes one or a few restriction sites 
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and cuts a double-stranded DNA molecule in a tidy, predictable pattern. The DNA can 
be cut through both strands directly (blunt end) or with 5’ or 3’ overhangs (sticky ends). 
Using two different restriction enzymes to digest the target vector and desired DNA insert 
allows further specific ligations and creations of the vectors carrying requested DNA 
genes mentioned in chapter 2.1.3.1. Ligation reaction in molecular biology refers to the 
joining of the two or more DNA fragments through the formation of covalent, 
phosphodiester bond. The reaction is catalyzed using ATP-dependent T4-DNA ligase 
that connects complementary sticky ends of the DNA fragments (vector and insert) 
created in the digestion reaction.  
Subcloning of β-etherases LigE and LigF in vector pETDuet-1  
LigE gene located on the pET-28a(+) vector was amplified by PCR using forward primer 
pET28a_NdeI_to_NcoI_fwd to introduce a NcoI restriction site and reverse primer 
pET28a_universal_rev as described in chapter 2.2.2.4 (Gene of interest amplification). 
The resulting ligE gene was purified using NucleoSpin® Gel and PCR Clean-up Kit 
following the manufacturer’s protocol. For the digestion reaction, pETDuet-1 vector 
(1000 ng) was combined with amplified ligE gene in molecular ratio 1:5 (vector:insert). 
To the reaction, three restriction enzymes; NcoI, HindIII and EcoRI, were added in 1 μL 
volume (EcoRI enzyme was added as an extra restriction enzyme to digest the undesired 
part of the vector to prevent self ligation in the further steps). Afterwards, 5 μL of 
CutSmart buffer were added and the reaction was filled up to 50 μL with MilliQ water. 
Restriction enzymes digestion reaction was performed for 2 hours at 37˚C.  Afterwards, 
the enzymes of the reaction were inactivated by exposing to the 85˚C for 20 min. From 
the received reaction, 6 μL of the product were analyzed on 0.8 % agarose gel as 
described in chapter 2.2.2.5 (Agarose gel electrophoresis). Subsequently, with the 
remaining digestion product (44 μL) the ligation reaction was performed. To the mixture, 
5 μL of T4 DNA Ligase buffer and 1 μL of T4 DNA Ligase were added. The ligation 
reaction was carried out for 2 hours at 20˚C and was followed by enzyme inactivation at 
65˚C for 30 min. After transformation of chemically competent E. coli DH5α, the 
successful insertion of the ligE in the MSC-1 of pETDuet-1 was verified by colony PCR 
using the protocol described in chapter 2.2.2.4 (Colony PCR) and sequencing.  
Further, ligF-NA gene was amplified from pET-28a(+) by PCR using forward primer 
pET28a_universal_fwd and reverse primer pET28a_universal_rev as described in 
chapter 2.2.2.4 (Gene of interest amplification). The resulting ligF gene was purified 
using NucleoSpin® Gel and PCR Clean-up Kit following the manufacturer’s protocol. For 
the digestion reaction, pETDuet-1_ligE vector (1000 ng) was combined with amplified 
ligF gene in molecular ratio 1:5 (vector:insert). To the reaction, three restriction enzymes; 
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NdeI, Xhol and EcoRV, were added in 1 μL volume (EcoRV enzyme was added as an 
extra restriction enzyme to digest the undesired part of the vector to prevent self ligation 
in the further steps). Afterwards, 5 μL of CutSmart buffer were added and the reaction 
was filled up to 50 μL with MilliQ water. Restriction enzymes digestion reaction was 
performed for 2 hours at 37˚C. Afterwards, the enzymes of the reaction were inactivated 
by exposing to the 85˚C for 20 min. From the received reaction, 6 μL of the product were 
analyzed on 0.8 % agarose gel as described in chapter 2.2.2.5 (Agarose gel 
electrophoresis). The remaining digestion product (44 μL) was used for the subsequent 
ligation reaction. To the mixture, 5 μL of T4 DNA Ligase buffer and 1 μL of T4 DNA 
Ligase were added. The ligation reaction was carried out for 2 hours at 20˚C and was 
followed by enzyme inactivation at 65˚C for 30 min. After transformation of chemically 
competent E. coli DH5α, the successful insertion of the ligF in the MSC-2 of pETDuet-
1_ligE was verified by colony PCR using the protocol described in chapter 2.2.2.4 
(Colony PCR) and sequencing. Finally, plasmid DNA was isolated with E.Z.N.A.® 
Plasmid Mini Kit I and digested using the endonucleases NcoI, HindIII, NdeI and XhoI to 
verify the presence of the two desired inserts. Additionally, an aliquot was sent for 
sequencing to Eurofins Genomics. 
Cloning of glutathione lyase in vector pIT2-MCS  
LigG-TD gene located on the pET-28a(+) vector was amplified by PCR using forward 
primer pET28a_universal_fwd and reverse primer pET28a_universal_rev as described 
in chapter 2.2.2.4 (Gene of interest amplification). The resulting ligG-TD gene was 
purified using NucleoSpin® Gel and PCR Clean-up Kit following the protocol. For the 
digestion reaction, pIT2 vector (1000ng) was combined with amplified ligG-TD gene in 
molecular ratio 1:5 (vector:insert). To the reaction, two restriction enzymes NcoI, and 
HindIII were added, each 1 μL volume. Afterwards, 5 μL of CutSmart buffer were added 
and the reaction was filled up to 50 μL with MilliQ water. Restriction enzymes digestion 
reaction was performed for 2 hours at 37˚C. Afterwards, the enzymes of the reaction 
were inactivated by exposing to the 85˚C for 20 min. From the received reaction, 6 μL of 
the product were analyzed on 0.8 % agarose gel as described in chapter 2.2.2.5 
(Agarose gel electrophoresis). Subsequently, with the remaining digestion product (44 
μL) the ligation reaction was performed. To the mixture, 5 μL of T4 DNA Ligase buffer 
and 1 μL of T4 DNA Ligase were added. The ligation reaction was carried out for 2 hours 
at 20˚C and was followed by enzyme inactivation at 65˚C for 30 min. After transformation 
of chemically competent E. coli DH5α, the successful insertion of the ligG-TD in the pIT2 
was verified by colony PCR using the protocol described in chapter 2.2.2.4 (Colony PCR) 
and sequencing. 




2.2.2.3 Preparation and transformation of chemically competent cells  
The competence is an ability of the cell to alter its genetical information and uptake the 
foreign/extracellular DNA through transformation process. Some prokaryotic cells bear 
natural competence, while in the E. coli cells, the competence has to be achieved 
artificially. Chemically competent cells are transiently permeable to DNA, which is 
caused by several chemical treatments. In this work chemically competent cells were 
prepared from E. coli DH5α, E. coli BL21 (DE3), E. coli BL21 Gold (DE3) and E. coli C43 
(DE3).  
Preparation of chemically competent cells  
For the preparation of chemically competent cells of the desired bacterium, 50 mL of LB 
medium was inoculated with an overnight culture to an optical density at 600 nm (OD600) 
of 0.1. The culture was incubated at 37 °C at 250 rpm until an OD600 between 0.4 and 
0.6 was reached. Afterwards, the cells were harvested by centrifugation (4000 rpm, 4 
°C, and 30 min) and resuspended in 20 mL of ice-cold RF 1 buffer. Suspension was kept 
on ice for 30 min. Subsequently, the mixture was centrifuged and the resulting pellet was 
resuspended in 4 mL of ice-cold RF 2 buffer. Prepared suspension was aliquoted by 100 
μL into the sterilized and precooled 1.5 mL tubes. Aliquots were shock frozen in liquid 
nitrogen and stored at -80 °C. 
Transformation of chemically competent cells 
Chemically competent E. coli cells were thaw on ice and 50 to 100 ng of plasmid DNA 
or ligation product was added to a cell aliquot. The cells were mixed with the DNA and 
afterwards incubated for 20 min on ice. Subsequently, the heat shock was performed for 
90 s at 42°C. After the heat shock, the cell mixture was cooled down on ice for 5 min.  
Thereafter, 500 µL of pre-warmed SOC medium was added to the cell mixture. Cells 
were incubated for 1 h at 37 °C at 800 rpm for cell recovery and antibiotic resistance 
expression. At last, the transformed cells were plated on LB agar plates containing the 
appropriate selection marker (antibiotic, Tab. 2.5) and grown overnight at 37 °C. 
 
2.2.2.4 Polymerase chain reaction (PCR) 
The polymerase chain reaction is an extremely flexible, multi-purpose laboratory 
technique allowing the amplification of a selected DNA sequence. The oligonucleotides 
(primers) binding to the DNA template, define the start of the amplification. The process 
of amplification consists of three steps: denaturation (breaking the hydrogen bonds 
between complementary bases of the double-stranded DNA template, yielding two 
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single-stranded DNA molecules), annealing (binding of the oligonucleotides to each of the 
single-stranded DNA templates) and elongation (the DNA polymerase is synthesizing a 
new DNA strand, complementary to the DNA template strand, framed by the 
oligonucleotides in the 5'-to-3' direction). In this work, the PCR was applied to selectively 
modify the restriction site of the gene coding for LigE, to verify if the ligation was 
successful (colony PCR) and to introduce mutations in ligE and ligF-NA genes via site-
directed mutagenesis. 
Gene amplification 
50-100 ng template DNA was added to a solution containing 1.0 U of Phusion© 
polymerase (1.0 μL), 20 % v/v of 5x Phusion HF buffer (10 μL), 200 µM of dNTPs (1 μL) 
and 3 % v/v of DMSO for microbiology (1.5 μL). The target DNA sequence was then 
selectively amplified using designed forward and reverse primers to a final concentration 
of 0.5 µM each. Finally, the volume was adjusted to 50 µL with MilliQ water. The gene of 
interest was amplified according to the temperature profile in Tab. 2.14. 
 
Tab. 2.14: Temperature profile of the PCR reaction for the gene amplification. 
Step Temperature (˚C) Time (s) Number of cycles 
1 98 120 1 
2 98 20  
3 55 30 30 
4 72 30 s per kb  
5 72 6000 1 
 
DNA fragments of interest were separated via agarose gel electrophoresis and 
extracted from agarose gel using NucleoSpin® Gel and PCR Clean-up Kit prior to 
further experiments. 
Colony PCR 
Colony PCR is an effective, high-throughput method designed to quickly identify if the 
ligation reaction was successful and DNA fragment was incorporated in to the new vector 
backbone. After E. coli DH5α was transformed with the ligation product and the cells 
were grown on LB agar with adequate antibiotic, several single colonies were picked to 
be analyzed by colony PCR. An individual colony was picked with the sterile pipette tip 
and visible number of cells were transported to the sterile pre-cooled PCR tube 
(providing the DNA template for the PCR reaction). Remaining cells from the individual 
colony could be used for separate cultivation, if the colony is needed. Several single 
colonies were reprocessed. The PCR tubes with the cells were filled with 20 μL of the “in 
house” made PCR master mix (Tab. 2.15), mixed and the gene, framed by the used 
oligonucleotides, was amplified according to the temperature profile in Tab. 2.16. After 
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amplification, the mix was directly loaded on the agarose gel and the results directly 
visualized. 
 
Tab. 2.15: Components of the “in house” made master mix used for colony PCR. Amounts of the shown 
components are necessary for the PCR of one colony. The master mix was prepared for x+1 reaction for x 
colonies, guarantying even composition in every reaction. 
Component Amount (μL) 
Green Go Taq® Flexi Buffer (10x) 2.0  
10 mM dNTP’s 0.4  
10 μM fwd_oligonucleotide 1.0  
10 μM rev_oligonucleotide 1.0  
DreamTaq DNA Polymerase 0.1  
MilliQ water 15.5  
 
Tab. 2.16: Temperature profile of the colony PCR reaction. 
Step Temperature (˚C) Time (min) Number of cycles 
1 95 5 1 
2 95 1  
3 55 0.5 30 
4 72 1  
5 72 3 1 
 
QuikChange ® PCR 
The site-directed mutagenesis and site-saturation mutagenesis was performed using 
QuikChange ® PCR strategy. The desired mutations were introduced to the DNA using 
set of complementary oligonucleotides designed by QuikChange® Primer Design 
webtool from Agilent. These oligonucleotides contain set of altered codons, introducing 
the desired change to the DNA sequence. Components of the of the QuikChange® PCR 
reaction are listed in the Tab. 2.17. After all of the components were mixed, the 
amplification of the vector was performed according to the temperature profile in Tab. 
2.18. 
 
Tab. 2.17: Components of the reaction mixture for the QuikChange ® PCR reaction. 
Component Amount (μL) 
PfuUltra II Hotstart Master Mix (2x) 25.0  
10 μM fwd_QuikChange_oligonucleotide 1.0  
10 μM rev_QuikChange_oligonucleotide 1.0  
DNA template (100 ng/μL) 1.0  
DMSO for microbiology 2.5  
MilliQ water 19.5  
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Tab. 2.18: Temperature profile of the QuikChange ® PCR reaction. 
Step Temperature (˚C) Time (s) Number of cycles 
1 95 120 1 
2 95 20  
3 55 20 20 
4 72 15 s per kb  
5 72 180 1 
 
After the QuikChange® PCR reaction, 1 μL of DpnI was added to the reaction to digest 
the DNA template vector. DpnI digestion was performed for 2 h at 37˚C. PCR product 
was purified by E.Z.N.A.® MicroElute DNA Clean Up Kit and analyzed.  
 
2.2.2.5 Agarose gel electrophoresis 
Agarose gel electrophoresis allows separation of the DNA fragments based on their size. 
The natural negative charge of the DNA caused by the phosphodiester bond in the 
backbone causes migration of the DNA towards the anode in the presence of electric 
field. The size separation is achieved by the agarose gel network hindering the larger 
molecules to a greater extent compared to the small molecules. 
Agarose gel electrophoresis was generally used for plasmid visualization and vector 
insert separation after restriction enzyme’s digestion. Agarose (0.8 or 1 % w/v) was 
mixes with TAE buffer and the mixture was heated up until dissolved. Hot agarose 
mixture was used to form an agarose gel. DNA samples were mixed with 6x sample 
buffer containing 1 % v/v of Midori Green Direct, and typically 10-20 µL were loaded on 
the gel together with 1 kb ladder (with Midori Green Direct) to reference the size of the 
DNA fragments. The separation based on molecular weight was performed using an 
electric current of 100 V. The TAE buffer was used as running buffer. The gel was 
visualized via GelPic LED Box. 
Alternation was done for the colony PCR, where to the lukewarm agarose mixture 0.0025 
% v/v of the HDGreenTD DNA Stain was added. The 10 µL of the colony PCR reactions 
were loaded to the agarose gel together with 1 kb ladder (with Midori Green Direct) to 
reference the size of the DNA fragments. The separation based on molecular weight was 
performed using an electric current of 100 V. The TAE buffer was used as running buffer. 
The gel was visualized via GelPic LED Box. 
 
2.2.2.6 Plasmid isolation 
The plasmid DNA as a foreign DNA was amplified by an E. coli DH5α strain. In order to 
confirm the successful ligation of a DNA fragment in a vector backbone or the presence 
of a desired mutation within a gene, plasmid DNA had to be isolated from the transformed 
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E. coli DH5α strain. For plasmid DNA isolation, the E.Z.N.A.® Plasmid Mini Kit was used 
based on the manufacturer’s instruction. 
 
2.2.2.7 DNA sequencing 
Isolated plasmid DNA was analyzed, and successful cloning and mutagenesis 
experiments were confirmed by sequencing at the company Eurofins Genomics 
(Ebersberg, Germany). 
 
2.2.3 Biochemical methods 
 
2.2.3.1 Recombinant protein expression in E. coli  
Overnight (ON) culture 
Heterologous protein expression started by picking a single colony growing on the LB-
agar with appropriate antibiotic, and inoculating 5 mL of the LB media with appropriate 
antibiotic. The culture was incubated overnight at 37˚C at 200 rpm.  
Culture conservation 
For long-term storage of E. coli cells, 500 µL of E. coli cells (ON culture) were mixed with 
500 µL of a solution of 50 % v/v glycerol (sterilized, reaching the 25 % v/v end 
concentration) and stored at -80 °C. In case of conservation of the mutant library culture 
in 96-well microtiter-plates, 100 µL of E. coli cells (ON culture) were mixed with 100 µL 
of a solution of 50 % v/v glycerol (sterilized, reaching the 25 % v/v end concentration) 
and stored at -80 °C. 
Expression of β-etherases and glutathione lyases  
Heterologous expression of the β-etherases and glutathione lyases was performed in E. 
coli BL21 (DE3), E. coli BL21 Gold (DE3) or E. coli C43 (DE3) strains using the T7 
expression system providing a high-level expression. T7 RNA polymerase, encoded in 
the genomic DNA of the E. coli strains combined with strong T7 promoter (pET-28a(+), 
pETDuet-1) or trc promoter (pIT2) allows controlled heterologous expression induced by 
the isopropyl-β-D-thiogalactopyranoside (IPTG). 
Heterologous protein expression was generally done in 500 mL TB media (2 L flask) with 
the respective selection markers. Prepared ON culture was used to inoculate 500 mL of 
TB media (1 % v/v inoculum). The cells were grown at 37 °C at 200 rpm until they 
reached OD600 of 0.4-0.6 (approx. 2 hours). After the induction with 0.1 mM of IPTG, 
expression was performed overnight (18 h) at 20˚C (the co-expression experiments were 
performed at variety of temperatures and lengths (chapter 3.2.2)). After the protein 
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expression, the cells were harvested by centrifugation at 4,000 rpm for 30 min at 4 °C, 
cell pellet was washed and stored at -20 °C until further experiments. 
 
2.2.3.2 Enzyme purification 
All of the expressed proteins, with intention of use as a purified enzyme, were designed 
to contain N-terminal hexahistidine tag, allowing relatively simple protein purification by 
immobilized metal affinity chromatography (IMAC). The principle of the IMAC purification 
is based on the specific interaction of the histidine to the immobilized metal ions (Ni2+, in 
our case). Target protein with the polyhistidine tag binds to the Ni2+ ions immobilized over 
NTA (nitrilotriacetic acid) groups on sepharose beads. After the successful binding of the 
target protein, non specific proteins of the cell were rinsed and the bound desired protein 
was eluted with the increased imidazole concentration. 
Purification using an ÄKTA FPLC system 
Cells pellets, prepared as described previously, were resuspended in the binding buffer 
containing 1 tablet of cOmplete™ Protease Inhibitor Cocktail per 10 mL of the cell 
mixture. Afterwards, cell mixture was lysed by sonication (5 min of active pulsing, 5 s 
pulse, 10 s break; at an amplitude of 60 %, on ice). Produced cell lysate was centrifuged 
(18,000 g, 20 min, 4˚C) resulting in separation of cell debris and cell-free extract (CFE). 
Further, CFE was filtered through a 0.45 μm cellulose acetate membrane filter prior 
loading it on an equilibrated HisTrapTM FF/HF column. Volume of the column was 5 mL, 
and the equilibration of the column was performed with 5 column volumes (CV) of binding 
buffer at a flow rate 1 mL/min. The filtered CFE was loaded to the column with a flow 
rate of 1 mL/min. The non-specific proteins were eluted by washing the column with 15 
CV of equilibration buffer with a flow rate of 1 mL/min. Afterwards, the concentration of 
the imidazole was gradually increased from 20 to 500 mM by mixing the binding buffer 
with the elution buffer over 60 minutes with a flow rate of 1 mL/min. Fractions of 1.8 mL 
were continuously collected and the elution of the target protein was followed by the 
changes of the intensity of the UV signal at 280 nm. 12 µL samples of the eluted fractions 
were analyzed by SDS-PAGE (2.2.3.3, SDS-PAGE) to determine the purity of each 
fraction. Fractions without impurities were pooled together and concentrated via 
ultrafiltration (Amicon Ultra-15 Centrifugal Filter with 10 kDa cut-off, Merck Millipore, 
Darmstadt, Germany). PD-10-columns (GE Healthcare) were used to change the buffer 
from elution to the protein storage buffer. The protein concentration was calculated with 
the extinction coefficient of the particular purified protein and the absorption at 280 nm 
measured with the NanoPhotometer NP80. 100 µL aliquots of the protein were stored at 
-20 °C until further use. 
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Purification using gravity flow columns 
For the purification of the smaller amounts of enzyme or in cases when several proteins 
had to be purified simultaneously, gravity flow columns were used. 100 mL of the cell 
culture with expressed protein was reprocessed (harvested, lysed and centrifuged) as 
before. Filtered CFE was loaded on an equilibrated column containing 2 mL of 
SepharoseTM 6 Fast Flow resin. After the CFE was loaded on the column, the column 
was washed with 10 CV of the binding buffer allowing non-specific proteins to wash out. 
Afterwards, the column was washed with 10 CV of the pre-elution buffer, with increased 
imidazole concentration, allowing the proteins with naturally high histidine contend to be 
washed out. And finally, the desired protein was washed out with 10 CV of the elution 
buffer. Received protein solution was subsequently concentrated, the elution buffer was 
replaced by the protein storage buffer and the protein was stored as described before.  
 
2.2.3.3 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Visualization and separation of the protein samples based on the size was performed 
using SDS-PAGE. Because the structural folding of the protein might influence the 
migration through the gel, the proteins were denatured with SDS and mercaptoethanol 
prior to the separation.  In the presence of SDS and a mercaptoethanol (cleaving 
disulfide bonds critical for proper folding) proteins were unfolded into linear chains with 
negative charge proportional to the molecular weight. Separation of the proteins was 
performed within the gel of acrylamide and bis-acrylamide, crosslinked by 
tetramethylethylendiamine (TEMED) and ammonium persulfate (APS). The gel hinders 
the migration of protein molecules in the electric field depending on their size. As result, 
the smaller molecules migrate faster than bigger molecules. 
For the typical separation, 12 % v/v acrylamide gels were used (composition in Tab. 
2.19). Prepared samples (either purified protein, CFE, or cell suspension) were mixed 
with 4x SDS PAGE-sample buffer, heated to 95˚C for 10 min, and centrifuged. 
Afterwards, 12 μL samples were loaded to the gel and run at 80 V for 10 min to allow the 
protein sample to penetrate through the stacking gel, followed by approximately 60 min 
at 120 V. The separation was performed using SDS PAGE-running buffer as electrolyte. 
After the protein separation, the gel was stained in the SDS PAGE-gel staining solution 
for 3 hours. Subsequently the gel was destained using SDS PAGE-gel destaining 
solution, preferably over night.  
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Tab. 2.19: Composition of the two gels that creates a 12 % v/v acrylamide SDS-PAGE gel. 
Component Stacking gel Running gel 
MilliQ water 1500 μL 2250 μL 
Acrylamide (40 %) 375 μL 1500 μL  
1.5 M Tris-HCL (pH 8.8), 0.4 % SDS - 1250 μL 
0.5 M Tris-HCL (pH 6.8), 0.4 % SDS 625 μL - 
10 % w/v APS 25 μL 50 μL 
TEMED 2.5 μL 5 μL 
 
2.2.4 Enzyme characterization 
 
2.2.4.1 Activity assays 
Specific activity of an enzyme is an important characteristic used to describe and 
compare enzymes catalyzing the same reaction. The measure of catalytic ability 
represented by enzyme activity can be quantified by the decrease in substrate 
concentration in a period of time or by the increase in concentration of a product after a 
period of time. For the characterization of β-etherases and glutathione lyases, the 1 mL 
reactions were performed. 
β-Etherase activity assay 
The β-etherase activity of each purified enzyme towards 1 and 2 was determined by 
quantifying the amount of released 2,6-dimethoxyphenol by HPLC. The quantification of 
the 2,6-DMP was performed by using calibration curve of respective commercial 
standard (Sigma–Aldrich). The 1 mL assay mixture contained 100 mM glycine/NaOH 
buffer, pH 9.5; 0.2 mM of substrate (dissolved in DMSO, final DMSO concentration, 5 % 
v/v); 1 mM of reduced GSH (5 eq. to the substrate), and 0.5-10 μg of purified β-etherase. 
Reactions were carried out at 25˚C and stopped by addition of 0.33 volume equivalents 
of 3.55 M H2SO4 (final H2SO4 concentration, 0.89 M) after different incubation times. 
Precipitated protein was removed by centrifugation (15,000 g for 5 min), and the 
supernatant was analyzed on HPLC system. HPLC chromatogram is shown in chapter 
7.7. One unit was defined as the amount of enzyme that converts 1 μmol of substrate 
per min. Specific activity was expressed as milliunits per milligram of protein. 
Ability of β-etherases to cleave ether bond in non-lignin substrates 30, 31, 32, 33, and 
34 was determined by decrease of peaks and formation of novel peaks observed on 
HPLC chromatograms. The 1 mL assay contained (10 reactions were prepared for each 
enzyme + 5 control, non-enzymatic reactions) 100 mM phosphate buffer, pH 8; 0.2 mM 
of substrate (dissolved in DMSO, final DMSO concentration, 10 % v/v); 1 mM of reduced 
GSH (5 eq. to the substrate), and 50 μg of purified β-etherase. Reactions were carried 
out at 25˚C with shaking 800 rpm. In the desired time point, whole volume of two 
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enzymatic reactions and one control reaction were stopped by dilution with DMSO in 
1:10 ratio to assure complete dissolving of the substrate and possible product/s. 
Precipitated protein was removed by centrifugation (15,000 g for 5 min), and the 
supernatant was analyzed on HPLC system.  
Glutathione lyase activity assay 
The glutathione lyase activity of each purified enzyme was determined by quantifying the 
amount of released veratryl glycerol (VG) or by quantifying the amount of released 3,4-
dimethoxyacetophenone (3,4-DAP) by HPLC. The quantification of VG was performed 
by using the calibration curve of enzymatically prepared VG (extracted and purified) and 
quantification of 3,4-DAP was performed by using the calibration curve of respective 
commercial standard (Sigma–Aldrich). The 1 mL assay mixture contained 100 mM 
glycine/NaOH buffer, pH 9.0; 0.2-0.4 mM of substrate; 1-2 mM of reduced GSH (5 eq. to 
the substrate), and 0.1-5 μg of purified glutathione lyase. Reactions were carried out at 
25˚C and stopped by addition of 0.33 volume equivalents of 3.55 M H2SO4 (final H2SO4 
concentration, 0.89 M) after different incubation times. Precipitated protein was removed 
by centrifugation (15,000 g for 5 min), and the supernatant was analyzed the HPLC 
system. HPLC chromatogram is shown in chapter 7.7. One unit was defined as the 
amount of enzyme that converts 1 μmol of substrate per min. Specific activity was 
expressed as units per milligram of protein. 
Vanillin release assay and enzyme kinetics 
The β-etherase activity of each purified enzyme (or prepared CFE) towards 3 was 
determined by continuous following of released vanillin by spectrophotometer. The 
quantification of the vanillin was performed using calibration curve of respective 
commercial standard (Sigma–Aldrich). The reactions were performed in 96-well 
microtiter-plates. The 200 μL assay mixture contained 100 mM glycine/NaOH buffer, pH 
9.5; diverse substrate 3 concentration (0.05, 0.075, 0.1, 0.2, 0.3, 0.4, 0.5, 0.75, 1.0, 1.25, 
1.5, 1.75, 2.0, 2.5, 3.0, 3.5 and 4.0 mM) while the DMSO, in which the substrate was 
dissolved, was kept at 10 % v/v. The concentration of the GSH was kept at 15 mM to 
ensure the saturation and the amount of each enzyme was kept constant (1-50 μg), while 
in case of CFE, 10 μL was used for the reaction. The reaction progress was monitored 
by absorption at 360 nm every 8 s for the 81 s reaction. The slopes from the measured 
reaction points were used in calculations. Relation between VG concentration and 
spectrophotometric response was calculated based on the calibration curve shown in 
chapter 7.11. One unit was defined as the amount of enzyme that converts 1 μmol of 
substrate per min. Specific activity was expressed as milliunits per milligram of protein. 
The kinetics parameters for β-etherases were determined by fitting the experimental data 
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with either the Michaelis-Menten equation (Eq. 1) or the Hill’s equation (Eq. 2) to include 
cooperative bindings in the fitting. Reaction rates (V) at different substrate concentrations 
([S]) were measured in order to determine KM (substrate concentration at which the 
reaction rate is at half-maximum), Vmax (maximum rate at a given enzyme concentration), 










               (𝑬𝒒. 𝟐) 
The kinetic parameters relative to β-etherases and substrate 3 were calculated by 
keeping the enzyme and GSH concentrations constant and varying the substrate 
concentration. Kinetic analyses of all prepared mutants in this thesis are shown in 
chapter 7.8. 
 
2.2.4.2 Selectivity assays 
E-value 
The selectivity of an enzymes is commonly quantified by the E-value. The E-value 
describes how effectively/preferentially the enzyme converts one enantiomer of a 
racemic mixture of a substrate. An E-value of a non-selective enzyme is described by 
value 1. The E-value of a strictly selective enzyme (only one enantiomer is converted) 
displays the E-value of ≥200. Due to the exponential increase of the analytical error in 
logarithmic formula, the E-values higher than 200 are not applied 130. The selectivity of 
the β-etherases was determined by using chiral HPLC analysis with a Chiralcel OD-RH 
column (4.6 × 150 mm). Biocatalytic reactions were performed as described in 2.2.4.1 
(β-etherases activity assay). The selectivity was calculated based on the decrease of the 
each 2,6-MP-VG enantiomers according to Eq. 3 130. 
E =
𝑙𝑛[(1 − 𝑐)(1 − 𝑒. 𝑒𝑆)]
𝑙𝑛[(1 − 𝑐)(1 + 𝑒. 𝑒𝑆)]
                 (𝑬𝒒. 𝟑) 
R/S ratio 
The selectivity of the glutathione lyases could not be calculated via E-value, since the 
enantiomers of the racemic substrate could not be separated by HPLC. Therefore, the 
specific activity towards each enantiomer was determined as described in 2.2.4.1 
(glutathione lyases activity assay) and compared. 
 
2.2.4.3 Tryptophan fluorescence assay 
Changes of the intrinsic tryptophan fluorescence upon titration with substrates 1, 2, 4, 5, 
and 6 were followed on a CLARIOstar microtiter plate reader. The reactions were 
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performed in 96-well microtiter-plates for fluorescence measurement (black). The 
starting volume of 200 μL consisted of the enzyme solution with concentration of 500 
μg/mL in 100 mM glycine buffer, pH 9.0. Emission spectra from 320 to 360 nm were 
recorded after excitation at 295 nm. The maximum emission wavelength of the intrinsic 
fluorescence of the protein was determined to be at 340.6 nm. Based on this, the change 
in intrinsic fluorescence intensity during titration with the ligand stock (10 mM, solved in 
DMSO) was measured at 340.6 nm. After each ligand titration, the fluorescence was 
measured. Values were corrected for dilution and also the changes of the fluorescence 
intensity caused by the DMSO (without ligand) were subtracted. Apparent binding 
constants were obtained by nonlinear regression. The fluorescence intensities were 
measured over a range of ligand concentrations and were subsequently fitted by 
nonlinear regression using Eq. 4, in which F is the observed relative fluorescence 
intensity, F0 the fluorescence intensity of the enzyme without ligand present, ΔFmax 
fluorescence change, [X] the ligand concentration, and KD the binding constant. 
𝐹 = [1 − (𝐹0 +
∆𝐹𝑚𝑎𝑥 ∙ [𝑋]
𝐾𝐷 + [𝑋]
) ]  ∙ 100 %            (𝑬𝒒. 𝟒) 
 
2.2.4.4 Isothermal titration calorimetry (ITC) 
Interactions between protein and ligand to determine the thermodynamic parameters in 
solution was performed by ITC using an MCS-ITC calorimeter. The cofactor reduced 
glutathione (GSH) was dialyzed against the LigF protein or against the LigF protein with 
the various substrate 4 concentration bound within the protein. Both, the GSH and 
proteins solution were solved with 100 mM HEPES with 10 % v/v methanol, pH 8. During 
the titration, 5 mM GSH was continuously injected into 0.1 mM of LigF protein at 25˚C in 
14 μL steps up to an 8-fold molar excess. The mixing heat of the GSH, measured by 
injecting GSH into buffer, was subtracted from the signals obtained from the binding 
reactions. ITC data of two independent measurements were analyzed using Origin V7.0 
with MicroCal ITC add-on.  
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2.2.5 Whole-cell reactions 
 
2.2.5.1 Analytical-scale reactions 
1 mL reactions containing 100 mM potassium phosphate buffer, pH 8, 0.2 mM substrate 
1 (dissolved in an organic solvent-water mixture (1:1) with a final organic solvent 
concentration of 0.5 % v/v in the reaction) and E. coli cells at an OD600 of 40 were 
performed at 25°C with shaking at 800 rpm. Samples were taken after different time 
intervals. Reactions were stopped by adding 0.33 volume equivalents of 3.55 M H2SO4 
(final H2SO4 concentration, 0.89 M), resulting also in partial cell lysis. Cells and cell debris 
were removed by centrifugation (17000 g, 10 min) before HPLC analysis. 
Conversions for optimization of enzyme expression were performed with cells at an 
OD600 of 10. Conversions for pH optimization were carried out in different reaction buffers 
with pH values of 5 - 11 using also an OD600 of 10. To study the impact of substrate 
concentration on the reaction rate, 1 was added in varying concentrations between 0.2 
and 10.0 mM, while the organic solvent concentration was fixed at 5 % v/v. Impact of the 
co-solvent and its concentration was tested using DMSO, isopropyl alcohol and 
methanol. Solvent concentrations (final concentration in the reaction mixture) were 
tested at 0.5 %, 2.5 %, 5.0 %, 7.5 %, 10.0 %, 12.5 % v/v, while the substrate 
concentration was fixed at 0.2 mM. Additionally, reactions without co-solvent were 
performed at substrate concentrations of 0.2 mM and 1.0 mM. To check the influence of 
glucose addition on the conversion of 0.8 and 10 mM 2,6-MP-VG (dissolved in methanol, 
5 % v/v final concentration in the reaction mixture), each 10 mM glucose was added to 
the reaction buffer. Increased substrate and solvent concentrations were performed in 
conversion of 10 mM 2,6-MP-VG with DMSO concentration of 5 %, 15 % and 25 % v/v. 
Reactions with recycling of the cell were performed at 5 mL volume containing cell at an 
OD600 of 40, with the substrate concentration fixed at 0.8 mM of the 2,6-MP-VG dissolved 
in DMSO or isopropyl alcohol or methanol, while the solvent concentration was kept at 5 
% v/v. In these reactions, the impact of the glucose was also tested by addition of 10 mM 
of glucose to the reaction. Reaction samples were taken after 4 hours and were 
reprocessed as described before. Remaining reaction mixture was centrifuged at 6,000 
g for 5 min. The supernatant was discarded and the cells were resuspended in the fresh 
medium containing new substrate (correlated to the volume of the sample taken). The 
cell recycle was repeated for four cycles. 
For comparison of kinetic resolutions using either E. coli C43 (DE3) cells harboring only 
LigE, E. coli C43 (DE3) cells harboring LigE and LigG-TD, or a combination of E. coli 
C43 (DE3) cells harboring LigE and E. coli C43 (DE3) cells containing LigG-TD to obtain 
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(S)-2,6-MP selectively, reactions were performed at an OD600 of 40 for each strain. The 
substrate concentration was set to 10.0 mM dissolved in methanol (final solvent 
concentration of 5 % v/v). Likewise, kinetic resolutions using either E. coli C43 (DE3) 
cells harboring only LigF-NA, E. coli C43 (DE3) cells containing LigF-NA and LigG-TD, 
or a combination of E. coli C43 (DE3) cells harboring LigF-NA and E. coli C43 (DE3) 
cells harboring LigG-TD to obtain (R)-2,6-MP selectively, were performed using the same 
reaction conditions. Relations between OD600 and dry cell weight was calculated based 
on calibration curve shown in chapter 7.11. 
 
2.2.5.2 Semi-preparative-scale reactions 
To prepare enantiopure (S)-2,6-MP-VG and (R)-2,6-MP-VG, semi-preparative-scale 
conversions were performed in 30 mL of 100 mM potassium phosphate buffer, pH 8, with 
10 mM substrate 2,6-MP-VG dissolved in methanol (final solvent concentration of 5 % 
v/v) and E. coli C43 (DE3) cells containing either LigE and LigG-TD at an OD600 of 80 or 
LigF-NA and LigG-TD at an OD600 of 40. Reactions were incubated at room temperature 
with shaking (800 rpm) and stopped by adding 0.33 volume equivalents of 3.55 M H2SO4 
(final H2SO4 concentration, 0.89 M) after 46 hours. Reaction mixtures were diluted in 1:9 
ratio using methanol. Cells were removed by centrifugation (3,488 g, 40 min) and the 
resulting supernatant was used for achiral and chiral HPLC analysis. Afterwards, the 
excess of methanol was removed again by evaporation to reduce the reaction volume 
and products were extracted from the water fraction with ethyl acetate (2x30 mL). The 
organic phases were combined and the ethyl acetate was removed by evaporation. The 
desired enantiomers (S)-2,6-MP-VG and (R)-2,6-MP-VG were purified by column 
chromatography (60M FLASH, 0.04-0.063 mm) using a mixture of dichloromethane and 
ethyl acetate in 2:1 ratio as solvent. 43 mg (80 % yield) of (S)-2,6-MP-VG and 39 mg (72 
% yield) of (R)-2,6-MP-VG were obtained as pure compounds. The enantiomers were 
dissolved in dichloromethane (c = 20 mg/mL) to determine their optical rotation on a 
Propol Digital Automatic Polarimeter (Dr. Kernchen, Seelze, Germany). Obtained 
specific rotation values for (S)-2,6-MP-VG and (R)-2,6-MP-VG are [α]20D = -21.85° and 
[α]20D = +21.15°, respectively. NMR data of both enantiomers were consistent with 
literature 110. 
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2.2.6 Protein engineering 
 
2.2.6.1 Generation of mutant libraries 
The site saturation random mutagenesis libraries were prepared via PCR reaction using 
degenerated primers (2.2.2.4, QuikChange® PCR). Afterwards, the chemocompetent E. 
coli DH5α cells were transformed (2.2.2.3, Transformation of the chemically competent 
cells), and the multiple cell colonies growing on LB agar with appropriate antibiotic were 
combined (mixed with 500 μL LB media) and the mutant library was isolated in form of 
plasmids (2.2.2.6). With isolated plasmid DNA of the library, the expressing strain E. coli 
BL21 (DE3) Gold was transformed. The single colonies were subsequently picked and 
transferred into the 96-well microtiter-plate containing 200 μL LB media with appropriate 
antibiotic. The cells were cultivated overnight at 37˚, 800 rpm. The cryo culture of the 
mutant library was prepared as described at 2.2.3.1 (Culture conservation) and sealed 
with SILVERSEAL SEALER Aluminium foil (Greiner Bio-One, Austria). The quality of the 
library was tested by sequencing of the isolated library plasmid (2.2.2.6).  
 
2.2.6.2 Recombinant protein expression in 96-well microtiter-plate format 
The expression of the created mutant libraries was performed in 96-well microtiter plates. 
The 200 μL of LB media with appropriate antibiotic and 0.1 mM IPTG was inoculated 
with 5 μL of the prepared ON-culture. The micro-titer plate was incubated for 24 h at 
20˚C with 800 rpm. During the time of the protein expression, the micro-titer plate was 
sealed with a breathable rayon film seal for biological cultures (VWR, USA) to prevent 
media evaporation and cross-contamination. Afterwards, the final OD600 of the cultures 
was measured on CLARIOstar microtiter plate reader by diluting the cell cultures in ratio 
1:20 with the LB media. The cells were harvested by centrifugation at 4000 g, 4˚C for 20 
min and stored at -20˚C until further use.  
 
2.2.6.3 Mutant library analysis 
The harvested cells from the mutant library were resuspended in 200 μL of B-PER 
(bacterial protein extraction reagent). The cells were lysed at room temperature while 
shaken at 800 rpm for 1 h. After the lysis, the cell lysate was centrifuged (4000 g, 20 min, 
4 °C), the supernatant was diluted 1:50 with storing buffer, and the prepared CFE was 
used for reaction. Analysis of the prepared mutant library was tested using vanillin 
release assay as described before (2.2.4.1 Vanillin release assay). However, in this 
case, the length of the reaction was extended to 30 min.  




2.2.6.4 Validation of interesting mutants 
Single mutants with interesting properties (increased activity, loss of activity) exposed by 
vanillin assay were validated by expressing the enzyme in 100 mL of TB media as 
described at 2.2.3.1 (β-etherases and glutathione lyases expression) and purified using 
gravity flow columns (2.2.3.2, Purification using gravity flow column). Prepared purified 
enzyme was subsequently further analyzed by HPLC. 
 
2.2.7 Analytical methods 
 
2.2.7.1 High-performance liquid chromatography (HPLC) 
HPLC is an important analytical method regularly used for separation and quantification 
of liquid samples. In this method, the sample is pumped by the mobile phase through a 
column that contains a stationary phase. Different interactions between sample 
components and the stationary phase, cause the components to move through the 
column with different average velocities and thus separating the components. One of the 
benefits of the HPLC method is that it is versatile and variety of modes are possible. The 
mode in which the mobile phase is polar and stationary phase is non-polar is called 
reverse-phase HPLC. In this thesis, the reverse-phase chromatography, where 
stationary phase consisted of small silica particles whereas the mobile phase consisted 
of mixture of polar solvents, was used. 
The samples containing substrates 1, 2, 4, 5, 6, 7, and 8 were analyzed with Nexera XR 
HPLC System with a Nucleosil® 100-5 C18 column (4.6 x 250 mm) as a stationary phase. 
The mobile phase consisted of an isocratic mixture of water, acetonitrile and 
trifluoroacetic acid (TFA) in volume ratio 49.95:50:0.05 with a flow rate of 1 mL/min. 
The samples containing non-lignin models 30, 31, 32, 33, and 34 were analyzed with 
Nexera XR HPLC System with a Nucleosil® 100-5 C18 column (4.6 x 250 mm) as a 
stationary phase operated with the flow rate of 1 mL/min using binary gradient of A (water 
and 0.1 % TFA) and B (acetonitrile) described on the Fig. 2.2.  
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Fig. 2.2: Binary gradient profile of A (water and 0.1 % TFA) and B (acetonitrile) of the analytical method for 
the analysis of substrates 30, 31, 32, 33, and 34. 
 
The chiral analysis was performed using Chiralcel OD-RH column (4.6 × 150 mm) as a 
stationary phase. The mobile phase consisted of isocratic mixture of water and 
acetonitrile in volume ratio 70:30 with a flow rate of 1 mL/min. 
 
2.2.7.2 Liquid chromatography–mass spectrometry 
LC-MS analyses were performed by Ulrike Beutling in cooperation with the Department 
of the Chemical Biology at the HZI Braunschweig in the group of Prof. Dr. Mark 
Brönstrup. For liquid chromatography, UHPLC-system a Ultimate3000RS from 
Dionex/Thermo (with autosampler, binary high gradient pump, column oven, 6-port-
column-switching-option, DAD-detector) was used. The samples were separated by 
column Kinetex 1,7µ C18 100A, 150x2,1 mm from Phenomenex as stationary phase 
operated with the flow rate of 300 µL/min using binary gradient of solvent A (water with 
0,1 % formic acid) and solvent B (acetonitrile with 0,1 % formic acid) at 40°C. Method 
gradient: 0-2 min - 1 % of solvent B, 2-20 min - 100 % of solvent B. After this analysis, 
the column was washed with 100 % B and returned to the starting conditions with 1 % of 
solvent B. Overall run time was 30 min.  
For the mass spectrometry, mass spectrometer Bruker maxis HD UHR-TOF equipped 
with source Apollo II Elektrospray was used. Within the first 0,3 min of the run a Na-
Formiat-Cluster as calibrant was infused to the system (for internal calibration). For the 
lock mass calibration with 622 m/z for positive and 556 m/z for negative ion mode 
Hexakis (2,2-difluoroethoxy) phosphazene was used. Calibrations were done in Data 
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Analysis software. Parameters for MS acquisition were as follows: source type: ESI; scan 
range: 50 – 1500 m/z; ion polarity: positive or negative; capillary voltage: 4500 V; 
nebulizer pressure: 4.0 bar; dry heater: 200°C, and dry gas: 9.0 L/min. 
 
2.2.7.3 Nuclear magnetic resonance 
NMR analyses were performed in the central facilities of the TU Braunschweig using 
Bruker Avance AVII 600 NMR spectrometer. 
 
2.2.7.4 Mass spectrometry 
MS analyses were performed in the central facilities of the TU Braunschweig by Dr. Uli 
Papke. 
 
2.2.8 Bioinformatic methods 
 
2.2.8.1 BLAST 
BLAST (Basic Local Alignment Search Tool) is an alignment based online tool provided 
by NCBI to align, compare and search for regions of local similarity between sequences. 
The program is able to compare nucleotide or protein sequences to big sequence 
databases and calculate the statistical significance of matches. BLAST can be used to 
infer functional and evolutionary relationships between sequences as well as help 
identify members of gene families. BLAST tool was used to search for the sequence-
wise related LigE and LigF homologs. Gathered sequences were align in multiple 
sequence alignment (MSA) using the free online tool BioEdit and are shown in chapters 






3.1 Production and analysis of recombinant β-etherases and 
glutathione lyases 
 
3.1.1 Heterologous production and purification of β-etherases and 
glutathione lyases 
The presented thesis is the continuation of the research performed by the Pere Picart 
that is summarized in excellent publications 105,110. Picart et al. 105,110 performed the 
cloning of the β-etherases and glutathione lyases into pET28a(+) vectors. β-Etherases 
that are used in this project are: LigE, LigF, LigP from Sphingobium paucimobilis SYK-
6; LigE-NS, LigF-NS from Novosphingobium sp. PP1Y; and LigE-NA, LigF-NA from 
Novosphingobium aromaticivorans DSM1244. Glutathione lyases used in this thesis are: 
LigG from Sphingobium paucimobilis SYK-6; LigG-NS form Novosphingobium sp. PP1Y; 
and LigG-TD from Thiobacillus denitrificans ATCC 25259. 
All of the above-mentioned enzymes were produced in E. coli BL21 (DE3) Gold. Cells 
were grown in TB media containing 50 μg/mL of kanamycin at 37˚C, 220 rpm until the 
optical density of the culture at 600 nm (OD600) reached 0.4-0.6. At that point, expression 
was induced using 0.1 mM of IPTG and the temperature was reduced to 20˚C for 18-22 
hours followed by harvesting by centrifugation. Since all of the enzymes carried an N-
terminal His-tag, the purification was carried out via immobilized metal affinity 
chromatography (IMAC) using a Ni-NTA column connected to an ÄKTA FPLC system. 
As an example, chromatograms of the purification process and the SDS-PAGE of the 
collected fractions of LigE are shown in Fig. 3.1. In order to elute the his-tagged protein 
from the Ni-NTA column, the imidazole concentration in the buffer was gradually 
increased. Proteins with no His-tag were eluted directly after the column loading, while 






Fig. 3.1: Top: Chromatogram for the purification of His-tagged LigE with the red line indicating protein elution 
via absorbance at 280 nm and the green line representing the imidazole concentration in the buffer. Bottom: 
SDS-PAGE analysis of fractions from LigE purification [lane 1: protein marker, lane 2: diluted cell debris after 
sonification and centrifugation, lanes 3-9: different fractions from the imidazole gradient for protein elution]. 
Fractions 20-26 show target protein LigE with a size of ~30kDa. Marker: PageRuler Prestained Ladder (Life 
Technologies). 
 
The fractions showing a clear band at the size of the desired protein were collected, 
concentrated and desalted. The yields of each of the purified proteins were calculated, 





Tab. 3.1: Protein yields (in mgPROTEIN/LMEDIA) of β-etherases and glutathione lyases after affinity purification 
and their molecular weight. 




LigE 34.2 40 
LigE-NS 33.0 130 
LigE-NA 33.3 76 
LigP 31.0 52 
LigF 31.8 67 
LigF-NS 30.8 146 
LigF-NA 30.6 52 
LigG 32.4 38 
LigG-NS 32.0 85 
LigG-TD 32.9 73 
 
Yields of the proteins ranged between 38 mgPROTEIN/LMEDIA and 146 mgPROTEIN/LMEDIA. When 
adding 2 mM MgSO4 to the cultivation media, the yield of LigE and LigF could be 
increased by 56 % and 190 %, respectively 270. 
During the purification process of LigF-NA, increased proteolytic activity was observed 
despite the fact that E. coli BL21 (DE3) Gold lacks the Lon and OmpT proteases which 
can degrade recombinantly produced proteins. Proteolytic digestion of LigF-NA was 
observed by formation of two distinct protein bands of similar size on the respective SDS-
PAGE gel (Fig. 3.2). Due to this, 10 μM phenylmethylsulfonyl fluoride (PSMF) and 
cOmplete™ Protease Inhibitor Cocktail were tested as protease inhibitors during cell 
disruption and purification. While using PMSF did not show any improvement, 
cOmplete™ Protease Inhibitor Cocktail prevented LigF-NA degradation. Therefore, the 
use of the cOmplete™ Protease Inhibitor Cocktail was standardly implemented into the 






Fig. 3.2: SDS-PAGE gel showing fractions of purified LigF-NA [lane 1: protein marker, lane 2: purified LigF-
NA without addition of protease inhibitor, lane 3: purified LigF-NA with 10 μM of PMSF, lane 4: purified LigF-
NA with cOmplete™]. In lanes 2 and 3 two bands at ~25kDa and ~27kDa are visible, suggesting degradation 
of the recombinant protein. Lane 4 shows target protein LigF-NA with a size of ~30kDa as one band. Marker: 
PageRuler Prestained Ladder (Life Technologies). 
 
3.1.2 Characterization of β-etherases 
β-Etherases were previously shown to cleave the β-O-4 aryl ether bond in different lignin 
model substrates as well as non-lignin ether compounds, which revealed a significant 
influence of the side chain as well as different substitution patterns on the aromatic rings 
on enzyme activity 104,107–110,112,131. Model substrates used in this work for the 
characterization of β-etherases at optimal pH and temperature are shown in Fig. 3.3. 
 
 
Fig. 3.3: Lignin model substrates and non-lignin ether compounds used in this work for characterization of 
β-etherases. [(1, rac-2,6-MP-VG): β-(2,6-dimethoxyphenoxy)-α-veratrylglycerone; (2, 2,6-MP-3,4-ON): β-
(2,6-dimethoxyphenoxy)-α-(3,4-dimethoxyphenyl)-ethan-1-on; (3, VN-VG): β-vanillinyl-α-veratrylglycerone; 
(4, rac-MTP-VG): β-(2-methoxytiophenoxy)-α-veratrylglycerone; (5, 2,6-MPL-3,4-ON): β-(2,6-






Substrate 1 represents the standard lignin model compound of β-etherases, for which 
activities have been determined previously 110. On the other hand, the corresponding 
achiral, side-chain-truncated model substrate 2 had not been tested before. Substrates 
4, 5, and 6 represent variations of model compound 1 where the aryl ether bond was 
replaced by a thioether bond or a carbon-carbon bond and the Cα carbonyl group was 
replaced by a hydroxyl group, respectively. Reactions with substrates 1, 2, 4 and 6 were 
analyzed by HPLC. In contrast, substrate 3 represents a model substrate suitable for 
spectrophotometric analysis. Hence, activity of the β-etherases towards substrate 3 was 
determined spectrophotometrically by measuring the released product, vanillin, at 360 
nm. Enantioselectivity of the enzymes in the kinetic resolution of 1 was analyzed by chiral 
HPLC which allowed separation of substrate enantiomers (R)-1 and (S)-1. Specific 
activities of all β-etherases in the conversion of substrates 1-6 as well as their 
enantioselectivities are summarized in Tab. 3.2. 
 
Tab. 3.2: Specific activities of β-etherases in the conversion of lignin model substrates 1-6 and their 
enantioselectivities in the kinetic resolution of 1. 
Enzyme Specific activity towards (U/mg) Stereoselectivity E-value* 
 1 2 3 4 5 6   
LigE 1.75 0.34 6.88 n.d. n.d. n.d. (R)-selective ˃200 
LigE-NS 1.00 0.30 3.44 n.d. n.d. n.d. (R)-selective ˃200 
LigE-NA 0.73 0.05 2.32 n.d. n.d. n.d. (R)-selective ˃200 
LigP 0.05 n.d. n.d. n.d. n.d. n.d. (R)-selective ˃200 
LigF 1.26 0.70 2.19 n.d. n.d. n.d. (S)-selective ˃200 
LigF-NS 1.60 1.30 1.43 n.d. n.d. n.d. (S)-selective ˃200 
LigF-NA 2.40 3.20 3.17 n.d. n.d. n.d. (S)-selective ˃200 
n.d.= not detected, 1U= 1 μmol/min, * calculated according to Chen et al. 130. 
 
In agreement with previously published information 107, the tested β-etherases display 
absolute enantioselectivity towards chiral substrate 1 with all E-type etherases exhibiting 
(R)-selectivity while F-type enzymes show (S)-selectivity. From the (R)-selective β-
etherases, LigE displays the highest specific activity, while LigF-NA is the most active 
among the (S)-selective β-etherases. Absolute activity values of β-etherases, however, 
differ from the ones published by Picart et al. 110. This is likely explained by the use of 
differing enzyme and substrate concentrations in reactions as well as different time 
points of sample drawing from the reactions, which will have an impact on the final activity 
values. A very similar trend for the specific activities of the β-etherases was observed 
with substrates 2 and 3, where LigE and LigF-NA were the most active (R)- and (S)-
selective enzymes, respectively. Substrates 2 and 3, however, were not converted by 
LigP. Neither of the produced β-etherases were able to convert substrates 4 and 5, in 
agreement with their specificity for ether bond cleavage. DFT calculations carried out by 




suggested that the cleavage of the thioether bond in 4 would be an endothermic reaction 
(compared to an exothermic reaction for conversion of the corresponding ether 
compound), which explains the observed lack of enzyme activity. Moreover, the 
substrate specificity of β-etherases was reported to be limited to Cα-carbonyl-containing 
lignin model substrates, whereas the corresponding hydroxyl-containing substrates are 
not converted 98–101,110. This could be confirmed in this work as no activity towards 
substrate 6 could be detected.  
To further analyze and compare the catalytic performance of the different β-etherases, 
kinetic studies using 3 as a substrate were performed to determine kinetic parameters 
KM and kcat spectrophotometrically (Tab. 3.3). 
 
Tab. 3.3: Kinetic parameters, KM and kcat, of studied β-etherases in the conversion of 3 determined at optimal 
pH, 20˚C, and with an excess of GSH. For LigF, substrate inhibition was observed. 
Enzyme  KM (mM) KI (mM) kcat (s-1) kcat/KM (mM-1 s-1) 
LigE 0.1±0.02 - 6.2±0.15 62 
LigE-NS 0.3±0.03 - 5.3±0.18 18 
LigE-NA 0.8±0.20 - 5.0±0.39 6.3 
LigF 0.9±0.16 3.6±0.97 4.8±0.56 5.3 
LigF-NS 0.7±0.07 - 3.5±0.11 5.0 
LigF-NA 0.4±0.07 - 6.0±0.26 15 
 
Similar to the specific activities of (R)-selective β-etherases, LigE exhibits the highest 
kcat. The turnover number of the LigE-NS and LigE-NA, compared to of LigE, display 15 
% and 20 % lower value, respectively. Moreover, the KM value of LigE is 3.5 and 7.5 
times lower than those for LigE-NS and LigE-NA, resulting in the highest catalytic 
efficiency of 62 mM-1 s-1 for LigE among the tested enzymes. Among the (S)-selective β-
etherases, LigF was found to display substrate inhibition with 3. This significantly affected 
the KM value of LigF for 3, which was ca. 1.5-fold and ca. 2-fold higher than that of LigF-
NS and LigF-NA, respectively. The highest turnover number of (S)-selective β-etherase 
was exhibited by LigF-NA. In contrast, the kcat of LigF and LigF-NS is ca. 20 % and ca. 
40 % lower, respectively, when compared to LigF-NA. The most active (S)-selective β-
etherase (LigF-NA) showed the KM value of 434 μM, which is ca. 2.0 and 1.5 times lower 
than those of LigF and LigF-NS, ensuring the highest catalytic efficiency of 15 mM-1 s-1 
for LigF-NA. Overall, this kinetic study confirmed that enzymes LigE and LigF-NA are the 
most efficient (R)-selective and (S)-selective β-etherases for conversion of the tested 
lignin model substrates. 
 
3.1.3 Characterization of glutathione lyases 
β-Etherases catalyze the nucleophilic attack of GSH on the β-position of model 




aromatic compound as products. Subsequently, glutathione lyases catalyze the further 
conversion of the GSH adduct with the help of another GSH molecule resulting in the 
release of GSSG and the final product. In this matter, various GSH-conjugates were 
tested in order to characterize the produced glutathione lyases (Fig. 3.4). 
 
 
Fig. 3.4: Model substrates used in this work for characterization of available glutathione lyases. [(rac-11, 
GS-VG): β-glutathionyl-α-veratrylglycerone; ((R)-11, (R)-GS-VG): (R)-β-glutathionyl-α-veratrylglycerone; 
((S)-11, (S)-GS-VG): (S)-β-glutathionyl-α-veratrylglycerone; (12, GS-3,4-ON): β-glutathionyl-α-(3,4-
dimethoxyphenyl)-ethan-1-on]. 
 
To produce GSH-conjugates, prior enzymatic reactions with β-etherases had to be 
accomplished. The substrate rac-11 was prepared from 1 by an enzymatic reaction with 
β-etherases LigE and LigF-NA. Similarly, 1 was incubated separately with β-etherases 
LigE or LigF-NA to synthesize the two enantiomers (S)-11 and (R)-11, respectively. The 
achiral model substrate 12 was synthetized using β-etherase LigF-NA as a biocatalyst 
and 2 as the substrate. All subsequent glutathione lyase reactions were analyzed by 
HPLC (Tab. 3.4). 
 
Tab. 3.4: Specific activities of glutathione lyases determined in reactions with different model substrates. 














LigG 5.01 5.42 0.62 9 3.6 
LigG-NS 14.8 16.9 0.42 42 2.8 
LigG-TD 11.0 13.3 6.21 2 2.0 
 
LigG-NS displayed the highest specific activity towards racemic 11. LigG and LigG-NS 
show strong preference for conversion of the (R)-substrate over the (S)-enantiomer. In 
contrast, LigG-TD converts (R)-11 only twice as fast as (S)-11, which makes it the least 
stereoselective glutathione lyase among the tested enzymes. Specific activities toward 
achiral substrate 12 show relatively different trend. LigG exhibit the highest value of 3.6 
U/mg, while the values of specific activities of LigG-NS and LigG-TD are ca. 20 % and 
ca. 45 % lower, respectively. Compared to the specific activities towards substrate 11, it 
can be deducted that the tested glutathione lyases show significant structural preference 





3.2 Whole-cell catalysis using β-etherases and glutathione 
lyases 
One of the major limitations of β-etherases and glutathione lyases for biocatalytic 
applications is their dependence on GSH. This tripeptide, naturally occurring in most 
living organisms, can exist in a reduced (GSH) and oxidized (GSSG) form. GSSG is 
converted back into two molecules of GSH by glutathione reductase, an enzyme 
commonly present in living cells. The use of glutathione reductase from Allochromatium 
vinosum for GSH recycling in an enzymatic cascade employing β-etherase and 
glutathione lyase for lignin depolymerization was already tested by Reiter et al. in 2013 
119. Considering the significant amounts of GSH present in E. coli cells together with the 
enzyme glutathione reductase, the use of a whole-cell catalyst combining the most 
effective β-etherases and glutathione lyase in E. coli was attempted for intracellular β-O-
4 aryl ether cleavage. 
 
3.2.1 Cloning of β-etherases and glutathione lyase 
Based on the information gained from experiments earlier, it was decided to combine the 
two most active and enantiocomplementary β-etherases LigE and LigF-NA as well as 
the least enantioselective glutathione lyase LigG-TD in one whole-cell catalyst. The 
pETDuet-1 vector was selected as the expression vector for β-etherase genes as it 
harbours two multiple cloning sites (MSC) under control of the T7 promoter. Both genes 
were available in vector pET28a(+) 110. Hence, the Ndel restriction site of ligE was 
replaced by Ncol for subsequent cloning into MSC-1 of pETDuet-1 using restriction sites 
NcoI and HindIII. Successful insertion of the gene was verified by colony PCR and 
sequencing, yielding vector pETDuet1_ligE. In the second step, the ligF-NA gene was 
cloned to MCS-2 of pETDuet1_ligE using restriction sites NdeI and XhoI. The resulting 
vector pETDuet1_ligE_ligF-NA was again confirmed by colony PCR and sequencing and 
is shown in chapter 7.4. At the same time, the gene encoding LigG-TD was cloned from 
pET28(+)_ligG-TD into vector pIT2 using NdeI and HindIII restriction sites. Vector pIT2 
132 was chosen due to its compatibility with pETDuet-1 (different origins of replication and 
different selection markers; both inducible by IPTG). The resulting vector pIT2_ligG-TD 
was confirmed by colony PCR and sequencing and is shown in chapter 7.4. 
3.2.2 Co-expression of both β-etherases and the glutathione lyase 
Two different expression hosts, E. coli BL21 (DE3) and E. coli C43 (DE3), were co-




plasmids in the strains was ensured by growth on solid media containing ampicillin (for 
pETDuet-1 selection) and tetracycline (for pIT2 selection). Heterologous co-expression 
of LigE, LigF-NA and LigG-TD was tested to achieve the best expression levels, and at 
the same time provide the highest enzyme activity. The initial expression experiment 
using E. coli strains BL21 (DE3) and C43 (DE3) was performed at 20˚C using Terrific 
Broth (TB) media. The activity of the produced whole-cell biocatalyst was concurrently 
tested in the conversion of 1. HPLC analysis confirmed the formation of 2,6-MP, GS-
βVG and the final product VG in both E. coli strains. The reaction using E. coli C43 (DE3) 
led to a complete conversion of substrate 1 within 5 h of reaction along with quantitative 
formation of 2,6-MP and VG. In contrast, the E. coli BL21 (DE3) strain did not achieve 
full conversion in either of the two steps of the cascade reaction, even after 20 h (1320 
min) (Fig. 3.5). Hence, E. coli C43 (DE3) seemed to be the better host for co-expression 
of the target proteins and, thus, was selected as host for all further experiments. 
 


























 E. coli C43 (DE3)
 E. coli BL21 (DE3)
 
Fig. 3.5: Conversion of substrate 1 using two different strains of whole-cell catalyst (4.33 g/L dry cell weight 
in 1 mL reaction). Each reaction was carried out in triplicate using 0.2 mM of substrate. 
 
The following expression experiments were carried out at 17, 20, 25, 30 and 37°C and 
the possible impact of the length of expression was tested after 18 h and 44 h. The goal 
was to achieve the highest activity of the whole-cell catalyst. For this, the activity of the 
resulting E. coli C43 (DE3) cells harboring LigE, LigF-NA and LigG-TD upon expression 
at different temperatures and for different cultivation times was compared. As a result, 




Higher or lower expression temperatures, as well as a prolonged cultivation time resulted 
in an evident decrease in activity. 
 
Tab. 3.5: Activities of whole-cell catalyst E. coli C43 (DE3) (pETDuet1_ligE_ ligF-NA) (pIT2_ligG-TD) 
towards the model substrate 1 depending on the length and temperature of expression. 
Length of expression (h)  18  44 
Temperature of expression (˚C)  17 20 25 30 37  20 25 30 37 
Activity (mU/gDCW)  55 81 44 18 17  37 30 18 9 
 
SDS-PAGE was used in an attempt to confirm expression of the three proteins. This, 
however, was complicated due to the very similar sizes of the proteins: 34 kDa, 31 kDa 
and 33 kDa for LigE, LigF-NA, LigG-TD, respectively. In order to improve the separation 
of the proteins on an SDS gel, the acrylamide concentration in the separation gel was 
increased to 20 % (compared to the standard 12 %), unfortunately with no enhancement 
in protein separation (Fig. 3.6). 
 
 
Fig. 3.6: SDS-PAGE analysis of purified enzymes LigF-NA, LigE and LigG-TD as well as cell-free extract 
(CFE) of E. coli C43 (DE3) harboring LigE, LigF-NA and LigG-TD. Marker: PageRuler Prestained Ladder 
(Life Technologies). 
 
Despite the inefficient separation of the proteins, sufficient expression of each protein 
was confirmed by chiral and achiral HPLC assay, as well as proteomic analysis of the 
produced cells. Proteomic investigation affirmed major amounts of LigE compared to Lig-
FA and LigG-TD, which in our whole-cell reactions presents an advantage since LigE 





3.2.3 Determination of pH optima  
Expressed β-etherases and glutathione lyase possess pH optima in the alkaline range 
(9-9.5) 105,110, which allows a nucleophilic attack of the glutathione thiolate on the β 
carbon of the substrate. The whole-cell approach, however, has to consider conditions 
necessary for the bacterial metabolism since the desired glutathione regeneration should 
occur in the cytosol. The pH optimum of the whole-cell reaction using 1 as the substrate 
was analyzed to achieve highest activity of the whole-cell biocatalyst (Fig. 3.7). Here, 
the whole-cell reaction displayed an optimum in conversion at pH 8.0. 
 
























Fig. 3.7: pH profile of E. coli C43 (DE3) (pETDuet_ligE_ ligF-NA) (pIT2_ligG-TD)-catalyzed conversion of 1 
[pH 5: 100 mM sodium acetate buffer, pH 6: 100 mM potassium phosphate buffer, pH 7: 100 mM potassium 
phosphate buffer, pH 8: 100 mM potassium phosphate buffer, pH 9: 100 mM glycine buffer, pH 10: 100 mM 
carbonate buffer, pH 11: 100 mM carbonate buffer]. Reactions were performed in triplicate. Values are given 
as relative activities (%) with the highest measured activity (81 mU/gDCW) set to 100 %. 
 
As expected, the pH optimum of the whole-cell biocatalyst does not copy the pH optimum 
of the expressed proteins, but ensures optimal conditions required by the cells to perform 
an active cell metabolism for provision and recycling of GSH. 
 
3.2.4 Impact of co-solvent and substrate concentration 
Due to the low solubility of substrate 1 in aqueous solution, it has to be dissolved in an 
organic solvent for the cascade reaction. So far, only DMSO had been tested as a 
possible co-solvent when using isolated β-etherases and glutathione lyases 105,110. For 




low volatility and resulting problems during product work-up. Hence, besides DMSO, also 
the polar co-solvents methanol and isopropyl alcohol were selected for their ability to 
efficiently dissolve the model substrate, and their impact on the whole-cell activity at 
different solvent concentrations (0.5–12.5 % v/v) was studied. Results revealed that at 
low solvent concentration (between 0.5 % and 5.0 % v/v), the use of isopropyl alcohol or 
methanol as co-solvents yielded higher activity of the whole-cell biocatalyst compared to 
DMSO. In contrast, at higher solvent concentrations (≥5.0 % v/v), only methanol still 
appeared to be a good alternative to DMSO, as here isopropyl alcohol resulted in a 
significant activity decrease (Fig. 3.8). 
 



























Fig. 3.8: Impact of co-solvent concentration on the whole-cell catalyst activity. The concentration of 1 was 
kept at 0.2 mM. Values are given as relative activities (%) with the highest measured activity (243 mU/gDCW) 
set to 100 %. 
 
Aliphatic alcohols have been reported to damage cellular membranes 133. Alcohols with 
a longer carbon chain length are more destructive than short ones. Hence, methanol is 
a better co-solvent choice for use in whole-cell conversions at higher concentrations than 
isopropyl alcohol. For comparison, reactions with 0.2 and 1 mM of 1 were performed 
without co-solvent addition. In these, specific activities decreased by approx. 20 % for 
the reaction with 0.2 mM of 1 and by ca. 70 % for the reaction with 1 mM of 1 compared 
to reactions using the same substrate concentrations with the addition of 5 % v/v organic 




































 no organic solvent
 
Fig. 3.9: Impact of co-solvent addition on the specific activity of E. coli C43 (DE3) (pETDuet_ligE_ ligF-NA) 
(pIT2_ligG-TD) cells towards 1. In case of co-solvent addition, the organic solvent concentration was kept 
at 5.0 % v/v. All reactions were performed in triplicate. 
 
This confirms the positive effect of co-solvent addition on the reaction rate of our whole-
cell conversions by solubilizing the substrate and probably also permeabilizing the cells 
for efficient substrate uptake. 
In addition, the impact of increasing substrate concentration, dissolved in the three 
previously tested co-solvents, was investigated. Thus, analytical-scale conversions were 
performed with substrate concentrations ranging from 0.2 to 10 mM, while the co-solvent 
concentration in the reaction mixture was kept at 5.0 % v/v. Subsequent HPLC analysis 
revealed that DMSO and methanol were superior compared to isopropyl alcohol at 
































Fig. 3.10: Impact of substrate 1 concentration on the whole-cell activity. Co-solvent concentration was kept 
at 5.0 % v/v. Values are given as relative activities (%) with the highest measured activity (1.1 U/gDCW) set 
to 100 %. All reactions were performed in triplicate. 
 
With 5.0 % v/v isopropyl alcohol as a co-solvent, a significant drop in activity was 
observed for substrate concentrations above 1.5 mM. This is to a lesser extent also 
observed with DMSO as the co-solvent. In comparison, methanol exhibited the lowest 
negative impact on the whole-cell activity in reactions with >2.0 mM substrate. Based on 
these results, methanol seems to be the best co-solvent choice among the tested ones 
to be applied in semi-preparative-scale conversions of our lignin model substrate, where 
a high substrate concentration is desired. 
 
3.2.5 Impact of glucose addition 
Depletion of GSH within the cell causes an activation of the pentose phosphate pathway, 
which produces NADPH and different sugar phosphates starting from glucose. The 
generated sugars can serve as precursors for the de novo synthesis of glutathione, while 
the NADPH cofactor is required by glutathione reductase to convert GSSG into GSH 134. 
For this reason, the addition of glucose to the whole-cell conversion was performed to 
supply the cells with a carbon and energy source for efficient NADPH and GSH 
production. Initially, the whole-cell reaction was performed with 0.8 mM of model 
substrate 1 and addition of 10 mM glucose. Interestingly, no improvement in conversion 
was observed upon glucose addition (Fig. 3.11). To check whether glucose addition 
might be beneficial at higher substrate concentrations, the whole-cell reaction was 




expected intracellular GSH concentration already by a factor of 57 or more 135,136. 
Nevertheless, glucose addition did not result in higher conversion of the lignin model 
substrate compared to reactions without glucose addition (Fig. 3.11). In both cases, 
however, no full substrate conversion was achieved within 22 h of reaction (48 % 
conversion with and 49 % conversion without glucose addition), suggesting that the 
limitation in the reactions is not caused by the lack of carbon source (GLC) in the 
reaction, but may be caused by slow reaction rate causing the degradation of the cells 
or by substrate inhibition. 
 





















 10 mM GLC
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Fig. 3.11: Impact of glucose (GLC) addition on the conversion of 1 to final product VG at two different 
substrate concentrations. Reactions were performed in triplicate. 
 
A higher solvent (DMSO) concentration (15 % v/v and 25 % v/v) was tested in the 
reaction with 10 mM of 1 to investigate the possible impact on the conversion rate. 
Increased solvent concentration ensures larger amounts of substrate to be dissolved and 
thus more substrate could be converted. However, as shown before, the increased 
organic solvent concentration has damaging effect on the biocatalyst. Investigation of 
the impact of 10 mM glucose addition to the reactions was also tested in these “harsher” 
conditions. HPLC analysis allows simultaneous analysis of both reaction steps of the 
cascade, and thus enables calculation of conversions for every step of the cascade 





Tab. 3.6: Conversion of substrate 1 to intermediate rac-11 (first step of the cascade, catalyzed by β-
etherases), conversion of rac-11 to product VG (second step of the cascade, catalyzed by glutathione lyase) 
and overall conversion of 1 to final product VG by E. coli C43 (DE3) (pETDuet1_ligE_ligF-NA) (pIT2_ligG-
TD) at increased DMSO concentrations compared to the standard reaction with 5 % v/v of DMSO with and 
without glucose addition. 
Concentration  




1 to rac-11 (%) 
Conversion of 
 rac-11 to VG (%) 
Overall conversion of 
1 to VG 
25 - 18.3 65.2 11.9 
25 10 mM 23.5 94.2 22.1 
15 - 23.0 80.8 18.6 
15 10 mM 27.0 96.3 26.0 
5 - 48.9 99.9 48.9 
5 10 mM 48.2 99.9 48.2 
 
Based on the HPLC data, the increased amount of DMSO had a negative effect on the 
conversion rate of both steps of the cascade. Interestingly, the increased solvent 
concentration had a larger effect on the reaction catalyzed by β-etherases (first step of 
the cascade) than on the reaction catalyzed by glutathione lyase (second step of the 
cascade), especially when glucose was added to the reaction. The low conversion rate 
of the first reaction could be caused by limited amount of LigF enzyme available since 
proteomic analysis confirmed mostly LigE expression. In that case, mainly one 
enantiomeric form of substrate would be converted, creating a “bottleneck:” of the 
cascade. Additionally, results show that when higher amount of the organic solvent in 
the reaction is used, the addition of the glucose has beneficial impact on the conversion. 
In the reaction with 25 % of DMSO, the first step of the reaction exhibit improvement in 
conversion by approx. 5 % and the second by ca. 30 % when comparing to the reaction 
without glucose addition. In the reaction with 15 % of DMSO, the addition of glucose 
enhanced the conversion of the first and second step of the conversion by approx. 4 % 
and 16 %, respectively. Beneficial impact of glucose addition in conversion rate in higher 
DMSO concentration is probably caused by better stress resistance. Cells with carbon 
source (GLC) available, can use the glucose for biosynthetic or assimilatory reactions, 
that are necessary due to the damage caused by high DMSO concentration (physical 
damage, cell wall disruption). Despite the fact that positive impact of the GLC was 
observed in both steps of the cascade with increased solvent concentration, the overall 
conversions are at levels of 22.1 % for reaction with 25 % of DMSO and 26.0 % for the 
reaction with 15 % of DMSO. These conversion rates were significantly lower than in 
standard reaction with only 5 % of DMSO. 
 
3.2.6 Repeated cell use 
One of the major benefits of using a whole-cell catalyst compared to a free enzyme is 
the possibility to recycle the cells in multiple rounds of reaction. However, drawbacks 




purification, lost of catalytic activity and viability of the catalyst, and production of 
unwanted by-products and/or degradation compounds. Due to the fact that the used 
lignin-model compound 1 is relatively small and hydrophobic and thus is able to 
permeate the cell wall, the possibility of a repeated use of the whole-cell catalyst in the 
reaction was explored. This way, the ability of the cells to regenerate the cofactor GSH 
in multiple rounds of the reaction was analyzed. At the same time, the addition of 10 mM 
glucose was also tested to inspect its effect on GSH regeneration and the reusability of 
the whole-cell biocatalyst. All three previously tested organic solvents were applied in 
reactions using 0.8 mM of 1 for comparison. Reactions were performed in 5 mL scale for 
4 hours. Afterwards, the sample was taken and the remaining reaction mixture was 
centrifuged at 6,000 g for 5 min. The supernatant was discarded and the cells were 
resuspended in the fresh reaction buffer containing substrate. The cell recycle was 
repeated for four cycles and the initial activities and conversion rates of each 4-hour 






Fig. 3.12: (A) Relative initial activity of the whole-cell catalyst towards model substrate 1 in repeated reaction 
cycles using different solvents with and without the addition of glucose. Values are given as relative initial 
activities (%) with the highest measured activity (0.73 U/gDCW) set to 100 %. All reactions were performed in 
triplicate. (B) Conversion of the whole-cell catalyst towards model substrate 1 in repeated 4-hour reaction 
cycles using different solvents with and without the addition of glucose. 
 
Subsequent HPLC analysis revealed several conclusions. As shown before (see section 
3.2.5), the impact of glucose addition on the initial activity of the catalyst in the first cycle 
is marginal and independent from the solvent used to dissolve the model substrate. In 
all cases though, the reactions with added glucose exhibit slightly higher initial relative 
activity (≤6 %). In agreement with previous results, using DMSO and MeOH as a co-
solvent result in a better reaction performance compared to isopropyl alcohol. Moreover, 
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for the second and third cycles of the reaction with added glucose, higher initial relative 
activities are obtained compared to their glucose free counterparts. In the second round 
of reactions using DMSO, IPA and MeOH with glucose addition, 11 %, 15 % and 21 % 
improvements in the initial activity, respectively, compared to the reactions with no 
glucose are observed. In the third round of the reactions, this improvement due to 
glucose addition is even higher: 14 %, 12 % and 32 % for DMSO, IPA and MeOH, 
respectively, compared to the respective reactions with no added glucose. For the fourth 
cycle of the reaction with added glucose, higher initial relative activity was observed with 
solvent DMSO and IPA by 28 % and 12 % respectively when compared to the reactions 
without glucose. Surprisingly, the fourth cycle of the reaction using MeOH as a solvent 
is the only case when relative activity was higher in glucose-free reaction by 11 %. 
Overall, glucose appears to have a beneficial impact on the initial activity during the 
repeated use of the whole-cell catalyst. Glucose addition might strengthen the cells 
towards the mechanical stress they are exposed to (centrifugation, resuspending) and 
also prevent cell lysis, which was observed in reactions without GLC, by providing a 
preferred carbon source.  
When considering the overall yield of the reactions with the reused biocatalyst regarding 
the production of the final product VG after four cycles of each 4-hour reactions, the 
preparation with DMSO+GLC reached the best yield of 41.7 mMVG/gDCW, followed by the 
IPA+GLC reaction with 39.6 mMVG/gDCW and MeOH+GLC with 39.0 mMVG/gDCW. 
Reactions without GLC using DMSO, MeOH and IPA achieved yields of 34.0 mMVG/gDCW, 
29.8 mMVG/gDCW and 26.5 mMVG/gDCW, respectively. Based on the results, it can be 
concluded that, overall, DMSO had the lowest negative impact on the whole-cell 
biocatalyst, probably due to the fact that alcohols are much better in permeabilizing the 
cell membrane than DMSO 133,137. Therefore, higher DMSO concentrations are usually 
compatible with living cells whereas alcohols are inhibiting cell growth already at much 
lower concentration 138. Regardless of the improved yield and conversion levels of the 
cascade with glucose addition, the observed decrease of conversion in every 
consecutive reaction cycle with the reused catalyst is not in accordance with an 
economically viable process. In order to improve the economy of the cascade, the 
application of immobilized whole cells in repeated use as well as a substrate feeding 





3.2.7 Kinetic resolution of rac-2,6-MP-VG (1) using the whole-cell 
catalyst 
Since β-etherases are highly stereoselective enzymes, our E. coli whole-cell approach 
can be applied in the kinetic resolution of lignin model substrates if only one β-etherase 
is present. This way, enantiopure substrate and enantiopure glutathione adduct can be 
accessed. As proof of concept, E. coli cells harboring either LigE together with LigG-TD 
or LigE alone as well as cells containing either LigF-NA together with LigG-TD or LigF-
NA alone were employed in reactions with 1. Application of (R)-selective β-etherase LigE 
will yield (S)-2,6-MP-VG and GS-β(S)VG, whereas (S)-selective LigF-NA will produce 
(R)-2,6-MP-VG and GS-β(R)VG. If the glutathione lyase LigG-TD is present, the 
glutathione adducts GS-β(S)VG and GS-β(R)VG will be further converted to GSSG and 
VG and hence, only enantiopure substrate remains. Initial kinetic resolution experiments 
were performed in a final volume of 1 mL and with 10 mM substrate. The four E. coli 
strains E. coli C43 (DE3)(pET28a(+)_ligE)(pIT2_ligG-TD) and E. coli C43 (DE3) 
(pET28a(+)_ligF-NA) (pIT2_ligG-TD) as well as E. coli C43 (DE3) (pET28a(+)_ligE) and 
E. coli C43 (DE3) (pET28a(+)_ligF-NA) were used in parallel and results were compared 
(Tab. 3.7). 
 
Tab. 3.7: Enantioselectivity E of whole-cell reactions in the conversion of 1 (rac-2,6-MP-VG) as determined 
by chiral HPLC [eeS: enantiomeric excess of substrate]. 












E. coli C43 (DE3) ligE 21.8 18 >100 35.4 27 >100 
E. coli C43 (DE3) ligE_ligG-TD 99.9 50 >100 99.9 50 >100 
E. coli C43 (DE3) ligF-NA 69.7 42 >100 89.4 48 >100 
E. coli C43 (DE3) ligF-NA_ligG-TD 99.9 50 >100 99.9 50 >100 
aCalculated according to Chen et al. 130. 
 
E. coli cells not harboring the glutathione lyase turned out to be less efficient in the kinetic 
resolution of 1, as even after 48 h of reaction no complete separation of substrate 
enantiomers was observed. In contrast, cells also containing LigG-TD displayed 50 % 
conversion after 30 h and the chiral HPLC chromatograms confirmed formation of 
enantiopure compounds. The significantly higher efficiency in reactions with glutathione 
lyase (resulting in a higher enantiopurity of leftover substrate) compared to reactions 
without LigG-TD confirms that the glutathione lyase step, and hence glutathione 
recycling within the cell, is required for efficient conversion of 5 mM substrate 




substrate). This glutathione recycling is likely performed by glutathione reductase, which 
is present in the E. coli cytoplasm 139. Since no glucose addition was required to reach 
full conversion of one substrate enantiomer, the energy status of the cells was obviously 
sufficient to supply the required NADPH for GSH regeneration. For comparison, whole-
cell reactions were also performed by combining E. coli cells that separately produced 
β-etherase (either LigE or LigF-NA) and glutathione lyase LigG-TD. A higher conversion 
rate of (R)-2,6-MP-VG and (S)-2,6-MP-VG was obtained using E. coli strains where both 
β-etherase and glutathione lyase were co-expressed (Fig.3.13). This further confirms 
that β-etherase and glutathione lyase have to be present within the same cell to enable 






Fig. 3.13: (A) Comparison of kinetic resolutions of rac-2,6-MP-VG (1) using either E. coli C43 (DE3) 
(pET28a(+)_ligE), a combination of E. coli C43 (DE3) (pET28a(+)_ligE) and E. coli C43 (DE3) 
(pET28a(+)_ligG-TD), or E. coli C43 (DE3) (pET28a(+)_ligE) (pIT2_ligG-TD) to obtain (S)-2,6-MP-VG. (B) 
Comparison of kinetic resolutions of rac-2,6-MP-VG (1) using either E. coli C43 (DE3) (pET28a(+)_ligF-NA), 
a combination of E. coli C43 (DE3) (pET28a(+)_ligF-NA), and E. coli C43 (DE3) (pET28a(+)_ligG-TD), or E. 
coli C43 (DE3) (pET28a(+)_ligF-NA) (pIT2_ligG-TD) to obtain (R)-2,6-MP-VG. Values are given as relative 
amounts (%) of substrate enantiomers with 5 mM set to 100 %. Reactions were performed in triplicate. 
 
3.2.8 Semi-preparative scale kinetic resolution 
To demonstrate the applicability of our whole-cell cascade for the preparation of 
enantiopure (S)- and (R)-2,6-MP-VG, semi-preparative scale reactions were performed 
using 10 mM (108 mg) racemic substrate with methanol as co-solvent (final solvent 
concentration of 5.0 % v/v). Based on initial results, reactions with E. coli C43 (DE3) cells 
harboring LigF-NA and LigG-TD were carried out at an OD600 of 40 to yield optically pure 
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(R)-2,6-MP-VG. In contrast, for the preparation of (S)-2,6-MP-VG an OD600 of 80 of E. 
coli C43 (DE3) (pET28a(+)_ligE) (pIT2_ligG-TD) had to be used to achieve full 
conversion of the (R)-configured substrate enantiomer. This higher cell density 
requirement is probably caused by the stereopreference of the glutathione lyase LigG-
TD. Despite the fact that this enzyme is able to catalyze the elimination of glutathione 
from both glutathione adduct enantiomers GS-β(R)VG and GS-β(S)VG, it is less efficient 
with the (S)-configured enantiomer that is formed by LigE catalysis 105. This may cause 
slower GSH recycling in E. coli cells harboring LigG-TD together with LigE. After 46 h of 
reaction, complete depletion of one substrate enantiomer (corresponding to 50.0 % 
conversion) was achieved in both cases. Reaction work up gave 43 mg of enantiopure 
(S)-2,6-MP-VG and 39 mg of enantiopure (R)-2,6-MP-VG (Fig. 3.14) in 80 and 72 % 
isolated yield, respectively. The specific rotation values of both enantiomers were 
determined to be [𝛼]20
𝐷  = -21.85° for (S)-2,6-MP-VG and [𝛼]20







Fig. 3.14: Chiral HPLC chromatograms of rac-2,6-MP-VG (top) and pure enantiomers obtained after kinetic 
resolution of racemic substrate on semi-preparative scale (middle and bottom). 
 
3.3 Mutational analysis of β-ethereases LigE and LigF  
The ability of bacterial β-etherases to cleave the β-O-4 arylether bonds in lignin in a 
predictable, defined manner, presents an important feature for possible industrial lignin 
upgrading. Several in vitro systems for the application of β-etherases in the 




an economically profitable lignin valorizing process, not only should catalytic procedures 
be improved, but the design of more efficient variants of existing enzymes is currently a 
major objective. Recently, the crystal structures of the well studied β-etherases LigE and 
LigF from Sphingobium sp. SYK-6 were solved 112. The exact mechanism of these 
enantiocomplementary enzymes is an enduring knowledge gap, although several 
assumptions have been made based on the character of the catalyzed reaction. During 
catalysis, β-etherases form an GSH-conjugate with stereochemical inversion of the chiral 
center at the β-carbon (from β(R)-substrate to β(S)-product for LigE and from β(S)-
substrate to β(R)-product for LigF), typical for an SN2 reaction mechanism 104,112,116. 
Understanding the mechanism details of each enzyme together with identifying important 
residues is a crucial step in comprehending the enzymatic activity. 
 
3.3.1 Alanine scan of LigE residues 
The solved crystal structure of C-terminally truncated LigEΔ255 (PDB code: 4YAN) with 
the glutathione molecule bound in the active site allowed docking of the model substrate 
β(R)-2,6-MP-VG in the hydrophobic binding pocket by Dr. Hauke Voß using the program 
AutoDock Vina 140 implemented in Yasara. Based on the location of the model substrate 
in the enzyme structure, several amino acid residues located in instant proximity, as 
shown in Fig. 3.15A, were chosen for further analysis. Amino acid residues located in 
the substrate binding pocket, namely Tyr23, Trp107, Phe115, Tyr122, Phe142, and 
Trp197, were subjected to an alanine scan, in order to identify those positions with great 
influence on the enzyme’s catalytic properties. Amino acid residues Tyr23 and Tyr122 
were also exchanged by phenylalanine to investigate the importance of the hydroxyl 





   
Fig. 3.15: (A) Active site of LigE (yellow, PDB code: 4YAN) with the cofactor GSH (magenta) and the docked 
substrate β(R)-2,6-MP-VG (orange). The amino acids in proximity to the docked substrate, chosen to be 
further analyzed, are Tyr23, Trp107, Trp115, Tyr122, Phe142 and Trp197 (all cyan). (B) Amino acid residues 
of LigE (yellow, PDB code: 4YAN) interacting with GSH (magenta) in its binding pocket: Asp71, Ser72, 
Val59, Arg138 and Tyr133 (all cyan) with hydrogen bonds shown. 
 
Based on the GSH position within the LigE structure, residue Arg138, which interacts 
with the glycine moiety of GSH, was chosen to be analyzed (Fig. 3.15B). Alanine 
substitution was performed by site directed mutagenesis using the QuikChange® 
protocol. Complementary primers were designed using the triplet codons GCU, GCC, 
GCA, or GCG for alanine and UUU or UUC for phenylalanine. Codons were chosen 
based on the similarity with the codon encoding the original amino acid residue. 
Successful mutagenesis was verified by sequencing. The expression strain E. coli BL21 
(DE3) Gold was transformed with corresponding plasmids pET28a(+) containing the 
desired mutation, and heterologous expression of the resulting LigE mutants was 
performed according to chapter 2.2.3.1. Purification was carried out via immobilized 
metal affinity chromatography (IMAC) using Ni-NTA gravity columns. For all generated 
LigE mutants, activity towards substrate 1 was determined by HPLC assay and kinetic 
parameters were obtained by spectrophotometric assay using substrate 3. Results are 





Tab. 3.8: Purification yields (in mgPROTEIN/LMEDIA) and relative activities of generated LigE mutants compared 
to wild-type in conversions of 1 (2,6-MP-VG) and 3 (VN-VG). Values are given as relative activities (%) with 
the activity of WT LigE towards 1 (1748 mU/mg) and 3 (6876 mU/mg) set to 100 %. Kinetic parameters, KM 
and kcat, for LigE and its mutants in the conversion of 3 (VN-VG) were determined at optimal pH and 25˚C. 
All reactions were performed in triplicate. 
Enzyme Protein 
yield  
 Relative activity towards   Kinetic parameters in reactions with 3 







(mM-1 s-1)  (mg/L) (%)  
LigE 40  100 100  0.10±0.02 - 6.2±0.15 62 
LigE-Y23A 5.5  1.7±0.21 39±2.5  0.43±0.07 4.8±1.43 4.1±0.10 0.1 
LigE-W107A 22  7.7±0.98 14±1.9  5.1±1.06 3.6±0.99 14±2.34. 2.7 
LigE-F115A 25  6.6±1.02 4.9±0.85  1.6±0.13 - 1.7±0.05 1.1 
LigE-Y122A 29  1.0±0.01 4.7±0.36  1.0±0.05 - 1.2±0.00 1.2 
LigE-F142A 22  30±1.6 0.5±0.02  3.6±0.34 - 0.4±0.03 0.1 
LigE-W197A 23  0.4±0.00 2.1±0.12  1.7±0.38 7.3±2.41 1.0±0.06 0.6 
LigE-Y23F 25  0.1±0.00 1.2±0.03  1.5±0.15 - 0.4±0.06 0.3 
LigE-Y122F 23  39±2.0 63±4.3  0.11±0.01 - 4.1±0.02 37 
LigE-R138A 19  n.d. n.d.  - - - - 
n.d. = not detected 
 
A general lower yield of purified proteins among the mutants compared to WT was 
observed, which is probably caused by the different, less efficient purification method 
using gravity-flow columns. This gravity-flow purification made use of Ni SepharoseTM 6 
Fast Flow resin loaded in a disposable column allowing as well for protein purification via 
N-terminal His-tag. Compared to the automated process, however, gravity-flow 
purification does not permit continuous visualization of the desired protein, thus allowing 
possible loss of the desired protein during i) loading of the cell-free extract to the column 
(if the amount of resin is not adequate) or ii) during protein elution since only fractions 
eluted with the highest imidazole concentration (500 mM) were collected and combined 
to obtain the purified protein (chapter 2.2.3.2). Despite this, the yield of mutant Y23A is 
reduced more significantly, suggesting a negative influence of the mutation on the 
enzyme’s expression level.  
Moreover, all amino acid exchanges resulted in reduced activity in reactions with both 
substrates, indicating the importance of those residues for substrate binding and 
catalysis. Interestingly, the relative activity loss of LigE mutants towards substrates 1 and 
3 differs in several cases, especially for mutants Y23A and F142A. The difference 
between both substrates is the substitution pattern at the aromatic ring next to the ether 
bond. In the enzyme structure, both positions Tyr23 and Phe142 are located in <5 Å 
distance to that aromatic ring of the substrate, which could explain the substrate-
dependent impact of the mutations on enzyme activity.  
Moreover, kinetic studies performed with LigE-Y23A, LigE-W107A and LigE-W197A 




increasing substrate concentration until it reached a maximum and, as the substrate 
concentration increased further, the reaction velocity decreased again. This curve 
progression is indicative of substrate inhibition. In this specific case, the substrate 
inhibition is likely caused by the fact that racemic substrate 3 was used. As mentioned 
before, LigE is strictly stereospecific converting only the (R)-enantiomer of the substrate. 
Based on this knowledge in combination with molecular docking, it is assumed that the 
non-converted (S)-enantiomer of the substrate is able to bind to the active site of these 
mutants and thus acts as an inhibitor. This would suggest that the residues Tyr23, 
Trp107 and Trp197 are important for enzyme’s enantioselective binding. 
This substrate inhibition introduces to the kinetics equation the constant KI, describing 
the dissociation constant of the inhibitor-enzyme complex. KI indicates the inhibitor 
concentration required to produce half maximum inhibition and thus, describes how 
potent the inhibition is. 
Based on the determined kinetic parameters for conversion of substrate 3 (kinetic 
analyses are shown in chapter 7.8), most mutations seemed to negatively influence both 
KM and kcat. Moreover, variant Y122F displays similar kcat and KM values as LigE WT, 
whereas exchange of Tyr122 by alanine resulted in a 10-fold higher KM value and a 5-
fold lower kcat value. This suggests that only the aromatic ring of Tyr122 is important for 
substrate binding and conversion, while the tyrosine hydroxyl group of the residue 122 
is not. Furthermore, exchange of Arg138, the amino acid residue interacting directly with 
GSH, by alanine caused a complete loss of enzyme activity towards both substrates. 
Therefore, it can be concluded that Arg138 is crucial for GSH binding and thus LigE 
catalysis.  
 
3.3.2 Alanine scan of LigF residues 
For insights into the catalytic mechanism of β-etherase LigF, the same procedure as for 
LigE was followed. The model substrate β(S)-2,6-MP-VG was docked by Dr. Hauke Voß 
into the crystal structure of C-terminally truncated LigFΔ242 (PDB code: 4TX0) with the 
glutathione molecule located in its binding site, using the program AutoDock Vina 140 
implemented in Yasara. The active site of LigF has a tunnel-like structure and based on 
their proximity to the model substrate, several amino acid residues were chosen to be 
subjected to an alanine scan. Possible direct interactions with the model substrate were 
predicted for residues Phe7, Asn12, Cys107, Trp108, Val110, Ser111, Trp115, Ile119, 
Ile122, Pro142, Gln144, Lys147, Trp148 and Ile199 (Fig. 3.16A). Analysis of the 
positioning of GSH within the LigF crystal structure revealed several amino acid residues 




those, Gln39 was chosen for replacement by alanine as well. Results of the alanine 
scanning experiment are summarized in Tab. 3.9. 
 
   
Fig. 3.16: (A) Active site of LigF (mint green, PDB code: 4XT0) with the docked substrate β(S)-2,6-MP-VG 
(orange). The amino acids in proximity to the docked substrate, chosen to be further analyzed, are Phe7, 
Asn12, Cys107, Trp108, Val110, Ser111, Trp115, Ile119, Ile122, Pro142, Gln144, Lys147, Trp148 and 
Ile199 (all cyan). (B) Amino acid residues of LigF (mint green, PDB code: 4XT0) interacting with GSH 
(magenta) in its binding pocket: Glu65, Ser66, Gln-52, Val-53, Gln-144, His-40, Trp-148, and Gln39 (all 
cyan) with hydrogen bonds shown. 
 
Tab. 3.9: Purification yields (in mgPROTEIN/LMEDIA) and relative activities of generated LigF mutants compared 
to wild-type in conversions of 1 (2,6-MP-VG) and 3 (VN-VG). Values are given as relative activities (%) with 
the activity of WT LigF towards 1 (1262 mU/mg) and 3 (2192 mU/mg) set to 100 %. Kinetic parameters, KM, 
KI and kcat, for LigF and its mutants in the conversion of 3 (VN-VG) were determined at optimal pH and 25˚C. 
All reactions were performed in triplicate. 
Enzyme Protein 
yield  
 Relative activity towards  Kinetic parameters in reactions with 3 







(mM-1 s-1) (mg/L) (%) 
LigF 67  100 100  0.93±0.16 3.6±0.97 4.8±0.56 5.3 
LigF-F7A 33  0.6±0.12 1.8±0.96  11±8.8 0.18±0.14 0.8±0.59 0.1 
LigF-C107A 30  8.2±0.01 9.2±0.63  3.9±2.88 0.83±0.69 1.0±0.63 0.3 
LigF-W108A 18  5.9±0.11 5.0±0.15  2.6±1.32 1.4±0.87 0.6±0.27 0.2 
LigF-V110A 14  14±1.0 68±1.2  3.3±2.12 0.61±0.46 7.7±0.96 2.4 
LigF-S111A 13  0.1±0.00 1.5±0.04  0.74±0.17 3.3±0.84 0.1±0.02 0.1 
LigF-W115A 17  n.d. n.d.  - - - - 
LigF-I119A 17  4.0±0.35 3.9±0.12  5.8±0.75 2.2±0.37 0.5±0.01 0.1 
LigF-I122A 13  43±1.2 34±1.9  1.2±0.36 1.9±0.73 2.0±0.48 1.7 
LigF-P142A 16  149±2.2 184±3.2  1.7±0.76 1.5±0.82 14±4.91 8.4 
LigF-Q144A 14  14±0.5 19±2.0  1.5±0.33 2.3±0.69 1.4±0.21 0.9 
LigF-K147A 14  0.3±0.03 0.7±0.13  9.1±6.60 0.77±0.61 0.3±0.15 0.0 
LigF-W148A 7.6  n.d. n.d.  - - - - 
LigF-I199A 8.3  4.0±0.42 3.9±0.63  1.5±1.46 6.2±1.73 0.7±0.44 0.5 
LigF-Q39A 11  n.d. n.d.  - - - - 





As observed for LigE mutants, lower yields of purified LigF mutants were obtained 
compared to the WT protein (67 mgPROTEIN/LMEDIA), probably caused by the less efficient 
purification method using gravity-flow columns. However, the most significantly affected 
protein yields were detected in the mutants W148A and I199A (7.6 and 8.3 
mgPROTEIN/LMEDIA, respectively), indicating a negative impact of the mutations on the 
enzymes’ expression levels. 
As observed for LigE mutagenesis, all amino acid substitutions in LigF except P142A led 
to a reduction in enzyme activity in reactions with both tested substrates. In both cases, 
the relative activity loss follows a very similar trend. An exception is residue V110A, for 
which the loss of activity is more severe with substrate 1 than 3, suggesting a larger 
impact of this residue on the release of 2,6-dimethoxyphenol from 1 than the release of 
vanillin from substrate 3. Determined KI values show that all mutants except I199A 
possess a lower KI than WT (3.6 mM) implicating increased substrate inhibition and 
hence, a negative effect on specific activity. In case of mutant I199A, however, the KI 
value is 1.7-times higher than that of WT, suggesting lower substrate inhibition. On the 
other hand, the KM value is 1.7-times lower than that of WT implying a negative effect of 
mutation I199A on substrate binding and positioning for conversion. Obtained kcat values 
and catalytic efficiencies of other LigF mutants were generally decreased except for 
mutant P142A. This LigF mutant displayed significantly improved activity towards both 
substrates as well as a 3-fold higher kcat value in the conversion of 3. Hence, this position 
was further analyzed by site saturation mutagenesis (SSM). In contrast, amino acid 
substitutions W115A and W148A inactivated the enzyme completely as no product 
formation in the conversion of substrates 1 and 3 could be observed. To investigate this 
in more detail, position W115 was also studied further by SSM. Moreover, similar to 
mutant R138A in LigE, exchange of residue Gln39, interacting with GSH in LigF, by 
alanine caused a complete loss of enzyme activity. Complete loss of activity in mutants 
Q39A and W148A (also interacting with GSH 112) suggests that amino acids interacting 
with GSH have important role in cofactor binding and/or positioning within the enzyme 









3.3.2.1 Site-saturation mutagenesis of residue P142 
Residue P142 of LigF was selected for site-saturation mutagenesis due to the observed 
improvement in enzyme activity of mutant P142A. For generation of the SSM library of 
LigF-P142X, primers containing the degenerated NNS codon were designed and the 
library was produced using the QuikChange® protocol. To investigate the quality of the 
SSM library, the isolated plasmid library was sequenced. The obtained sequencing result 
indicated successful randomization of the desired nucleotides (Fig. 3.17). In the first and 
second position of the codon, all fours bases are present in the library, while in the third 
position only cytosine and guanine are observed, as expected from the used NNS codon 
for library generation.  
 
Fig. 3.17: Sequencing result of pET28a(+)ligF-P142NNS with the degenerated NNS codon marked. 
 
After successful transformation of the SSM library, cells were grown and LigF mutants 
were expressed in a 96-well microtiter plate. Cells were lysed within the microtiter plate 
using lysozyme or B-PER treatment to obtain cell-free extract. After addition of substrate 
3 and the GSH cofactor to each well, the activity of each mutant could be determined 
spectrophotometrically by measuring the release of vanillin at 360 nm. The measured 
slopes of vanillin production were first normalized to OD600 and the mean value of the 
wild-type controls. Additionally, the resulting data was converted to relative improvement 
or deterioration (in percent) of each reaction compared to the mean value of the WT. 
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Fig. 3.18: Results of the activity screening of the LigF-P142X library using the vanillin release assay. 
Measured slope of the reaction was normalized with OD600 and the mean value of the wild type controls and 
afterwards calculated in % of improvement/deterioration compared to the WT. Wells without cell growth are 
labeled as Ø and wild type controls are marked as underlined bold. 
 
Of the screened LigF-P142X library, mutants displaying enhanced activity were chosen 
to be sequenced and further analyzed. Among these, several hits turned out to be wild 
type containing different triplets coding for proline. Additionally, several promising non-
wild type mutants of LigF-P142X were identified, which were subsequently expressed, 
purified and characterized. Results are summarized in Tab. 3.10.  
 
Tab. 3.10: Purification yields (in mgPROTEIN/LMEDIA) and relative activities of promising LigF-P142X mutants 
compared to wild-type in conversions of 1 (2,6-MP-VG) and 3 (VN-VG). Values are given as relative activities 
(%) with the activity of WT LigF towards 1 (1262 mU/mg) and 3 (2192 mU/mg) set to 100 %. Kinetic 
parameters, KM, KI and kcat, for LigF and its mutants in the conversion of 3 (VN-VG) were determined at 
optimal pH and 25˚C. All reactions were performed in triplicate. 
Enzyme Protein 
yield 
 Relative activity towards  Kinetic parameters in reactions with 3 








(mg/L) (%)  
LigF 67  100 100  0.93±0.16 3.6±0.97 4.8±0.56 5.3 
LigF-P142A 16  149±2.2 184±3.2  1.7±0.76 1.5±0.82 14±4.90 8.4 
LigF-P142S 43  123±4.8 162±6.8  1.4±0.41 2.6±0.93 8.0±1.61 5.6 
LigF-P142Y 68  105±9.2 113±9.3  2.2±1.83 1.5±1.37 10±2.61 4.6 
LigF-P142F 16  118±2.9 147±7.4  1.9±0.80 2.1±1.06 7.6±2.36 4.0 
LigF-P142I 86  89±3.4 99±2.9  0.78±0.19 4.4±1.43 4.0±0.52 5.1 





Besides mutant P142I, all identified and characterized LigF-P142X mutants showed 
improved activity with both substrates compared to the wild type enzyme, with mutant 
P142A displaying the highest activity increase. Kinetic analyses of these mutants (shown 
in chapter 7.8) with substrate 3 revealed that this activity increase is caused by 
significantly higher kcat values, while KM values are either unchanged or slightly 
increased. Exceptions are mutants P142I and P142H, for which the obtained kinetic data 
are similar to wild-type LigF. Moreover, mutants P142A, P142Y and P142F appear to 
exhibit slightly lower KI values than the WT, suggesting that despite their increased 
relative activities, the mutations negatively affected the enzymes’ substrate inhibition. 
Assuming that the inhibition is caused by the non-converted substrate enantiomer, lower 
KI values (stronger inhibition) indicate a better binding of (R)-3 which acts as the inhibitor. 
Interestingly, the relative activity increase was in most cases higher with substrate 3 than 
substrate 1, except for mutant P142H. In case of LigF-P142H, activity was only 
significantly increased with substrate 1. 
 
3.3.2.2 Site-saturation mutagenesis of residue W115  
As substitution of W115 with alanine in LigF resulted in a complete loss of enzyme 
activity, site-saturation mutagenesis of position W115 was performed with the goal to 
investigate if tryptophan in this position is crucial for LigF catalysis or if other residues 
are accepted as well. Complementary primers were designed with altered codons for 
QuikChange® PCR to enable generation of mutants with all of the 20 standard canonical 
amino acids at position Trp115. The respective SSM library was successfully cloned, 
sequenced and mutants were produced in 50 mL media as described in chapter 2.2.3.1. 
Cell-free extract of each mutant was used to determine activity by HPLC assay using 1 
as substrate. Based on this activity test, only three mutants, W115H, W115Y and W115F, 
were still able to catalyze the cleavage of the β-O-4 aryl ether bond in 1. These mutants 
were successfully purified and characterized regarding their catalytic parameters, which 





Tab. 3.11: Purification yields (in mgPROTEIN/LMEDIA) and relative activities of active LigF-W115X mutants 
compared to wild-type LigF in conversions of 1 (2,6-MP-VG) and 3 (VN-VG). Values are given as relative 
activities (%) with the activity of WT LigF towards 1 (1262 mU/mg) and 3 (2192 mU/mg) set to 100%. Kinetic 
parameters, KM, KI and kcat, for LigF and the LigF-W115X mutants in the conversion of 3 (VN-VG) were 
determined at optimal pH and 25˚C. All reactions were performed in triplicate. 
Enzyme Protein 
yield  
 Relative activity towards  Kinetic parameters in reactions with 3 








(mg/L) (%)  
LigF 67  100 100  0.93±0.16 3.6±0.97 4.8±0.56 5.3 
LigF-W115H 29  5.2±0.96 6.5±0.25  0.88±0.16 4.5±1.60 0.1±0.07 0.1 
LigF-W115F 25  1.0±0.01 1.5±0.02  4.2±1.66 1.0±0.42 0.4±0.08 <0.1 
LigF-W115Y 24  1.0±0.00 0.8±0.00  3.0±1.17 1.5±0.67 0.1±0.04 <0.1 
 
Obtained results indicate that position Trp115 in LigF can be substituted by any other 
aromatic amino acid in order to keep some enzymatic activity. However, activity values 
towards substrate 1 and substrate 3 as well as catalytic efficiency are strongly reduced. 
Moreover, mutants W115F and W115Y exhibit significantly lower KI values, and hence 
stronger inhibition, compared to WT as well as higher KM values, implying that W115 is 
important for preferential binding of the (S)-enantiomer of the substrate (kinetic analyses 
are shown in chapter 7.8). Based on these results, it is hypothesized that tryptophan at 
position 115, which is also one of the conserved amino acid residues in LigF homologs, 
has a large impact on the enzyme’s function and that the aromatic character of the 
residue is important for the direct interaction with the substrate possibly through cation-
π interaction. The cation-π interactions are noncovalent binding forces provided by 
aromatic amino acids, in which the aromatic residues provide a surface of negative 
electrostatic potential able to bind a wide range of cations 141. In case of position Trp115, 
the cation-π interactions could arise between tryptophan or mutants W115H/F/Y 
(aromatic residues) and Lys147 as a cation, which is located in proximity (˂5Å). Cation-
π interactions are relatively common in proteins affecting the secondary structure and 
thus the catalytic properties of the enzymes. 
 
3.3.3 Serine residues involved in LigE and LigF catalysis 
Crystal structures of LigE and LigF revealed that in both proteins, serine residues are 
located in proximity to the thiol of the bound GSH 112. Several GST classes contain 
conserved catalytic serine residues, though it has been proven that in some bacterial 
enzymes, the active site serine was not essential for catalytic activity 142–144. In case of 
LigE and LigF, Ser21 and Ser13, respectively, were previously shown not to be essential 
for direct deprotonation of GSH as mutants S21A and S13A did not cause complete loss 




the active site, orienting the sulfhydryl group of GSH in the catalytic step, or stabilizing 
the transition state. In that matter, both serine residues were chosen for further analysis. 
In both cases, NNS libraries were prepared using the QuikChange® protocol and 
screened in MTP format for activity with the vanillin-releasing spectrophotometric assay. 
Since the goal was to investigate the influence of this position on substrate binding and 
conversion, not only improved, but also less active mutants were chosen to be 
characterized further. In the LigE-S21X library, a high number of wild type enzyme was 
identified among the active hits, while many mutants completely lost activity. In contrast, 
the LigF-S13X library contained more active mutants. These were successfully purified 
and the resulting activity data is summarized in Tab. 3.12. 
 
Tab. 3.12: Purification yields (in mgPROTEIN/LMEDIA) and relative activities of active LigE-S21X mutants and 
active LigF-S13X mutants compared to wild-type LigE and LigF in conversions of 1 (2,6-MP-VG) and 3 (VN-
VG). Values are given as relative activities (%) with activities of WT enzymes towards 1 and 3 set to 100% 
[LigE: 1748 mU/mg with 1 and 6876 mU/mg with 3; LigF: 1262 mU/mg with 1 and 2192 mU/mg with 3]. 
Kinetic parameters, KM, KI and kcat, for LigE-S21X and LigF-S13X mutants in the conversion of 3 (VN-VG) 
were determined at optimal pH and 25˚C. All reactions were performed in triplicate. 
Enzyme Protein 
yield  
 Relative activity towards  Kinetic parameters in reactions with 3 








(mg/L) (%)  
LigE 40  100 100  0.10±0.02 - 6.2±0.15 62 
LigE-S21A 23  1.4±0.01 3.1±0.01  0.23±0.03 - 0.2±0.00 0.9 
LigE-S21G 15  29±1.8 22±0.3  0.48±0.06 - 3.0±0.11 6.2 
          
LigF 67  100 100  0.93±0.16 3.6±0.97 4.8±0.56 5.3 
LigF-S13A 26  1.4±0.01 5.4±0.81  1.6±0.42 0.82±0.22 0.6±0.10 0.4 
LigF-S13N 28  n.d. 0.2±0.00  7.0±6.51 0.40±0.38 0.1±0.08 <0.1 
LigF-S13C 17  12±0.6 68±2.2  1.4±0.42 0.50±0.16 6.1±2.14 4.3 
LigF-S13G 17  45±2.5 80±2.3  1.2±0.16 1.6±0.26 7.5±0.70 6.0 
 
All of the tested mutants displayed a (severe) loss of activity in reactions with both 
substrates, indicating the importance of Ser21 and Ser13 for catalysis of LigE and LigF, 
respectively. Position Ser21 in the LigE enzyme is predicted to be responsible for 
activation of GSH in its thiolate form supporting the enzyme’s catalytic function. As 
described by Helmich et al. 112, Ser21 seems to be important but not crucial for LigE 
catalysis, as severe but not complete loss of activity was observed. In the SSM 
experiment, only one additional amino acid residue, glycine, was accepted at position 
Ser21 without complete loss of activity. Glycine, as the smallest amino acid with only 
hydrogen as the side chain, in mutant S21G was able to retain activity towards substrates 
1 and 3 in levels of 29 and 22 % compared to WT, respectively. Since glycine has no 




in its thiolate form, it is hypothesized that another residue is compensating for the 
absence of the serine-OH. Possibly, Tyr23, which is located in near proximity to the 
cysteinyl moiety of GSH, could provide the necessary hydrogen bridge. When comparing 
the specific activities of mutants S21A and S21G, the more dramatic loss of activity in 
the alanine variant might be explained by the larger size of the residue and possible 
structural hindering caused by methyl side chain.  
Compared to LigE, kcat values of LigE-S21A and LigE-S21G are ~10-fold and ~2-fold 
lower, respectively, while corresponding KM values are ~2-fold and ~5-fold higher, 
indicating that Ser21 is critical for both substrate binding and turnover in LigE.  
The SSM experiment performed at position Ser13 of LigF identified multiple residues 
that retained catalytic activity of the enzyme to some extend. As described before by 
Helmich et al. 112, Ser13 is important but not crucial for LigF catalysis, as the exchange 
of serine to alanine only led to a serious activity reduction. Our SSM results additionally 
revealed that glycine, cysteine and asparagine at position Ser13 kept residual catalytic 
activity of the enzyme, although the activities are evidently lower than for WT. As was 
suggested in literature, Ser13 together with Asn12 are responsible for GSH activation in 
LigF 115. According to the crystal structure of LigF, the conserved Asn12 is located in 
near proximity (3.258 Å) to the thiol group of GSH and hence, would be able to activate 
the GSH molecule by stabilizing it in its thiolate form through hydrogen-bonding (Fig. 
3.19). Glycine at position Ser13 kept activity towards substrate 1 and 3 in levels of 45 
and 80 % of WT, respectively. In mutant S13G, the small, uncharged side-chain of 
glycine probably did not affect the structural properties of the enzyme and enabled Asn12 
to activate GSH by deprotonation. In case of mutant S13A, the specific activity towards 
1 and 3 declined to 1.4 and 5.4 % of the WT value, respectively, suggesting that the 
methyl side-chain of alanine affects the enzyme’s ability to deprotonate GSH. The 
question is why in mutant S13A, the expected GSH activation by Asn12 was impaired 
as well. A possible explanation could be that alanine in position 13 does not only affect 
the activation of GSH, but also its positioning as well as the positioning of Asn12, and 
thus could negatively affect the hydrogen bonding between Asn12 and the GSH thiol. In 
contrast, cysteine at position Ser13 retained 12 and 68 % of activity towards substrates 
1 and 3, respectively. Possibly, the thiol group of cysteine may potentially form a disulfide 
bridge with the thiol of bound GSH ensuring correct positioning and deprotonation of the 
GSH within the enzyme. Asparagine in position 13 was found to reduce catalytic activity 
towards substrate 3 to only 0.2 % of the WT, while the ability to convert substrate 1 was 
completely lost. Asparagine, like serine, can form a hydrogen bond with the thiol of 




the residue, however, possibly prevented correct GSH positioning for nucleophilic attack 
and hence, hindered catalysis. Accordingly, mutants LigF-S13N and LigF-S13A display 
~50-fold and ~8-fold lower kcat values, respectively, and ~70-fold and ~16-fold higher 
KM values, respectively, than WT LigF. In contrast, mutants LigF-S13C and LigF-S13G, 
despite the decline in activity levels and an increase of KM values compared to WT LigF, 
revealed similar kcat as WT. The observed negative impact on the relative activity of the 
tested mutants is also influenced by changes in substrate inhibition. All tested mutants 
displayed significantly lower KI values compared to WT LigF. While KI of mutant S13G is 
two times lower than that of WT, mutants S13A, S13N and S13C displayed even stronger 
substrate inhibition. These results indicate that upon mutagenesis of Ser13, the affinity 
for binding of the non-converted (R)-enantiomer of the substrate increases, suggesting 
that possibly Ser13 is important for preferential binding of the right substrate enantiomer 
as well.  
 
 
Fig. 3.19: Glutathione binding site (magenta) in LigF (blue, Protein Data Bank code: 4XT0). Residues Ser13 
(yellow) and Asn12 (orange) with respective distances to the thiol group of GSH (sulphur atom of GSH 
highlighted in green) are shown. 
 
Similar to Ser13, the impact of Asn12 on LigF activity was evaluated by site-saturation 
mutagenesis. Thus, an NNS library was generated at position Asn12 using the 
QuikChange® protocol. Of the screened LigF-N12X library, mutants displaying improved 
as well as decreased activity were chosen to be sequenced and further analyzed. All of 
the generated mutants were expressed, purified and analyzed by HPLC and the 




described Ser13, a double mutant was created by substituting both amino acid residues 
with alanine (LigF-N12A+S13A). Tab. 3.13 summarizes all of the gathered data. 
 
Tab. 3.13: Purification yields (in mgPROTEIN/LMEDIA) and relative activities of active LigF-N12X mutants 
compared to wild-type LigF in conversions of 1 (2,6-MP-VG) and 3 (VN-VG). Values are given as relative 
activities (%) with the activity of the WT LigF towards 1 (1262 mU/mg) and 3 (2192 mU/mg) set to 100%. 
Kinetic parameters, KM, KI and kcat, of LigF-N12X mutants in the conversion of 3 (VN-VG) were determined 
at optimal pH and 25˚C. All reactions were performed in triplicate. 
Enzyme Protein 
yield  
 Relative activity towards  Kinetic parameters in reactions with 3 







(mM-1 s-1) (mg/L) (%) 
LigF 67  100 100  0.9±0.16 3.6±0.97 4.8±0.56 5.3 
LigF-N12A 20  2.1±0.03 11±0.9  1.1±0.13 1.4±0.20 0.6±0.07 0.5 
LigF-N12H 54  158±2.5 147±1.9  0.8±0.18 5.1±1.61 9.1±1.14 11 
LigF-N12M 1.4  84±2.9 76±1.9  0.7±0.19 2.7±0.87 3.5±0.92 5.4 
LigF-N12F 22  50±1.7 -  - - - - 
LigF-N12R 8.9  0.8±0.02 -  - - - - 
LigF-N12T 34  42±2.3 -  - - - - 
LigF-N12K 25  5.1±0.31 -  - - - - 
LigF-N12A+S13A 28  n.d. n.d.  - - - - 
n.d.= not detected, “-“=not measured 
 
The obtained results revealed that Asn12 is not crucial for catalysis but does have an 
effect on enzymatic activity. While the KM values of the tested mutants are rather similar 
to WT, the KI value of mutant N12A indicates stronger substrate inhibition compared to 
WT. In contrast, the only mutant that displayed improved relative activity towards 1 and 
3 compared to the WT, LigF-N12H, seems to exhibit slightly reduced substrate inhibition. 
This together with the significantly improved kcat value are the main driver for the 
observed higher relative activity of this mutant. Like asparagine at position 12, histidine 
will also be capable of hydrogen bonding with the –S- group of GSH through its positively 
charged imidazole side chain. Moreover, histidine serves as base for deprotonation of 
serine and cysteine side chains in other enzymes (e.g. proteases or esterases and 
lipases) due to the suitable pKa of the imidazole side chain. Hence, in contrast to 
asparagine, histidine could further support GSH activation by direct deprotonation of the 
thiol group.  
In contrast, mutagenesis of Asn12 and Ser13 together, yielding double mutant LigF-
N12A+S13A, led to an inactive enzyme variant, indicating that both residues Asn12 and 
Ser13 together contribute to GSH activation.  
 
3.4 Substrate binding analyses 
Despite the fact that LigF and LigE enzymes display a significant structural difference, 
they catalyze very similar reactions. Moreover, both enzymes possess rather 




(tyrosine, tryptophan, phenylalanine) are responsible for the intrinsic fluorescence of a 
protein. Tryptophan has a stronger fluorescence, absorption and higher quantum yield 
than the other aromatic amino acids, and its fluorescence dominates when excited at 
280 nm showing a fluorescence peak with maximum at 330–360 nm 145,146. The quantum 
yield, intensity and wavelength of the maximum fluorescence is highly sensitive to the 
microenvironment of the tryptophan molecule 146–148. Changes of the polarity in the direct 
surrounding of the molecule affects the fluorescence intensity. Changes in the 
fluorescence emission spectra of tryptophan-containing proteins can be observed in 
response to subunit association, denaturation, protein conformational transitions or 
ligand binding, all of which alter the environment surrounding the indole ring of 
tryptophan residues. In this work, this property was used in high throughput 
measurements for investigating the binding of various substrates to the active sites of 
LigE and LigF. Additionally, several measurements based on isothermal titration 
calorimetry (ITC) were performed as well.  
 
3.4.1 Substrate binding based on tryptophan fluorescence 
 
3.4.1.1 Substrate binding without GSH addition 
To analyze the affinity of the enzyme to bind the substrate, several lignin-model 
substrates were tested. First, fluorescence emission spectra of LigE and LigF were 
measured to determine their fluorescence maxima, which were in both cases observed 
at 340.6 nm, as shown in Fig. 3.20.  
 
 
Fig. 3.20: Fluorescence emission spectra of tested protein in the absence of substrate (black line) and in 
presence of increasing concentrations of substrate 1 (0.5–3.5 mM) from black line onwards. 
 










































With that knowledge, the tryptophan fluorescence of both enzymes upon titration of 
substrates 1, 2, 4, 5 and 6 was analyzed. Binding of these substrates to the proteins 
decreases its intrinsic fluorescence, indicating conformational changes in the 
microenvironment of the tryptophan residues. Plotting of the fluorescence data versus 
substrate concentration (Fig. 3.21) and fitting of the resulting titration curves using the 
non-linear regression (chapter 2.2.4.3, Eq.4) yielded binding constants KD for each 
enzyme-substrate combination (Tab. 3.14). Binding experiments were performed in the 
absence of GSH to prevent substrate conversion.  
 
 
Fig. 3.21: Binding of lignin-model substrates 1, 2, 4, 5, and 6 to the active site of WT LigE (A) and WT LigF 
(B) as observed by tryptophan fluorescence. All measurements were performed in duplicate. 
 
Tab. 3.14: Binding constants (KD) and Hill coefficients (N) of LigE and LigF for binding of the model 
substrates 1, 2, 4, 5, and 6 resulting from tryptophan fluorescence measurements. All measurements were 
performed in duplicate. 
Parameter LigE  LigF 
ligand  ligand 
1 2 4 5 6  1 2 4 5 6 
KD (μM) 196±1.6 241±5.5 129±1.0 - -  182±1.7 245±2.7 166±2.2 - - 
N 2.1 1.8 1.8 - -  1.9 1.7 2.0 - - 
 
Based on the tryptophan fluorescence assay with the enzymes LigE and LigF, several 
interesting results could be observed. Substrate 6, differing from model substrate 1 only 
in the presence of a hydroxyl group at the Cα carbon instead of a carbonyl group, yielded 
no changes in protein fluorescence during substrate titration. This suggests that this 
compound does not affect the surrounding of the tryptophan residues in the active site 
and thus, does not bind to the enzymes. This result was partially expected, since the 
tested β-etherases showed no catalytic activity towards substrate 6 (chapter 3.1.2) and 
generally, the Cα hydroxyl-containing substrates were proven not to undergo the desired 
bond cleavage 98–101,110. A lack of affinity of the enzymes towards the Cα hydroxyl-

























































































containing substrates could be one of the reasons for the absence of catalysis. In 
contrast, the titration of substrate 5, in which the aryl ether bond of 1 was replaced by 
carbon-carbon bond, seemed to affect the intrinsic florescence of both enzymes, even 
though enzymes LigE and LigF showed no catalytic activity towards substrate 5 (chapter 
3.1.2). The binding data received for the fluorescence binding assay however do not 
follow any obvious trend and therefore, it is difficult to conclude if binding of 5 to the 
active site occurs or not. Apart from that, clear binding of substrates 1, 2 and 4 to both 
enzymes, LigE and LigF, was observed by tryptophan fluorescence. The data describing 
the titration of the standard model substrate 1 could be fitted to the Hill equation and thus 
quantify the binding affinity of the enzymes LigE and LigF towards the substrate. KD 
values for LigE and LigF were found to be 196 and 182 μM, respectively. The ability of 
the enzymes LigE and LigF to convert substrate 1 (chapter 3.1.2) envisioned necessary 
binding of the substrate in catalytic site of these enzymes. The affinity of the enzymes 
LigE and LigF towards the achiral, side-chain-truncated substrate 2 yielded KD values of 
241 and 245 μM, respectively. Lower affinity of the enzymes towards the substrate 2, 
when compared to substrate 1, potentially explains lower catalytic activity observed in 
chapter 3.1.2. Surprisingly, data describing the titration of substrate 4, where the aryl 
ether bond of 1 was replaced by thioether bond, revealed the KD values for LigE and 
LigF to be 129 μM and 166 μM respectively. These results demonstrate stronger ligand-
protein affinity compared to substrates 1 and 2, even though catalysis with substrate 4 
was not detected (3.1.2) due to the different properties of the thioether bond present in 
4. DFT calculations suggested that cleavage of the thioether bond in 4 would be an 
endothermic reaction, explaining the lack of enzyme activity, whereas cleavage of the 
corresponding ether bond is an exothermic process.  
In all cases, where substrate binding was observed, a Hill coefficient N close to 2 was 
obtained. Both, LigE and LigF, are homo-dimeric enzymes. Hence, a Hill coefficient 
closed to 2 indicates that binding of the substrate to one active site influences substrate 
binding at the second active site, resulting in cooperative substrate binding. 
Additionally, several LigE and LigF mutants with reduced or increased activity or fully 
inactive were analyzed by tryptophan fluorescence assay to investigate their KD values 





Tab. 3.15: Binding constants (KD) and Hill coefficients (N) of LigE and LigF mutants for binding of model 
substrates 1, 2, and 4 in comparison to their previously determined relative activities. All measurements 
were performed in duplicate. 
Enzyme Ligand 
1  2  4 
KD (μM) N Relative 
activity 
(%) 
 KD (μM) N Relative 
activity 
(%) 
 KD (μM) N Relative 
activity 
(%)  
LigE 196±1.6 2.1 100  241±5.5 1.8 100  129±1.0 1.8 n.d. 
LigE-Y122A 145±2.1 1.6 1.0±0.01  135±4.0 1.3 0.9±0.00  77±1.2 2.1 n.d. 
LigE-Y23F 184±1.3 1.9 0.1±0.00  225±4.6 1.6 0.2±0.00  128±0.7 1.8 n.d. 
LigE-R138A 142±1.5 2.0 n.d.  112±2.5 1.3 n.d.  99±1.4 2.1 n.d. 
            
LigF 182±1.7 1.9 100  245±2.7 1.7 100  166±2.2 2.0 n.d. 
LigF-F7A 177±1.1 1.9 0.6±0.12  287±3.7 1.8 0.5±0.01  174±1.8 2.0 n.d. 
LigF-S111A 179±4.3 1.5 0.1±0.00  248±3.9 1.7 0.1±0.00  153±4.4 1.6 n.d. 
LigF-W115A 170±2.1 1.9 n.d.  276±4.9 1.7 n.d.  167±1.5 2.1 n.d. 
LigF-I122A 118±2.3 1.8 43±1.2  281±3.1 1.9 33±2.9  117±1.9 1.7 n.d. 
LigF-P142A 190±3.0 1.7 149±2.2  284±3.3 1.8 123±5.8  210±2.0 2.2 n.d. 
LigF-K147A 139±2.4 2.0 0.3±0.03  275±2.9 1.8 0.4±0.00  118±1.3 1.8 n.d. 
LigF-Q39A 199±1.5 2.0 n.d.  267±3.6 1.8 n.d.  180±1.4 2.3 n.d. 
n.d.= not detected  
 
Interestingly, the obtained results indicate that the binding of substrates 1, 2, and 4 
seemed rather unaffected in the tested mutants. This suggests that the mutants, despite 
the observed effects on activity, are still able to bind the substrates in the active site. It 
was noted, however, that the affinity for substrate 2 is in most cases lower compared to 
the other substrates. Additionally, LigF-I122A seems to have a higher affinity towards 
substrates 1 and 4 than WT LigF. Moreover, LigE mutants Y122A and R138A seem to 
have a higher affinity for all three tested substrates compared to WT. As described before 
for LigE and LigF WT, the binding of substrates 1, 2, and 4 to the mutants resulted again 
in Hill coefficients N of approx. 2, suggesting cooperative substrate binding.  
Based on the LigF structure with docked substrate 1, it was hypothesized that replacing 
the small amino acid Ala11, located at the entrance of the substrate-binding tunnel, by a 
large aromatic phenylalanine may affect access of the substrate to the active site and 
therefore influence KD (Fig. 3.22). To confirm this hypothesis, mutant LigF-A11F was 





   
Fig. 3.22: Surface of the tunnel-like active site of LigF (Protein Data Bank code 4XT0) with model substrate 
1 (orange) docked into the active site. GSH (cyan) and residue Ala11 (yellow), located at the possible 
entrance of the substrate-binding site are shown as well. (A) Wild-type LigF, (B) LigF mutant with Ala11 
replaced by phenylalanine, possibly blocking the entrance of the substrate to the active site. 
 
Tab. 3.16: Activity, kinetic parameters and KD value of mutant LigF-A11F compared to WT LigF. Activity and 
kinetic measurements were performed in triplicate, tryptophan fluorescence measurements for substrate 
binding were performed in duplicate. 
Enzyme Relative activity 
 towards  
 Kinetic parameters towards 3  Thermodynamic 
parameters to 1 












LigF 100 100  0.93±0.16 3.6±0.97 4.8±0.56 5.3  0.18±1.69 1.9 
LigF-A11F 0.5±0.01 2.0±0.01  9.4±3.59 0.53±0.22 1.3±0.42 0.1  0.18±1.88 1.8 
 
The mutant A11F, compared to WT, displayed an obvious loss in catalytic activity (˃99 
% for 1 and ˃98 % for 3) and catalytic efficiency (˃97 %), confirming a clear negative 
effect of mutation A11F on substrate binding and conversion. On the other hand, 
substrate binding described by the thermodynamic parameter KD indicated only a minor 
change (~10 %) when compared to wild-type LigF. These results suggest that, despite 
the ability of mutant A11F to bind the substrate in the active site, the 
positioning/arrangement of the substrate within the active site is altered and the 
conversion of the substrate is thus negatively affected. Furthermore, the KI of the mutant 
A11F is 7-times lower than that of WT, causing a significant increase in substrate 
inhibition, which negatively affects the mutant’s activity as well. 
 
3.4.1.2 Substrate binding with GSH addition 
All previous binding experiments with the tryptophan fluorescence assay were performed 
without cofactor GSH to prevent the reaction from occurring. We hypothesized, however, 




enzyme active site. To test this hypothesis, the tryptophan fluorescence assay was 
repeated in the presence of 1 mM GSH and 10 mM GSH (Fig. 3.23).  
 
 
Fig. 3.23: Comparison of the binding curves of model substrate 1 to the active sites of LigE (A) and LigF (B) 
without GSH cofactor (green), with 10 mM GSH (red) and with 1 mM GSH (blue). All measurements were 
performed in duplicate. 
 
Based on the obtained data, it is apparent that the binding affinity was negatively 
impacted in both enzymes in the presence of GSH. For LigE, the KD value in reaction 
with 1 mM GSH and 10 mM of GSH is approx. 2.6 and 2.8-times higher, respectively, 
than in the reaction without GSH. Similarly, for enzyme LigF, the KD value in the reaction 
with 1 mM GSH is approx. 2.4-times higher, while in the reaction with 10 mM of GSH the 
KD is approx. 2.6-times higher than in the reaction without GSH. An evident decrease of 
substrate affinity was also observed in several LigE and LigF mutants as shown in Tab. 
3.17. 
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Tab. 3.17: Dissociation constants KD and Hill coefficients N of LigE and LigF wild type and mutants with 
model substrate 1 without GSH cofactor, with 10 mM GSH and with 1 mM GSH. All measurements were 
performed in duplicate. 
Enzyme Ligand 1 
without GSH  10 mM GSH  1 mM GSH 
KD (μM) N  KD (μM) N  KD (μM) N 
LigE 196±1.6 2.1  514±29.7 1.4  545±20.2 1.5 
LigE-Y122A 145±2.1 1.6  371±19.2 1.4  419±12.4 1.6 
LigE-Y23F 184±1.3 1.9  440±72.9 1.4  466±14.3 1.6 
LigE-R138A 142±1.5 2.0  426±12.3 1.3  525±11.2 1.4 
         
LigF 182±1.7 1.9  432±20.5 1.4  473±43.9 1.5 
LigF-F7A 177±1.1 1.9  463±14.0 1.7  467±15.1 1.6 
LigF-S111A 179±4.3 1.5  320±11.7 1.5  405±10.6 1.6 
LigF-W115A 170±2.1 1.9  478±20.9 1.5  567±16.2 1.7 
LigF-I122A 118±2.3 1.8  432±21.1 1.4  533±20.2 1.7 
LigF-P142A 190±3.0 1.7  452±13.9 1.7  471±19.1 1.7 
LigF-K147A 139±2.4 2.0  456±20.4 1.4  443±41.9 1.4 
LigF-Q39A 199±1.5 2.0  437±16.8 1.6  520±14.1 1.6 
 
A possible explanation of the effect of GSH on substrate binding is that the continuous 
conversion of the bound substrate in the active site with subsequent product release 
requires a higher substrate concentration in order to achieve a certain change in 
tryptophan fluorescence. A surprising observation was made for the mutants LigE-
R138A and LigF-Q39A. Both mutated residues appear important for GSH binding in LigE 
and LigF, respectively. Despite the fact that both mutations caused a complete loss of 
enzymatic activity, likely caused by inefficient GSH binding, the addition of GSH during 
tryptophan fluorescence measurements still had a negative effect on binding of substrate 
1. Among all tested mutants and wild-type enzymes, no major difference in the effect of 
1 mM and 10 mM GSH addition was observed, suggesting that 1 mM already caused full 
saturation of the binding pocket with GSH.  
 
3.4.1.3 Binding of the cofactor GSH 
A tryptophan fluorescence assay was also attempted to measure the dissociation 
constants of LigE and LigF for binding of the cofactor GSH, but no intrinsic fluorescence 
changes were observed when GSH was titrated to the proteins. This is likely explained 
by the lack of tryptophan residues in the GSH-binding pocket. However, it was 
speculated that the binding of GSH may be followed by tryptophan fluorescence when 
substrate is already bound in the enzyme active site. A tryptophan fluorescence assay 
was performed with addition of 0.2 mM and 2.0 mM substrate 1 (12.5 eq and 125 eq 
compared to the protein concentration), while GSH was subsequently titrated to the 




LigE and LigF. While titration of GSH to LigE results in a clear trend in the change of 
fluorescence intensity, the fluorescence data of LigF upon GSH titration is only scattered.  
 
 
Fig. 3.24: (A) Tryptophan fluorescence of LigE upon titration of cofactor GSH in the presence of 0.2 mM 
(black) and 2.0 mM (red) model substrate 1. (B) Tryptophan fluorescence of LigF upon titration of cofactor 
GSH in the presence of 0.2 mM (black) and 2.0 mM (red) model substrate 1. All measurements were 
performed in duplicate. 
 
The binding of GSH to LigE in the presence of 0.2 mM or 2.0 mM of 1 partially resembles 
a typical binding curve, though the observed fluorescence changes could not be fitted to 
equation Eq.4. A possible explanation for the curve shape observed with 0.2 mM 1 
(black) is that at the beginning, with addition of 0-64 μM GSH, tryptophan fluorescence 
decreases (shown as steep increase of relative fluorescence intensity) due to GSH 
binding. This is followed by a fast increase in fluorescence (shown as decrease of the 
curve) at higher GSH concentration due to substrate conversion and depletion. Hence, 
the intrinsic tryptophan fluorescence goes back to the level of the enzyme without 
substrate present. In contrast, with 2 mM 1 (red) it takes more time and GSH to observe 
this fluorescence increase (described by a decrease of the curve), as more substrate is 
present. These results suggest that at low GSH concentration, the change in 
fluorescence intensity possibly describes the GSH binding behaviour, but the competing 
substrate conversion prevents from receiving a typical binding curve and hence, an 
accurate KD value. 
The fact that only scattered data is observed in the analysis with LigF could be explained 
by the structure of the enzyme. As shown in Fig. 1.12, the active site of LigF is located 
in a tunnel-like structure, which is partially closed from one side, as compared to the 
surface-exposed active site of LigE. Hence, prior substrate binding in the active site of 
LigF might prevent later GSH binding. Another possible explanation could be the lack of 
detectable fluorescence changes upon GSH binding to LigF. 
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3.4.2 Isothermal titration calorimetry (ITC) 
The inability to quantify GSH binding to the β-etherases directly via tryptophan 
fluorescence assay prompted us to test a different method. ITC represents a direct, 
quantitative technique used to determine the thermodynamic parameters of interactions 
between small molecules (ligand) and larger molecules (protein). The complex formation 
between GSH and LigF protein was studied by this method. When GSH was titrated to 
free LigF, a dissociation constant of 80 μM was determined, which indicates a rather 
strong interaction (Fig. 3.25A and Tab. 3.18). The impact of 50, 100 and 200 μM of 
compound 4 on GSH binding in measurements with 100 μM of LigF protein was tested 
as well (Fig. 3.25B and Tab. 3.18). Compound 4 was chosen for this experiment due to 
its confirmed binding to the active site of LigF, while it cannot be converted by the 
enzyme. In the presence of lignin model substrate 4, approx. 4-times higher KD values 
were obtained for GSH binding. This is in agreement with the previously observed higher 
KD values for lignin model substrate binding in the tryptophan fluorescence assay in the 
presence of GSH compared to measurements without GSH. Based on the received data, 
it appears that GSH binding is weaker in the presence of substrate compared to GSH 
alone. Similarly, binding of substrate seems to be weaker in the presence of GSH 
compared to substrate alone.  
 
 
Fig. 3.25: (A) ITC measurement for the binding of GSH to wild-type LigF. The thermogram shows 
considerable heat release upon titration of the cofactor GSH to the LigF protein. (B) The ITC heat data, 
corrected for dilution, are plotted against the molar ratio of GSH to protein LigF with different amounts of 
substrate 4 present, and GSH. Sigmoidal curves typical of exothermic-binding reactions were obtained in all 
cases, however, changes in binding behaviour were observed in experiments with added substrate 4. 
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Tab. 3.18: Dissociation constant KD and coefficient N (referring to the number of binding sites) obtained from 
ITC measurements for the binding of cofactor GSH to wild-type LigF in the presence and absence of 
substrate 4. All measurements were performed in duplicate. 
Enzyme GSH binding 
no addition of 4   50 μM of 4  100 μM of 4  200 μM of 4 
KD (μM) N  KD (μM) N  KD (μM) N  KD (μM) N 
LigF 80±6.0 1.1  386±31.6 1.0  386±56.1 1.9  323±45.6 2.0 
 
This observed change in affinity might be the result of structural changes within the GSH 
binding site upon substrate binding. At the same time, it was observed that the parameter 
N changed from approx. 1 in the measurements of GSH binding without analog 4 and in 
the presence of 50 μM 4, to a value of approx. 2 in the presence of 100 μM and 200 μM 
of 4 (in the latter cases the substrate concentration was equal to or higher than the 
enzyme concentration). The parameter N in ITC analyses describes the stoichiometry of 
protein and ligand binding. Hence, at first glance, the increased N-value could suggest 
the presence of two GSH binding sites in LigF. 
 
3.5 Non-lignin-based substrates 
Previous characterizations of β-etherases and glutathione lyases were demonstrated on 
either lignin-like model substrates 104,107,108,110,112,131 or using various purities of polymeric 
lignin 27,119,120,122. In contrast, the ability of these enzymes to cleave ether bonds in non-
lignin like molecules could potentially increase their applicability. To test this, several 
compounds representing oligomers of manmade plastic material were provided by Prof. 
Dr. D. E. Kaufmann from the Institute of Organic Chemistry at TU Clausthal, Germany. 
Substrates 30, 31, 32, 33, and 34 were tested in reactions with β-etherases and 






Fig. 3.26: Non-lignin-based substrates tested in reaction with β-etherases and glutathione lyases used in 
this work. [(30, 3,3'-((propane-2,2-diylbis(4,1-phenylene))bis(oxy))bis(1-phenoxypropan-2-one)), (31, 
mixture of 3,3'-((propane-2,2-diylbis(4,1-phenylene))bis(oxy))bis(1-phenoxypropan-2-ol) and 1-(4-(2-(4-
(oxiran-2-ylmethoxy)-phenyl)propan-2-yl)phenoxy)-3-phenoxypropan-2-ol), (32, 2,2'-(((propane-2,2-
diylbis(4,1-phenylene))-bis(oxy))-bis(methylene))bis(oxirane)), (33, 4,4'-(propane-2,2-
diyl)bis(methoxybenzene)), (34, 5,5'-(propane-2,2-diyl)bis(1,3-dibromo-2-ethoxybenzene))]. 
 
3.5.1 Compound 30 
Compound 30 (eluting at 18.13 min on the HPLC chromatogram) was initially assumed 
to be pure. However, the HPLC chromatogram of 30, dissolved in pure DMSO, revealed 
a contamination eluting at 16.86 min (Fig. 3.27). 
 
 
Fig. 3.27: Chromatogram of compound 30 dissolved in DMSO. Two peaks are observed, a minor peak at 
16.86 min and a major peak at 18.13 min, of which the structure is depicted in the figure. 
 
Based on the structure of the major compound of mixture 30, it was hypothesized that 




performed at 25°C using all available β-etherases (LigE, LigE-NS, LigE-NA, LigP, LigF, 
LigF-NS, LigF-NA) and consisted of 0.2 mM of non-lignin substrate, 1 mM GSH and 50 
μg of tested enzyme. In order to efficiently dissolve the substrate and still ensure catalytic 
activity of the enzymes, 10 % v/v of DMSO was used as co-solvent in the reaction 
(compared to standard 5 % v/v of DMSO used with lignin model substrates). Despite the 
increased solvent concentration, substrate 30 as well as the other tested non-lignin-like 
substrates were not completely dissolved under these conditions, complicating sample 
drawing and subsequent HPLC analysis. Hence, an alternative approach for sample 
drawing and analysis was followed. Instead of preparing a reaction of bigger volume to 
take several samples over time, 10 parallel reactions with the same composition (along 
with respective control reactions) have been prepared and started simultaneously. For 
sample drawing at different time points, always two parallel reactions were stopped at 
the same time by dilution with DMSO in 1:10 ratio. This also ensured complete 
dissolution of the substrates and possible products, and consecutive centrifugation 
separated precipitated protein. Received samples were analyzed by HPLC. With this 
approach it was possible to follow the reaction progress over time (five individual time 
points). Example chromatograms of a respective reaction of substrate 30 and the non-
enzymatic control reaction are shown in Fig. 3.28.  
 
 
Fig. 3.28: Comparison of the chromatograms at time point 0 min (purple), after 180 min (blue) and the non-
enzymatic control reaction (dashed orange) of a reaction with substrate 30 and LigE-NA as catalyst. A visible 
decrease of the peak at 16.86 min was accompanied with the appearance of a new peak at 15.09 min. The 
major peak at 18.13 min remained relatively unchanged. No activity was observed in control reaction. 
 
Fig. 3.28 depicts the reaction results using β-etherase LigE-NA, but enzymes LigE, LigF, 




levels of activity. Enzymes LigE-NS and LigP showed no activity and no background 
reaction was observed in control reaction without enzyme. Based on the peak changes, 
it was assumed that the peak eluting at 16.85 min represented the substrate of the 
reaction, while the new peak at 15.09 min represented the formed product. Since the 
substrate peak (16.85 min) never fully disappeared, it was hypothesized that the 
substrate might be racemic. However, the combination of the two most active enantio-
complementary β-etherases (LigE and LigF-NA) in the reaction did not result in complete 
conversion of the substrate (data not shown), and thus this hypothesis was not 
confirmed. In order to identify the substrate and the product, MS analysis was performed 
in TU Braunschweig facilities with help from Dr. Uli Papke. The obtained MS results 
(shown in chapter 7.6) enabled identification of the potential substrate and product of the 
reaction as shown in Fig. 3.29.  
 
 
Fig. 3.29: Scheme of the reaction catalyzed by β-etherases based on mixture 30 as proposed by the MS 
results. 
 
The ether bond of the substrate was successfully cleaved with release of phenol and the 
glutathione adduct. In order to investigate a further possible conversion of the formed 
glutathione adduct, glutathione lyases LigG, LigG-NS and LigG-TD together with fresh 
GSH were added to the reaction, however, no further cleavage occurred (data not 
shown). Despite the fact that a potential novel substrate for cleavage of the ether bond 
by β-etherases was identified, further analysis will be necessary. NMR data of substrate 
and product could not be obtained due to the limited amount of received mixture 30.  
 
3.5.2 Mixture 31 
Mixture 31 was expected to contain two major compounds (eluting at 19.20 and 20.28 
min on the HPLC chromatogram in Fig. 3.30) with known structures. Both structures 
represent intermediates in the chemical synthesis of compound 30. However, the HPLC 
chromatogram of mixture 31, dissolved in pure DMSO, showed again an unknown 






Fig. 3.30: HPLC chromatogram of mixture 31 dissolved in DMSO. Three peaks are observed, an unknown 
one at 18.75 min and two expected ones at 19.20 min and 20.28 min, for which the structures are depicted 
in the figure. 
 
The major compound of mixture 31 (with retention time 20.28 min) is structurally similar 
to compound 30, except for the presence of hydroxy groups at the β-carbons (relative to 
the ether bonds) compared to keto groups in compound 30. The other known compound 
of mixture 31 (with retention time 19.20 min) is structurally similar but additionally carries 
an epoxide ring. Reactions with mixture 31 as a possible substrate were performed using 
all available β-etherases (LigE, LigE-NS, LigE-NA, LigP, LigF, LigF-NS, LigF-NA) 
identically to the pervious reactions with substrate 30. A representative HPLC 
chromatogram after enzymatic catalysis together with the non-enzymatical reaction are 






Fig. 3.31: Comparison of the chromatograms at time point 0 min (red), after 180 min (plum) and the non-
enzymatic control reaction (dashed green) of a reaction with mixture 31 as substrate and LigE-NA as 
catalyst. A visible decrease of the peak at 19.20 min was accompanied with the appearance of a peak at 
15.94 min. The peaks at 18.75 min and 20.28 min remained unchanged. No activity was observed in control 
reaction. 
 
Based on the chromatogram shown in Fig. 3.31, it was assumed that during the reaction 
the compound represented by the peak at 19.20 min was converted by the β-etherases 
with formation of a new product eluting at 15.94 min. The other two peaks at 18.75 min 
and 20.28 min remained unchanged during the reaction. Similar results were obtained 
for reactions catalyzed by LigE, LigE-NS, LigE-NA, LigF, LigF-NS and LigF-NA. In 
contrast, the enzyme LigP showed no activity and no background activity was observed 
in control reaction without enzyme. This time, the substrate structure was known but the 
product structure had to be determined. In order to identify the substrate and the product, 
LC-MS analysis was performed in collaboration with the group of Prof. Dr. Mark 
Brönstrup (Department of Chemical Biology at the Helmholtz Centre for Infection 
Research (HZI) Braunschweig). The obtained LC-MS results (shown in chapter 7.6) 
enabled identification of the putative reaction product as shown in Fig. 3.32. 
 
 
Fig. 3.32: Scheme of the reaction catalyzed by β-etherases starting from mixture 31 as proposed by the LC-
MS results. 
 
This time, no ether bond was cleaved but the epoxide ring was opened by nucleophilic 




although a variety of mammalian glutathione S-transferases, including enzymes from the 
alpha, pi and mu class, have been reported to catalyze epoxide ring opening on a variety 
of substrates forming corresponding GSH-conjugates 149–151. Because of the limited 
amount of the substrate, the reaction could not be explored further and no NMR data of 
substrate and product could be obtained.  
Subsequent conversion of the formed glutathione conjugate with glutathione lyases 
(LigG, LigG-NS, and LigG-TD) was tested as well, but no further conversion was 
observed.  
 
3.5.3 Substrates 32, 33 and 34 
Substrates 32-34 were received as pure compounds. Since all three contained either 
ether bonds or epoxide rings, it was hypothesized that they could represent new 
substrates for β-etherases. The substrates were tested using all available β-etherases 
(LigE, LigE-NS, LigE-NA, LigP, LigF, LigF-NS, LigF-NA). Although even increased 
amounts of enzymes were used, no conversion of substrates 33 and 34 could be 
observed (data not shown). The only substrate which was converted during the reaction 
was compound 32, for which the respective HPLC chromatogram is shown in Fig. 3.33.  
 
 
Fig. 3.33: Comparison of the chromatograms at time points 0 min (black), 30 min (red), 180 min (green) and 
non-enzymatic control reaction (dashed yellow) of a reaction with substrate 32 and LigE-NA as catalyst. A 
visible disappearance of the substrate peak at 17.43 min was observed within 30 min of the reaction. 
Formation of a new peak at 14.15 min was visible at time point 30 min, which decreased again with further 
reaction. After 180 min of the reaction the peak had disappeared, suggesting it to be an intermediate of the 
reaction. At the same time, a second new peak appeared at 9.17 min which further increased until time point 






Based on the chromatograms of the reaction, substrate 32 (eluting at 17.43 min) is 
immediately converted to an unknown intermediate (eluting at 14.45 min), which is 
further converted to the final product (eluting at 9.17 min) of the reaction. Identical results 
(with various levels of activity) were obtained using β-etherases LigE, LigE-NA, LigF, 
LigF-NS and LigF-NA. In reactions with enzymes LigP and LigE-NS no activity towards 
substrate 32 could be detected. The non-enzymatic control reaction shows minor peak 
eluting at 14.15 min assigned to the background reaction possibly caused by high 
glutathione concentration. No background reaction was observed at the peak eluting at 
9.17 min. The resulting product was further tested for possible conversion by glutathione 
lyases, although no further conversion was observed. LC-MS measurements were 
performed to identify the formed intermediate and the final product of the β-etherase-
catalyzed reaction. The obtained LC-MS results (shown in chapter 7.6) enabled 
identification of both compound structures as shown in Fig. 3.34.  
 
 
Fig. 3.34: Scheme of the reaction catalyzed by β-etherases starting from mixture 32 as proposed by the LC-
MS results. 
 
Since substrate 32 contains two epoxide rings, both can be attacked by glutathione. 
Accordingly, in the intermediate of the reaction only one epoxide ring is opened by 
nucleophilic attack of glutathione, whereas the final product has both epoxide rings 
opened with glutathione. Based on these results, it can be assumed that β-etherases are 
able to open epoxide rings of arylaliphatic compounds. Although the LC-MS data are 
convincing, further NMR analyses of the intermediate and the final product would be 
necessary.  
Based on the previous results, two further arylaliphatic epoxides available in the 






Fig. 3.35: Schemes of arylaliphatic epoxide substrates tested for conversion by β-etherases [(7, 2-
(phenoxymethyl)-oxirane), (8, 2-phenyloxirane)]. 
 
Unfortunately, epoxides 7 and 8 were not converted by any of the tested β-etherases. 
The control reactions with no enzyme added, however, already shown a strong 
background reaction (data not shown). This was rather unexpected as in previous 
reactions with epoxide substrates no or only a limited chemical background reaction was 
observed. In case of reactions with substrates 7 and 8, a relatively high concentration of 
GSH in the aqueous environment probably caused the high chemical background of 







In this work, the potential of different glutathione-dependent enzymes was explored in 
various settings. The investigated β-etherases and glutathione lyases have a huge 
potential for the cleavage of ether bonds in lignin in a predictable manner and thus, for 
the production of aromatics from lignin. The strict stereoselectivity of β-etherases makes 
these enzymes attractive for various applications in which enantiopure compounds are 
envisaged. To overcome the economically unattractive cofactor requirement, a whole-
cell biocatalyst with glutathione regeneration was established, as described in the first 
part of this thesis. Co-expression of the most active β-etherases with complementary 
stereoselectivity (LigE and LigF-NA) and a glutathione lyase converting both 
enantiomers of the resulting glutathione adduct (LigG-TD) in E. coli provided a whole-
cell catalyst with efficient GSH recycling. 
In the second part of this thesis, the best-studied β-etherases LigE and LigF underwent 
further analysis, in which active site residues of both enzymes were subjected to 
mutagenesis to investigate their impact on substrate binding and enzyme activity. In both 
cases, most of the introduced mutations had a negative impact on catalytic activity, while 
some of the LigF mutants displayed increased activity. 
In the last part, the ability of β-etherases to convert different manmade, non-lignin-
derived compounds was investigated. 
 
4.1 Heterologous expression and enzyme activity 
To date, β-etherases and glutathione lyases have been described in various 
publications. In these, different E. coli strains were used for heterologous expression of 
these enzymes: E. coli B834 107,109,115, E. coli MV1190 97 or E. coli BL21 (DE3) 
105,110,119,122. In this thesis, the E. coli BL21 (DE3) strain was used for enzyme expression. 
Yields of purified β-etherases and glutathione lyases are comparable with those of Picart 
et al. 105,110, which is explained by use of the same expression strain and a similar 
expression protocol (LB broth as inoculum media in this thesis compared to TB media in 
Picart et al. 105,110, and expression at 20˚C for both, β-etherases and glutathione lyases 
compared to 25˚C for the glutathione lyases in Picart et al. 105). In an experiment of Jan 
Terbrack 270 (bachelor student, 2018), however, the expression level of LigE and LigF 
could be increased by 56 % and 190 %, respectively, through addition of 2 mM MgSO4 
to the cultivation (expression) media 270. Several publications discuss possibilities of how 
to improve the heterologous expression of proteins in E. coli 153–157. These suggest that 




the sugar metabolism of the cells and thus affects culture growth and enzyme 
expression. The results obtained by Jan Terbrack in his bachelor thesis 270 support this 
and demonstrate that even higher yields of β-etherases and glutathione lyases are 
possible if the expression medium is further optimized. 
Moreover, the produced β-etherases and glutathione lyases have been biocatalytically 
characterized towards different model dimeric substrates. The specific activity values 
obtained in this thesis differ significantly from previously published data 105,110 (Tab. 4.1). 
Other enzyme properties, such as stereoselectivity (LigE, LigE-NS, LigE-NA and LigP 
are strictly (R)-selective while LigF, LigF-NS and LigF-NS are strictly (S)-selective; LigG, 
LigG-NS and LigG-TD all possess (R)-stereopreference), are in agreement with the 
published data.  
 
Tab. 4.1: Comparison of measured activity values for β-etherases and glutathione lyases with literature 
values by Picart et al. 105,110. 








LigE rac-1 5.93 110 1.75 -71 
LigE-NS rac-1 2.78 110 1.00 -64 
LigE-NA rac-1 2.67 110 0.73 -73 
LigP rac-1 0.10 110 0.05 -50 
LigF rac-1 2.60 110 1.26 -52 
LigF-NS rac-1 0.37 110 1.60 +332 
LigF-NA rac-1 6.79 110 2.40 -65 
LigG (R)-11 1.74 105 5.40 +210 
LigG (S)-11 0.09 105 0.60 +567 
LigG-NS (R)-11 71.4 105 16.9 -76 
LigG-NS (S)-11 0.02 105 0.40 +1900 
LigG-TD (R)-11 36.2 105 13.3 -63 
LigG-TD (S)-11 0.12 105 6.20 +5067 
 
There are several reasons that could explain the large disparity between the herein 
measured activity data and the published values. A major difference in the activity 
measurement was the applied enzyme concentration. While a constant amount of 10 μg 
of the β-etherases was used by Picart et al.110, lower amounts of β-etherases (0.5-2 μg) 
were commonly used in our case to achieve a more accurate and linear product 
formation as the basis for specific activity determination. Moreover, the activity 
measurements for β-etherases and glutathione lyases were performed in a stronger 
buffer (100 mM) compared to Picart et al. (20 mM for β-etherases 110 and 50 mM for 
glutathione lyases 105). This may have had a direct impact on enzyme activity but might 
have also ensured a more constant pH during the reaction. Despite the differences in 
absolute activity values, the order of β-etherases with increasing activity is still the same, 




active (S)-selective β-etherase. Likewise, glutathione lyase LigG-TD is still the enzyme 
with the lowest stereopreference. 
 
4.2 Whole-cell biocatalyst with GSH recycling 
In order to implement β-etherases and glutathione lyases on an industrial scale, not only 
increased protein yields are necessary. One of the major obstacles for these enzymes 
is their dependence on the relatively expensive cofactor glutathione (as of March 2020, 
the price of reduced glutathione varied from 200 USD/kg 271 to 5190 USD/kg 272 
depending on the purity and the country of origin). In favour of avoiding this requirement, 
Reiter et al. 119 used an NADH-dependent glutathione reductase from Allochromatium 
vinosum in combination with enzymes involved in lignin degradation (NAD+-dependent 
Cα dehydrogenase LigD as well as β-etherase LigF and glutathione lyase LigG) to 
achieve GSH recycling. This way, Reiter et al. 119 were able to setup a self-sufficient 
biocascade for the cleavage of lignin model substrates with internal regeneration of both 
cofactors, NAD+ and glutathione. A different approach was followed in this thesis to 
achieve GSH recycling intracellularly by E. coli-innate, NADPH-dependent glutathione 
reductase. Based on our research, as of February 2016 (beginning of this project), the 
most active enantiocomplementary β-etherases were LigE ((R)-selective) and LigF-NA 
((S)-selective), and the glutathione lyase with the lowest stereopreference (to convert 
both enantiomers of the formed glutathione adduct) was LigG-TD (R/S = 2). Hence, these 
enzymes were chosen to be co-expressed within a single E. coli cell.  
E. coli cells contain a significant amount of NADPH-dependent glutathione reductase 
that catalyzes the reduction of oxidized glutathione (GSSG) into two molecules of GSH. 
GSH and NADPH are produced by the E. coli metabolism and are important for 
maintaining a reducing environment within the cell 158. Hence, the E. coli cell metabolism 
was utilized to provide and regenerate GSH and NADPH required for our enzyme 






Fig. 4.1: Biocascade of GSH-dependent enzymes for ether bond cleavage, co-expressed in E. coli cells to 
ensure efficient GSH provision and recycling by the cell metabolim. 
 
This whole-cell approach was tested with two E. coli strains: BL21 (DE3) 159 and C43 
(DE3) 160,161. E. coli BL21 (DE3) is commonly used in laboratories for recombinant protein 
production. The typical lack of lon and ompT proteases together with harboring the 
prophage DE3, derived from a bacteriophage λ, makes it probably the most widely used 
strain in high-level T7 expression of recombinant proteins 162,163. The C43 (DE3) strain 
was derived as a double mutant from the parental BL21 (DE3) strain. The C43 (DE3) 
strain is proven to grow to high saturation cell density and is also able to over-express 
toxic proteins. Both strains were selected because they are highly suitable for expression 
of our GSH-dependent β-etherases and glutathione lyases. 
The activity of both generated whole-cell biocatalysts was tested in the conversion of 
substrate 1. As a result, full conversion of substrate 1 was only achieved with the E. coli 
C43 (DE3) (pETDuet1_ligE_ ligF-NA) (pIT2_ligG-TD) strain after 5 h of reaction 
compared to the E. coli BL21 (DE3) (pETDuet1_ligE_ ligF-NA) (pIT2_ligG-TD) strain, in 
which a conversion of 52 % was observed after 20 h of reaction. This could be explained 
by the difference in expression of proteins in each strain. While in the BL21(DE3) strain, 
the T7 RNA polymerase gene is under the control of the powerful, IPTG-inducible lacUV5 
promoter, the strain C43(DE) contains three mutations in the lacUV5 promoter, turning 
this promoter into the much weaker wild-type lac promoter, ensuring a reduced 
transcription rate in C43 (DE3) 164,165. As a result, proteins in BL21 (DE3) are expressed 




compared to the slower expression in the C43 (DE3) strain, securing proper enzyme 
folding 166,167. Additionally, the C43 (DE3) strain is known for improved plasmid stability, 
which could lead to improved expression of the proteins as well 160. Unfortunately, 
expression levels of the soluble β-etherases and glutathione lyase by BL21 (DE3) and 
C43 (DE3) strains have not been compared.  
The constant interest of the research community in the field and the potential application 
of these enzymes led to multiple discoveries by other researchers within the timeframe 
of the experiment. In a publication about database mining for novel bacterial β-etherases 
111, enzymes displaying even higher activity than LigE and LigF-NA have been identified. 
The LigE-type β-etherase with (R)-stereoselectivity from Altererythrobacter sp. 66-12 
(GeneBank number: OJU60283) displayed ~ 2.9-times higher activity than LigE from 
Sphingobium sp. SYK-6, while the LigF-type β-etherase with (S)-stereoselectivity from 
Altererythrobacter sp. Root672 (GeneBank number: WP_055919008) exhibited ~2.3-
times higher activity than LigF-NA from N. aromaticivorans. Similarly, progress was also 
made on the available range of glutathione lyases. The analysis by Kontur et al. 109 of 
the phylogenetic three of GSTs, known or predicted to catalyze reactions involved in the 
sphingomonad pathway for breaking the β-aryl ether bond, described various novel 
glutathione lyases with low stereopreference. One of them, NaGSTNu, from N. 
aromaticivorans (GeneBank number: WP_011446237), was tested by Till Peters 273 
(bachelor student, 2019) within his bachelor project and compared to LigG-TD (Tab. 4.2). 
 
Tab. 4.2: Comparison of measured activity values and stereopreference for glutathione lyases LigG-TD 
(used in the whole-cell biocatalyst) and NaGSTNu. 
Enzyme Specific activity  
towards rac-11 
(U/mg) 
Specific activity  
towards (R)-11 
(U/mg) 




/ Rate (S) 
LigG-TD 11 13.3 6.2 2.1 
NaGSTNu 184 190 152 1.3 
 
This new NaGSTNu not only exhibits an improved R/S ratio, suggesting that this 
glutathione lyase is the least stereospecific so far, but also the specific activity towards 
rac-11 is almost 17-times higher. Hence, more active and less stereoselective enzymes 
could be applied in our whole-cell approach for internal GSH recycling in the future. 
 
4.2.1 Optimal conditions for production and application of the whole-
cell catalyst 
Different conditions for protein expression were tested to yield a whole-cell catalyst with 




expression temperatures (17˚C-37˚C), 20˚C resulted in the highest activity, suggesting 
that a lower temperature negatively impacted the level of protein expression. In contrast, 
higher expression temperatures should lead to faster expression of the recombinant 
proteins, which can be accompanied by protein aggregation via hydrophobic patches 
and hence formation of inclusion bodies if the newly formed proteins do not fold fast 
enough.  
Optimal conditions for the whole-cell catalyzed reaction were also identified. The optimal 
extracellular pH for the reaction was investigated. The pH optimum for conversion of 1 
using the whole-cell catalyst was observed at pH 8, whereas all three heterologously 
expressed enzymes display pH optima in the more alkaline range (LigE and LigF-NA at 
pH 9 111 and LigG-TD at pH 9.5 105). This difference is not surprising, as the applied 
extracellular pH will not directly influence the intracellular pH, since E. coli cells will keep 
a rather constant intracellular pH independent of the extracellular conditions. It is 
reported that the intracellular pH of E. coli at optimal conditions is 7.6 168. The whole-cell 
reaction pH optimum of 8 therefore represents an extracellular pH value in which the E. 
coli metabolism is able to ensure satisfactory regeneration of GSH and other essential 
processes, while allowing a nucleophilic attack of GSH on the β carbon of the 1 catalyzed 
by β-etherases, for which the alkaline environment is desired.  
Using model substrates for the investigation of β-etherases and glutathione lyases has 
proven useful due to the simple analysis of both reaction steps of the cascade by HPLC 
and their relatively simple organic synthesis, while representing the common β-O-4 
arylether bond of “real” heteropolymeric lignin 20. One of the obstacles that are connected 
with this substrate, and also represents a major problem with polymeric lignin, is its low 
solubility, which requires addition of cosolvent. The choice of organic solvent plays an 
important role in biocatalysis; not only is cosolvent addition necessary to dissolve 
hydrophobic substrates in the aqueous reaction mixture, it was also shown that in some 
cases the selection of organic solvent may affect the enzyme’s chemoselectivity, 
stereoselectivity and regioselectivity 169,170. Additionally, the added cosolvent facilitates 
substrate uptake through the outer and inner membrane into the cytosol of E. coli, where 
catalysis and GSH regeneration occur, as it makes the cell membrane more permeable. 
A negative impact of increased solvent concentration on the whole-cell performance was 
confirmed for all of the tested solvents. Isopropyl alcohol as a solvent in low 
concentrations (0.5 % and 2.5 % v/v) appeared to have the lowest negative impact on 
the relative activity of the whole-cell catalyst. This was rather unexpected based on 
published data 133 reporting that aliphatic alcohols have the most damaging effect on the 




isopropyl alcohol was more apparent since the relative activity of the catalyst decreased. 
This negative impact of isopropyl alcohol is caused by its hydrophobic character, 
resulting in a slow permeabilization of the cell membrane with a detrimental effect on the 
cell metabolism 137 which is necessary for NADPH and GSH regeneration. In contrast, 
methanol as a solvent yielded the highest conversions with larger amounts of cosolvent 
in the reaction (≥2.5 % v/v). Overall, methanol had the lowest negative impact on the 
relative activity of the whole-cell catalyst. It was previously reported that methanol as a 
short-chain alcohol has only a weak ability to interfere with the lipid bilayer of a cell and 
thus is only minimally affecting membrane structure 171,172. Methanol has been proven to 
have only low toxicity on E. coli growth compared to different other alcohols 133,138. Up till 
now, several E. coli strains were engineered not only to tolerate high concentrations of 
methanol during growth and in the resting phase, but also to use methanol as a carbon 
source 173–177. 
DMSO, as commonly used cosolvent and even cryoprotectant for long-term storage of 
bacteria was expected to yield the highest relative activity of the whole-cell catalyst. To 
our surprise, however, the performance of the whole-cell reaction in combination with 
DMSO was rather mediocre. Lower activities of the catalyst in reactions where DMSO 
was used as solvent might be explained by its stiffening effect on the fluidity of the water-
liquid interface of the cell membrane as well as the non-polar part of the membrane 178. 
Stiffening the phospholipid layer of the cells may hinder the diffusion of substrate through 
the cell membrane. On contrary, methanol was shown to slightly increase the cell 
membrane fluidity 178, which would support substrate diffusion into the cell and thus the 
activity of the whole-cell catalyst. Despite the negative impact of organic cosolvents on 
the metabolism, viability and energy balance of the biocatalyst, efficient dissolution of 
the substrate is required for efficient catalysis. This was impressively demonstrated in a 
reaction using 1.0 mM substrate 1 without cosolvent, resulting in a decrease of the 
specific activity of the whole-cell catalyst by ca. 70 %. 
Additionally, the impact of the tested solvent may be also influenced by a different 
solubilization behaviour of substrate 1. Regarding the tested cosolvents, methanol has 
the highest relative polarity (0.762) compared to DMSO and isopropanol with relative 
polarities of 0.444 and 0.546, respectively 274. It could be that at higher substrate 
concentration, depending on the used cosolvent, substrate 1 was not completely 
dissolved anymore in the reaction mixture, which would impact conversion and specific 
activity. A limited solubility of 1 would usually be observed by precipitate formation, 
however, since the whole-cell biocatalyst was used, the reaction mixture was turbid 




to keep the substrate fully dissolved. Further test would be necessary to investigate the 
solubility of 1 in different concentrations in reactions with addition of the three cosolvents 
tested herein.  
Apart from the cell viability and integrity, the tested organic solvents will also affect the 
structure and stability of the enzymes used in our cascade. Direct information on the 
solvent tolerance of purified β-etherases and glutathione lyases is not available, 
however, some indications are found in literature 122. Thus, it was shown that β-etherases 
are compatible with higher DMSO concentrations (up to 25 %) than glutathione lyase 
LigG-TD (up to 10 %). For future applications, further cosolvents could be tested in 
combination with our whole-cell catalyst and the impact of each solvent on the activity 
and stability of the involved enzymes should be investigated. Moreover, different 
methods have been developed over the years to “stabilize” a biocatalyst in the presence 
of organic solvents. Examples are the use of hydrophobic solvents in a two-phase 
system 179,180 or the immobilization of the catalyst 181,182, which could be tested for our 
system as well. 
 
4.2.2 Glucose impact on GSH regeneration and whole-cell catalyst 
reuse 
The whole-cell approach was developed to enable GSH provision and regeneration by 
the E. coli metabolism. As in each step of the tested biocascade (Fig. 4.1) one molecule 
of reduced GSH is consumed, two molecules of GSH per molecule of substrate 1 are 
required to achieve full conversion to the final product VG with simultaneous generation 
of GSSG. The latter is reduced again by E. coli-innate, NADPH-dependent glutathione 
reductase, according to equation Eq. 5 183. 
𝐺𝑆𝑆𝐻 + 𝑁𝐴𝐷𝑃𝐻 + 𝐻+  → 2𝐺𝑆𝐻 + 𝑁𝐴𝐷𝑃+               (𝑬𝒒. 𝟓) 
Hence, incorporating our biocascade into the metabolism of E. coli could interfere with 
the central cell metabolism, especially pathways requiring NADPH as a cofactor. 
In bacteria, NADPH is generated in the oxidative phase of the pentose phosphate 
pathway and can also be formed from NADP+ by the use of NADH within a cell 275. As 
glucose is the preferred carbon source for E. coli 275 and the initial substrate for the 
pentose phosphate pathway as well, it was assumed that the addition of glucose to the 
reaction may compensate for NADPH consumption. Moreover, the synthesis of GSH in 
the cell is dependent on ATP, which is mainly produced by ATP-synthase using the 
transmembrane proton motive force 275. The latter is created by the electron transport 




TCA cycle starting directly from glucose. Moreover, ATP can also be generated by the 
Embden–Meyerhof–Parnas pathway directly from glucose 275. Based on this information, 
we assumed that glucose addition should have a positive impact on the activity of the 
whole-cell catalyst. Surprisingly, no positive effect of glucose addition was observed in 
the whole-cell reaction. This was rather unexpected since in a similar cascade, 
expressing enantioselective pinoresinol reductase from Arabidopsis thaliana (AtPrR2) or 
enantiocomplementary pinoresidol lariciresinol reductase from Forsythia intermedia 
(FiPLR) for NADPH-dependent pinoresinol reduction while using the metabolism of E. 
coli C41 (DE3) to regenerate NADPH, addition of 0.11 M (20 g/L) glucose to the reaction 
mixture had a positive impact on the catalyzed whole-cell reaction 184. It was later 
demonstrated that in that whole-cell reaction, another side reaction catalyzed by the E. 
coli metabolism was consuming cell-innate NADPH, causing a shift in the 
NADP+/NADPH equilibrium and thus, glucose addition indeed ensured higher NADPH 
concentration within the cell 184. Our cascade, however, directly started from rac-1 as the 
substrate and thus, no side reactions were expected or observed.  
Obtained results in our experiment suggest that the required amounts of GSH and 
NADPH for conversion of 0.8 mM substrate via the whole-cell catalyst could be provided 
by the cell alone. Based on literature, E. coli cells contain glutathione in a concentration 
of 10 µmol 135 to 27 μmol per gram of dry cells 136. Considering that our 1 mL reactions 
with OD600 of 40 contained about 13 mg of dry cell weight and that two molecules of GSH 
are required for cleavage of a β-O-4 aryl ether bond, the applied substrate concentration 
of 0.8 mM required at least 4.5-times higher GSH concentration compared to the one 
present within the cells. Hence, substantial GSH recycling and associated NADPH 
synthesis/regeneration obviously occurred within the cells without requirement for 
external glucose. Interestingly, even at increased substrate concentrations, no activity 
improvement was observed upon glucose addition, although in the reactions with 10 mM 
substrate (with and without glucose addition), only approx. 50 % conversion could be 
reached. This suggests that the amounts of cofactors NADPH and GSH produced by the 
cell metabolism are not the limiting factor in the reaction. Incomplete conversion in these 
cases may actually be caused by continuous whole-cell catalyst death 185. Another 
possibility of the limited conversion in the high substrate concentration experiment may 
be explained by the formation of the final product, veratrylglycerone. This compound is 
not further consumed by the E. coli strain and is structurally similar to several compounds 
that are confirmed to have a toxic effect on the E. coli metabolism 186. 
On the other hand, when the solvent concentration was dramatically increased to 15 % 




and thus more substrate to be available for the catalyst to convert, the addition of glucose 
resulted in a conversion improvement of 26 % and 22 %, respectively. In this case, 
however, the benefit of glucose was maybe rather to help the whole-cell catalyst protect 
against the solvent by providing carbon and energy for cell membrane regeneration 
processes, rather than to provide GSH and NADPH for the reaction. Similarly, when re-
using the cells for multiple rounds of conversion of 0.8 mM substrate, glucose addition 
had a positive effect on the reaction rate as well. On average, the second, third and fourth 
rounds of reaction showed activity improvements by 16 %, 20 % and 10 %, respectively. 
It was also observed that in the reactions with added GLC, the reused cells were more 
stable and viable, meaning that the cell pellet after centrifugation was firmer and less cell 
lysis had occurred. Hence, it is assumed that glucose addition as carbon and energy 
source was beneficial for cell viability rather then GSH recycling.  
Overall, by using the whole-cell catalyst, substrate 1 was successfully converted without 
the addition of the cofactor GSH required for the reaction. It is confirmed that the cell 
metabolism was able to recycle the formed GSSG to GSH for further rounds of substrate 
conversion. The whole-cell biocascade setup can theoretically be applied for a variety of 
substrates for which the β-etherases and glutathione lyases show activity. The only 
requirement is an uptake or diffusion of the substrate into the cell.  
 
4.2.3 Kinetic resolution using the whole-cell catalyst 
Since β-etherases display strict stereoselectivity, a possible application of our whole-cell 
approach was the provision of enantiomerically pure lignin model substrates, such as 
(R)-1 or (S)-1. For this, three different setups were compared.  
In the first approach, the whole-cell catalyst harbored either LigE or LigF-NA only. In this 
case, the catalyst was able to convert only one enantiomer of rac-1 to form the respective 
glutathione adduct, while the non-reacted enantiomer remained unconverted. Recycling 
of the consumed GSH was not possible. Results of the kinetic resolution of 1 in this case 
did not achieve full conversion of one substrate enantiomer. Hence, it was assumed that 
an ether bond cleavage could only proceed until the cell-innate GSH was depleted. The 
absence of glutathione lyase in this construct prevented further degradation of the 
glutathione adduct and thus GSH recycling, resulting in incomplete kinetic resolution. 
The general function of GSTs is to maintain redox balance and form exportable 
conjugates from various toxins. In this set up, lack of the glutathione lyase caused 
formation of the GSH-conjugates, which are more soluble and thus more likely to be 
transported out of the cell. Several ATP-dependent transporters belonging to the family 




GSSG out of the cell have been described in eukaryotic organisms. The presence of 
such a transporter for a GSH-conjugate in E. coli has not been described but is assumed 
to be present as well. 
In the second setup, E. coli cells harbouring a combination of one β-etherase and the 
glutathione lyase (LigE together with LigG-TD or LigF-NA together with LigG-TD) have 
been used. In this case, the formed glutathione adduct was further converted into VG, 
but also GSSG, which could be recycled. This setup gave satisfactory results as full 
kinetic resolution of 1 was achieved. In the subsequent semi-preparative-scale kinetic 
resolution of 1, full conversion of the desired enantiomer could be achieved as well, as 
confirmed by chiral HPLC analysis, yielding 39 mg of enantiopure (R)-1 and 43 mg of 
enantiopure (S)-1. Using whole-cell biocatalysis for kinetic resolutions has already been 
proven efficient previously 190. Jeon et al. 190 reported that the co-expression of two 
enzymes; a stereoselective amine dehydrogenase (AmDH) and a cofactor-regenerating 
NADH oxidase (Nox), in E. coli BL21 (DE3) enabled the effective kinetic resolution of 
various racemic amins. Similar to the observations made in this thesis, their reported 
kinetic resolution reactions within the whole-cell catalyst yielded enantiopure amines with 
˃99 % ee without any requirement for cofactor addition. In comparison, the kinetic 
resolution using purified enzymes gave the desired products with only 26 % ee. It was 
also shown that use of a whole-cell biocatalyst increased the stability of the heterologous 
enzymes and reduced substrate and product inhibition. Similar to our experiment, the 
whole-cell biocatalyst was further used in semipreparative scale, and 50 mM rac-2-
aminoheptane and 20 mM rac-α-methylbenzylamine were successfully resolved to 
produce enantiomerically pure compounds with satisfactory yields 190.  
The third approach tested in this thesis combined two separately produced whole-cell 
catalysts, one containing the β-etherase, the other containing the glutathione lyase. In 
order to obtain (S)-1, cells expressing LigE were used in combination with cells 
expressing LigG-TD. The (R)-1 enantiomer was obtained by combining cells expressing 
LigF-NA with cells expressing LigG-TD. This setup, separating each reaction step of the 
cascade into different cells, yielded only an incomplete kinetic resolution, even after 30 
h of reaction. This is likely explained by a hindered GSH regeneration and the 
requirement for different transport steps. Since production of the GSH-conjugate 
happens in one cell, whereas further conversion of this conjugate will take place in 
another cell, the produced GSH-adduct has to be transported from one to the other cell, 
which might not be efficient. Moreover, if the GSH-adduct is transported from one cell to 
another, GSH can only be recycled in the cells containing the glutathione lyase, and not 




containing cells could, however, be exported from the cytoplasm to the periplasm via the 
CydDC exporter 191 and further through the outer membrane to the reaction environment. 
From there, the β-etherase-containing cells could import the regenerated GSH via the 
yilABCD importer to the cytoplasm 192, where the GSH could be used for further rounds 
of 1 conversion. This transcellular transport is possible, but will take some time. 
Moreover, all of the mentioned transporters are ATP-dependent 135,191,192 and thus, more 
energy is required for sufficient GSH regeneration in the kinetic resolution of 1 using this 
setup. 
Previously, Xiao et al. 193 also tested various setups for combination of (2R,3R)-2,3-
butanediol dehydrogenase from Bacillus subtilis (ydjL) and NADH oxidase from 
Lactobacillus brevis in an enzymatic cascade for production of (3R)-acetoin, (3S)-acetoin 
and (2S,3S)-2,3-butanediol. Similar to our observations, the approach where the 
stereoselective dehydrogenase and the cofactor-regenerating NADH oxidase were 
expressed in separate cells, low conversion of meso-2,3-butanediol was observed. Only 
upon co-expression of both enzymes, (2S,3S)-2,3-butanediol with ˃99 % ee was 
produced. Even though in their case the cofactor to be regenerated was NAD+ and not 
GSH, these results support our observation that co-expression of the cofactor-
regenerating enzyme in the same cell as the cofactor-consuming enzyme is crucial in 
order to achieve efficient kinetic resolution as well as effective cofactor regeneration in 
whole-cell biocatalysis 193. 
Overall, it was shown that only the co-expression of β-etherase and glutathione lyase 
within one whole-cell biocatalyst enabled efficient kinetic resolution of lignin model 
substrate 1, presumably due to the possibility of efficient intracellular GSH recycling. 
 
4.2 Mutational studies 
 
4.2.1 LigE  
The previously solved crystal structures of LigE and LigF 112 were very helpful in allowing 
us to gain more insight into the catalytic mechanism of both etherases and the 
role/involvement of active-site residues. The herein obtained results can now be the 
starting point for furture protein engineering of β-etherases, tailoring their catalytic 
performance and possibly enlarging the substrate spectrum.  
The LigE structure was previously solved with the bound cofactor GSH, while a 
substrate-bound structure could not be obtained. Using Yasara, docking of the substrate 




modes appeared to represent a productive substrate binding conformation, which would 
also enable catalysis. For LigE, this has been reported before 111. Also, recently 
performed MD (molecular dynamics) and QM/MM (quantum mechanics/molecular 
mechanics) simulations did not provide successful predictions due to the structure of the 
entrance to the catalytic region 116. For the predicted SN2 mechanism of β-etherases, the 
distance between the substrate’s β-carbon and the GSH thiolate is expected to be lower 
than 4 Å 116. However, from the calculated binding modes, the shortest Cβ-to-S distance 
was 5.622 Å. Hence, the predicted substrate binding pose likely does not represent the 
productive substrate conformation. The difficulties to obtain a reliable substrate binding 
pose for LigE are likely explained by the enzyme’s crystal structure. It has been proposed 
that the active site of LigE is partially occupied by aromatic residues Tyr23 and Trp107 
in this structure 116. Additionally, the crystal structure of LigE was only obtained for a C-
terminally truncated variant (removal of 27 residues at the C-terminus of LigE) and thus, 
the structure of this truncated LigE variant might not reflect the catalytically active 
conformation of LigE 112. Based on our results and literature data 116, it is anticipated that 
for substrate (R)-1 to bind to the active site, extensive conformational changes in the 
structure of LigE have to occur. The herein presented substrate binding analysis of 1 
using tryptophan fluorescence, indicating cooperative substrate binding behavior, 
confirms the presence of structural changes upon substrate binding.  
Molecular docking represents a bioinformatic modelling tool that attempts to predict the 
structure of a ligand-receptor complex (enzyme-substrate, drug-protein, drug-nucleic 
acid, protein-nucleic acid, and protein-protein) with optimized conformation and the 
intention of possessing less binding free energy 194,195. During the calculation of 
molecular docking, thousands of possible ligand/receptor poses for the interaction are 
investigated and evaluated. Based on the ligand/receptor structures, the pose with the 
lowest energy score is predicted as the “best match”, referring to the binding mode. 
Despite the continuous development and widespread use of molecular docking, the 
process of rapid and accurate prediction of ligand/receptor interaction is complex and 
challenging, and drawbacks continue to affect the calculated outcome 196,197. Knowing 
the structural location of the binding site, as well as the flexibility of ligand and/or receptor, 
the charge of the structures’ environment and the interactions with the adjacent water 
molecules can complicate the quantitative analysis and thus the “correct” prediction of 
the binding pose 195,198. Up to now, several studies comparing different docking programs 
have been published 199–202 and it was shown that molecular docking methods average 
an approx. 60-75 % success rate on the identification of correct poses 202,203. The docking 




(as an extension of the virtual reality software YASARA), exhibits up to 78 % of accuracy 
for the receptor-ligand docking. This makes the AutoDock Vina one of the more efficient, 
accurate and fast docking programs available 202,204.  
Despite the unsatisfactory docking results with the crystal structure of LigE, several 
amino acid residues in proximity to the substrate and GSH were chosen to be exchanged 
by alanine (alanine scanning). All amino acid exchanges had a severe impact on the 
activity of LigE towards both tested model substrates 1 and 3. Selected amino acid 
residues Tyr23, Trp107, Phe115, Tyr122, Phe142 and Trp197 of LigE were compared 
to a multiple sequence alignment (MSA) of LigE-homologs (shown in chapter 7.9), which 
consisted of 37 sequences acquired from a BLAST search. According to this MSA, 
positions Trp107 and Tyr122 seem to be conserved among all compared sequences, 
which confirms the findings published by Voß et al. 111. Positions Tyr23 and Trp197 are 
more flexible as also phenylalanine is found at these positions in the homologous 
sequences. This, however, represents only a minor alteration since the residues are all 
bulky, hydrophobic and aromatic, which is in direct agreement with previously published 
data 111. On the other hand, the positions Phe115 and Phe142 of LigE seem to have a 
relatively random amino acid residue occupancy in the MSA.  
Interestingly, despite the fact that no positive effect on the activity of tested mutants was 
observed, the impact of individual mutations on specific activity was substrate-
dependent. Mutation Y23A resulted in a dramatic loss of activity (~98 %) towards 
substrate 1, while the same mutant displayed only an activity reduction by ~60 % towards 
substrate 3. In contrast, the mutant F142A exhibited decreased activity by ~70 % towards 
substrate 1, compared to 98.5 % towards substrate 3. These results suggest that the 
different model substrates bind slightly differently in the enzyme’s active site. Hence, 
active site residues are more or less important for substrate binding depending on the 
substrate structure. A strong substrate specificity of LigE was previously reported 110, as 
the specific activity of the enzyme was greatly dependent on the substitution pattern at 
the phenyl ring(s). This confirms the fact that mutations that have a severe impact on 
one substrate are not confined to have the same effect on another substrate 205.  
Until now, several structural analyses of LigE have been published 111,112,115,116. By 
solving the x-ray crystal structure of the LigE-GSH complex (LigE as C-terminally 
truncated version), Helmich et al. 112 identified the amino acid residues responsible for 
stabilization of GSH in its binding pocket (Asp71, Ser72, Val59, Arg138 and Tyr133). 
From these, residue Arg138 was subjected to an alanine mutation in this thesis. This 
revealed the importance of Arg138 for catalysis since its exchange by alanine led to a 




seems to be crucial for LigE catalysis.  
Similarly, it was proposed 112 that amino acid Ser21 may be of catalytic importance, as 
the hydroxyl group of serine could activate the GSH by providing a hydrogen bond to the 
sulfhydryl group of GSH, promoting formation of the thiolate anion 94,206. This hypothesis, 
however, could not really be confirmed since the mutant S21A did not completely lose 
activity, although a severe activity loss was detected 112. Despite the fact that Ser21 does 
not seem to be absolutely crucial for LigE activity, only alanine and glycine at position 21 
were found in this thesis to retain some catalytic activity of the respective mutants. The 
exchange to alanine resulted in a great loss of activity (˃96 %), while the decrease in 
activity of mutant S21G was less severe (70-80 %, depending on the substrate). Hence, 
it seems to be important for activity that the amino acid at position 21 carries only a small 
side chain. In the MSA consisting of 37 sequences of LigE homologs (chapter 7.9), 
position 21 is strictly conserved, thus supporting the theory that Ser21 is important for 
LigE catalysis by supporting GSH binding or ensuring proper thiol orientation 112.  
In the presented mutational studies of the active site of LigE, we were able to confirm 
the non-essential role but importance of residue Ser21 for LigE catalysis. Additionally, 
residue Arg138 was found to be essential for GSH binding. However, no further residues 
of catalytic importance could be identified among the mutated positions. Hence, further 
studies (computational and experimental) of LigE are necessary in the future to further 
expand our knowledge on the catalytic mechanism of this β-etherase. 
 
4.2.2 LigF 
A comparable approach was followed for the analysis of the LigF active site. Based on 
the previously solved crystal structure of LigF containing the cofactor GSH, substrate 
(S)-1 was docked in to identify potentially important active-site residues. This time, the 
predicted binding pose likely represented the productive binding mode, as concluded 
based on substrate geometry and the distance between the β-carbon and the GSH 
thiolate (3.421 Å). It also agreed with the recently published substrate binding mode 
resulting from MD and QM/MM simulations of LigF 116. Based on the calculated 
prediction, several amino acid residues located in proximity to the docked substrate and 
GSH were targeted by alanine scanning: Phe7, Asn12, Cys107, Trp108, Val110, Ser111, 
Trp115, Ile119, Ile122, Gln144, Lys147, Trp148 and Ile199. Moreover, residue Pro142 
was selected even though it is located furthest from the GSH (8.8 Å). When comparing 
these positions to the corresponding residues of homologous LigF sequences in a 
multiple sequence alignment (MSA) consisting of 41 sequences obtained by BLAST 




Asn12, Cys107, Trp108, Val110, Ser111, Trp115, Gln144, Lys147, Trp148 and Ile199.  
The large number of conserved amino acid residues among LigF homologs in the active 
site indicates that these residues could have important catalytic or structural functions. 
A high level of conservation in sequence clusters spanning the active sites of LigF-type 
β-etherases was recently reported 111, implying that substantial catalytic function is 
encoded in these regions and has been maintained by natural selection during biological 
evolution. This conservation of sequence motifs among homologous enzymes was 
recently used to broaden the scope of available β-etherases 111. A peptide pattern 
recognition (PPR) tool 207 was used to classify and cluster LigE- and LigF-type β-
etherases form a large number of homologous sequences by the presence of specific 
peptide motifs. Three motifs, LYSFGPxANSxKP, TESTVICEYLEDxxP and 
AxMRxWTKWVDEYFCWCVSTxGW, were identified for LigF-type β-etherases 111. 
Several amino acid residues mutated in this thesis correspond with residues located in 
the reported sequence motifs (F7, N12, S13, C107, W108, V110, S111, W115; marked 
bold in previous motifs). In contrast, residues I119 and I122 are less conserved because 
also valine and methionine were found at these positions in the MSA (chapter 7.10). 
Alanine exchange for all mentioned amino acid residues in LigF resulted in a severe 
impact on enzyme activity; in case of W115A and W148A, even a complete loss of 
activity was observed.  
Furthermore, special attention was drawn to position Pro142, for which the alanine 
exchange resulted in improved activity with both of the tested substrates. Using site 
saturation mutagenesis, several amino acids at position 142 led to improved activity 
compared to the wild-type enzyme. Among them serine, tyrosine, phenylalanine, 
histidine, as well as the previously mentioned alanine, which represents a rather diverse 
set of amino acids regarding their characteristics. Additionally, according to the MSA of 
LigF homologs (chapter 7.10), proline at position 142 is not conserved, as multiple amino 
acids with variable properties (proline, valine, isoleucine, alanine, phenylalanine and 
lysine) are found at this position in the MSA. This large natural diversity of position 142 
speaks against a catalytic function of this residue. Interestingly, position Pro142 within 
the enzyme’s structure is located rather far from the predicted active site and hence, its 
role for enzyme activity cannot be fully understood. It might be, however, that position 
142 is important for protein dynamics of LigF, which could play a role during catalysis. It 
has also been shown for other enzymes that single mutations located remotely from the 
active site (˃10 Å) can have a significant impact on catalytic function 208–214. Moreover, 
LigF was subjected to random mutagenesis by error-prone PCR very recently and two 




Both residues are again distantly located from the active site (both more than 20 Å, based 
on our docking). As mentioned, those positions as well as P142 could have an impact 
on structural and dynamic features of the enzyme, and therewith also enzyme activity, 
which might imply larger protein motions during catalysis. However, further studies are 
needed to confirm the biological relevance of position P142 for LigF catalysis. 
Additionally, site-saturation of Trp115 revealed the importance of the aromatic character 
of this residue for substrate binding. A complete loss of activity was observed when 
Trp115 was exchanged by non-aromatic amino acids, whereas LigF mutants W115F, 
W115T and W115H still displayed activity. However, even substitution of W115 with 
these aromatic residues (phenylalanine, tyrosine and histidine) had a severe negative 
impact on activity and enzyme kinetics. The required aromatic character of this residue, 
which is located in direct proximity to the docked substrate, is very likely responsible for 
the correct positioning of the substrate in the active site. 
The importance of Trp148 and Gln39 for LigF catalysis was confirmed by the observed 
complete loss of activity after an exchange by alanine. These amino acid residues were 
previously described to interact with the glycine part of GSH. Hence, our results suggest 
that the correct positioning of GSH is crucial for LigF catalysis. Binding of the GSH 
cofactor to the G-site of the thioredoxin domain is stabilized by a network of hydrogen 
bonds provided by surrounding residues. Apart from W148 and Q39, these include also 
E65, S66, Q52, Q144 and H40 112,216.  
As catalysis by GSTs typically depends on activation of the GSH molecule to form its 
thiolate form via hydrogen bonds with active-site residues 217, it was previously 
suggested by Helmich et al. 112 that the hydroxyl group of Ser13, which is located in the 
active site of LigF, could hold this function. Further research, however, refuted this 
theory, since no complete loss of activity was observed when Ser13 was exchanged to 
alanine 112. Site-saturation mutagenesis of this residue in this work revealed several 
amino acid residues (alanine, glycine, cysteine, asparagine) that still ensured catalytic 
activity, though with severe activity losses. This suggests that Ser13 is indeed important 
but not essential for LigF catalysis. Later, Kontur et al. 115 suggested that activation of 
GSH by deprotonation of the thiol may involve the conserved residue Asn12. Site-
saturation mutagenesis of this residue in the present work revealed that position Asn12 
alone is also not crucial and thus not solely responsible for GSH activation. Different 
amino acid residues (alanine, histidine, methionine, phenylalanine, arginine, threonine, 
lysine) at position 12 were shown to maintain catalytic activity. Moreover, mutation N12H 
even had a positive effect on enzyme activity. This is likely explained by the fact that 




where de- and reprotonation steps are required during catalysis 218,219. Based on MD and 
QM/MM simulations of LigF catalysis, Prates et al. 116 recently proposed that both amino 
acid residues, Asn12 and Ser13, are cooperatively responsible for activation of GSH. 
Asn12 interacts directly with the GSH thiolate via a hydrogen bond, while Ser13 
hydrogen bonds with the thiolate via a water molecule as shown in Fig. 4.2. The 
experimental data collected in this thesis support the theoretical data published by Prates 
et al. 116. While single mutants, in which Asn12 or Ser13 were exchanged for non-
hydrogen bonding residues, enzymatic activity, activity was not completely lost. For the 
corresponding double mutant LigF-N12A+S13A, however, no residual activity could be 
detected anymore. This experiment proves the importance of residues Asn12 and Ser13 
for GSH activation, and their cooperative effect on LigF catalysis, thus supporting the 
theoretical data previously published. 
 
 
Fig. 4.2: Proposed SN2 reaction mechanism of LigF in cleavage of β-O-4 aryl ether bond in substrate 1. Blue 
arrows indicate electron flow and dashed lines represent important hydrogen bonds for catalysis 116. 
 
Furthermore, in the LigF mechanism proposed by Prates et al. 116, residue Ser111 is 
responsible for mediating proton transfer from a water molecule to the oxygen of the 
leaving group (2,6-MP in Fig. 4.2) upon ether bond cleavage. The importance of this 
residue was confirmed by mutation S111A, which resulted in a severe activity loss (≥98.5 
%). Enzymatic activity of LigF S111A, however, was not abolished completely, 
suggesting a possible compensation by a different residue or water directly. This could 
possibly be ensured by neighbouring Trp115 (H-to-O distance of 2.566 Å) or by a water-
mediated proton, but further analysis is necessary to confirm these theories. 
In summary, with the herein presented mutational study of the catalytic site of LigF, the 
cooperative importance of residues Ser13 and Asn12 for GSH-activation was 
demonstrated. Moreover, residue Trp115 was shown to play an important role for LigF 
catalysis, likely for correct substrate positioning as only aromatic residues at this position 
retained residual activity. Additionally, different LigF mutants with improved catalytic 




position Pro142, implying that the catalytic properties of LigF can be further improved by 
protein engineering and that structural changes of the enzyme may occur during 
catalysis.  
 
4.3 Substrate binding studies 
Tryptophan is an α-amino acid that is relatively rare in proteins. On average, only ~1 % 
of the amino acid residues in protein structures is reported to be tryptophan 220,221 which 
is also reflected by the fact that there is only one DNA codon for tryptophan. This has 
been concluded to be connected with evolutionary and functional reasons since 
tryptophan is the largest amino acid residue and its synthesis requires more ATP than 
any other proteinogenic amino acid. Therefore, it is also assumed that, in most cases, 
tryptophan plays an important biological and functional role in proteins. Moreover, as an 
aromatic amino acid, tryptophan possesses intrinsic protein fluorescence, which is 
strongly affected by its local environment. This property has been used in protein-related 
research to quantify conformational changes of tryptophan residues as well as changes 
in the tryptophan environment. 
The LigE monomer contains 11 tryptophan residues in its structure. Six of them (W25, 
W114, W136, W141, W178, and W216) are buried inside the hydrophobic core of the 
protein, one (W68) is located at its surface and two (W73 and W105) are located in the 
dimer interface. The latter are likely involved in the interaction of both monomers. The 
remaining two tryptophan residues, W107 and W197, are found in the active site (Fig. 
4.3A). Hence, the intrinsic fluorescence of these tryptophan residues should change 
upon binding of the substrate. Similarly, one LigF monomer contains eight tryptophan 
residues in its structure, two of which (W43 and W57) are located at the surface. Another 
two (W98 and W101) are located at the dimer interface and are believed to play a role 
in dimer formation. Residue W225 is located inside the protein’s hydrophobic core 
structure, while W148 was shown to interact with GSH. Again, two residues, W108 and 
W115, are located in the active site and their fluorescence is expected to change upon 





   
Fig. 4.3: (A) Active site of LigE (yellow, PDB code: 4YAN) with the docked substrate β(R)-2,6-MP-VG 
(orange) and the tryptophan residues located in the active site: Trp107 (red) and Trp197 (green), which 
intrinsic fluorescence is expected to be altered upon substrate binding. (B) Active site of LigF (green, PDB 
code: 4XT0) with the docked substrate β(S)-2,6-MP-VG (orange) and the tryptophan residues located in the 
active site: Trp108 (yellow) and Trp115 (blue), which intrinsic fluorescence is expected to be altered upon 
substrate binding. 
 
Thus, a tryptophan fluorescence assay was developed and applied in this thesis to 
analyze the binding of different model substrates in LigE and LigF. This revealed that in 
addition to lignin model substrates 1 and 2, also substrate 4, containing a thioether bond, 
displays high affinity for binding to the active sites of LigE and LigF despite the fact that 
this substrate is not converted by any of the tested β-etherases. According to collected 
data, substrate 4 can bind to the active sites of LigE and LigF, even though it is not 
actively converted by these enzymes. The latter is likely explained by the fact that the 
cleavage of the thioether bond by nucleophilic attack of GSH was found to be 
endothermic according to DFT calculations. Hence, compound 4 could be useful as a 
substrate analog in enzyme crystallography or mechanistic studies of β-etherases in the 
future. Moreover, compound 5, lacking the β-O-4 aryl ether bond, resulted in changes of 
intrinsic tryptophan florescence upon titration to LigE and LigF. However, these changes 
did not follow any trend. This might be explained by a random interaction of this 
compound with tryptophan residues located on the surface of the enzymes as well as in 
the active sites. This data suggests that substrate 5 does not effectively bind to the active 
site of enzymes LigE and LigF. Binding of substrate 5 to the active site of LigF-NA 
enzyme was previously analyzed by Voß 269 using micro scale thermophoresis (MST). 
The received results of the measurement were unfortunately not unambiguous and it 
was not possible to conclude if real binding or only binding artefacts were measured. 




substrate for the NAD-dependent Cα dehydrogenases (LigD, LigO, LigN and LigL) that 
are described as early enzymes in the lignin β-O-4 aryl ether cleavage pathway in 
Sphingobium sp. SYK-6 105,118. In this pathway, enzymes LigD, LigO, LigN and LigL 
catalyze the stereospecific oxidation of the Cα hydroxy group of 6 to generate a keto 
group in Cα position 102,222, which is a prerequisite for ether bond cleavage by β-
etherases 107,110,119. This keto group is suggested to be essential for subsequent cleavage 
due to intramolecular activation of the ether bond and the altered molecule geometry. 
Our experimental data shows that 6 is also not bound to the active site of β-etherases. 
Furthermore, the binding of substrates 1, 2 and 4 was described by sigmoidal binding 
curves, suggesting cooperative binding. Cooperative substrate binding, as described by 
the Hill equation, can be observed in some multimeric enzymes where binding of one 
substrate molecule alters the affinity of another binding site due to ligand-induced 
conformational changes 223–225. In the case of LigE, LigF and their mutants, Hill 
coefficients close to 2 were observed, indicating significant cooperativity, as both β-
etherases form homodimers. This cooperativity, however, was not observed during 
kinetic measurements. The reason for this difference is not clear yet. It cannot be 
excluded that the use of a racemic substrate mixture, of which only one enantiomer is 
actually converted by the enzyme, or the conditions of the tryptophan fluorescence assay 
itself are influencing the binding behavior. Hence, further investigation is necessary to 
answer the question if substrate binding to LigE and LigF happens indeed in a 
cooperative fashion or not. In general, GSTs were for a long time considered as 
noncooperative enzymes, meaning that substrate binding to one subunit of the 
homodimeric protein would not modify the catalytic properties of the other one 226–228. 
However, mutagenesis studies of the homodimeric maize glutathione S‐transferase have 
shown a positive cooperativity for 1‐chloro‐2,4‐dinitrobenzene (CDNB) binding as well 
as for binding of 1‐hydroxyl‐2,4‐dinitrobenzene (HDNB) 229. Positive cooperativity in this 
case was induced by a mutation on the dimeric interface and was explained by causing 
conformational communication between monomeric subunits upon substrate binding. 
Additionally, positive cooperativity for GSH binding was confirmed in mutational studies 
of human GST P1‐1 230, which is responsible for the conjugation of prostaglandins J2, 
A2 231 and halide ions 232. In addition, wild‐type human GST P1‐1 was reported to display 
temperature‐dependent positive and negative cooperativity of GSH binding above 35˚C 
and below 25˚C, respectively 233. 
Additionally, it was shown that LigE and LigF mutants with severely reduced or even 
completely abolished activity still displayed substrate binding according to the tryptophan 




LigF, independent from their impact on catalytic efficiency, did not completely prevent 
substrate binding but rather resulted in unfavorable positioning of the substrate with 
regard to catalysis. Moreover, binding of substrate 1 to the active site of LigE and LigF 
was highly affected when the cofactor GSH was present. In this case, binding affinities 
were generally 2.4-2.8-times lower compared to measurements without GSH. This drop 
in affinity could simply be the result of iterative lignin model substrate conversion and 
product release during the tryptophan fluorescence assay due to the presence of GSH. 
On the other hand, it cannot be ruled out that the enzymes’ affinity for substrate binding 
is indeed affected by the cofactor GSH. The latter could actually be tested in the future 
by using compound 4 as model substrate together with GSH in the tryptophan 
fluorescence assay, as compound 4 does bind to the active site of LigE and LigF but 
cannot be converted. 
Furthermore, ITC was used to determine the binding affinity of LigF for GSH in the 
absence and presence of substrate. Results indicated strong binding of GSH to LigF (KD 
= 80 μM) in the absence of substrate. This value is rather similar to the binding affinity of 
the glutathione S-transferase from Plasmodium falciparum for GSH (KD = 70 μM) 234. 
When model compound 4 was present, the KD value increased, suggesting a lower 
affinity of LigF for GSH. In this case, however, the observed drop in affinity cannot be 
caused by substrate conversion, since model compound 4 cannot be cleaved by LigF. 
Hence, GSH binding is indeed altered in the presence of substrate and therefore, it is 
likely that also substrate binding is affected by GSH, as observed in the tryptophan 
fluorescence assay. Similar findings were previously observed for plant GST from 
Mangifera indica 235 for which crystal structures were solved for the GSH-enzyme and 
GSX-enzyme (GSX: model of the GSH-hexyl conjugate) complexes. Here, it was 
confirmed that binding of GSH to the enzyme active site at the G-site causes 
conformational changes to the enzyme. It was even suggested that the binding of GSH 
is required for proper structural formation of the substrate-binding site for catalysis 235. 
This would also explain why substrate binding affinity of LigE and LigF wild-type enzymes 
and their mutants, as measured by tryptophan fluorescence assay, changed upon GSH 
addition. 
Furthermore, the higher affinity of LigF for GSH binding in absence of substrate may 
have a physiological purpose. This way, release of GSH from the enzyme active site 
could be prevented before substrate is present for catalysis. 
Furthermore, during ITC measurements a change in the value of N from 1 to 2 was 
observed upon substrate addition. The parameter N usually represents the number of 




suggest that there are two GSH binding sites per LigF monomer when 100 μM and 200 
μM of model compound 4 was present, in comparison to only one binding site when only 
GSH was present. This is, however, rather unlikely based on the known LigF crystal 
structure and based on the shape of the binding curve (if two binding sites were present, 
the binding curve should have double-sigmoidal shape). Apart from the number of 
binding sites, the parameter N can be influenced as well by structural changes in the 
binding sites. In case of homodimeric LigF this could mean that upon substrate binding 
both GSH binding sites are structurally not identical anymore. This could explain why in 
our measurements without model compound 4 (and with only 50 μM of 4) an N value of 
1 is obtained, as here both GSH binding sites of the homodimer are likely symmetric, 
whereas this value increases to 2 as the concentration of 4 reaches the level of the 
enzyme concentration, which results in substrate binding to the enzyme. This binding of 
substrate analog 4 to the active site of LigF likely involves structural changes in the active 
site and hence, possibly also in the GSH binding site, which could make both GSH 
binding sites of homodimeric LigF asymmetric. Even minor alterations in the GSH binding 
site would be sufficient to cause changes in the N-value. Overall, our results support the 
hypothesis that structural changes occur in LigF (and likely also other β-etherases) upon 
substrate or GSH binding, a fact that has already been observed in multiple other GSTs 
234–236. Additionally, the molecular dynamics (MD) simulation of LigF by Prates et al. 116 
in the presence of substrate and GSH indicated that 51 % of the predicted substrate 
positions involved hydrogen bonding between substrate and GSH. This result further 
supports our findings that binding of GSH and substrate influence each other. On the 
other hand, it cannot be completely ruled out that the observed increase in the N value 
during ITC measurements is simply an artefact. N is rather sensitive parameter in ITC 
as small inconsistencies in the concentrations of ligand or protein during the 
measurement may cause alterations in this value. Hence, further analyses are necessary 
in the future to better understand binding of substrate and GSH to the β-etherases and 
the possible involvement of conformational changes during binding. 
Substrate binding studies with LigE and LigF enzymes using the tryptophan fluorescence 
assay provided valuable information about the binding behavior with multiple substrates 
as well as GSH. This analysis indicated that substrate binding is significantly affected in 
the presence of cofactor GSH. Likewise, ITC measurements revealed that the high 





4.4 Novel non-lignin substrates of β-etherases 
To investigate the biocatalytic potential of β-etherases further, they were tested in 
reactions with potential novel, non-lignin-like substrates. All of the tested compounds 
(30-34), provided by Prof. Dr. Dieter E. Kaufmann from the Institute of Organic Chemistry 
at TU Clausthal, Germany, contained a common key building block. This unit, known as 
bisphenol A (BPA, Fig. 4.4A), is an industrial chemical that has been commonly used in 
the synthesis of certain plastics and epoxy resins 237. However, despite the positive effect 
of the compound on the properties of the resulting polymers (Fig. 4.4B), the use of BPA 
is very controversial due to its toxicity towards algae, invertebrates, fish, as well as 




Fig. 4.4: Structure of the bisphenol A (A) and the commonly used bisphenol A-polycarbonate (B). 
 
The toxic effects of bisphenol A are associated with early sexual maturation, altered 
behavior, and effects on prostate and mammary glands 240–242. It has also been 
connected to cardiovascular disease, diabetes and male sexual dysfunction 243–248. The 
European Union listed BPA as a potential endocrine disruptor and restricted its use in 
certain food-contact materials. It has been in use since the 1960’s until today and 
released into the environment at low doses, although BPA and its polymeric forms are 
barely degraded in wastewater treatment plants 249. Hence, methods are required to 
improve their degradability. As an alternative to conventional processes for phenol 
removal, several microbial approaches have been described to degrade a monomeric 
BPA, including ligninolytic enzymes from fungi (LiP, MnP, and laccase) 250–252 as well as 
bacterial strains Sphingomonas sp. BP-7 and Sphingomonas yanoikuyae BP-11R 253.  
The compounds that were tested as β-etherase substrates within this thesis contained 
aryl ether bonds which were previously found to improve the stability of BPA polymers 
towards hydrolytic degradation and photodegradation in sunlight 254. A low but proven 
catalytic activity of the bacterial β-etherases towards polyphenolic compounds 30, 31, 
and 32 was observed, demonstrating their potential for BPA degradation. The cleavage 
of aryl ether bonds (compound 30) in non-lignin-like compounds by β-etherases as well 
as their activity for epoxide ring opening with GSH (compounds 31 and 32) have not 




been reported to grow on monomeric BPA as the sole carbon source 253,255–259. So far, 
the most promising strain appears to be Sphingomonas sp. strain AO1 255, which was 
able to degrade 115 μg/ml of monomeric BPA within 6 hours. Recently, in a quantitative 
proteomics and metabolomics study of the BPA-degrading strain Sphingobium sp. BiD32 
258, which had been isolated from activated sludge, a hydroxylated metabolite has been 
detected and a p-hydroxybenzoate hydroxylase enzyme was identified to be involved in 
BPA degradation. Despite multiple studies of BPA-degrading bacterial strains, our 
knowledge of metabolic pathways for BPA degradation as well as the knowledge of 
involved enzymes and genes is still rather limited. What has been found out is that when 
multiple organisms were exposed to increased concentrations of BPA (or its alternative 
bisphenol F and bisphenol S), the activity and expression levels of GSTs were 
significantly increased 260–262. Based on that, it is likely that GSTs (including β-etherases) 
might have potential for degradation of BPA and its analogs. Overall, the herein obtained 
data is a good starting point for further analysis regarding the application of β-etherases 
on non-lignin-like substrates. 
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5 Conclusions and future perspectives 
Glutathione-dependent β-etherases and glutathione lyases catalyze the reductive 
cleavage of β-O-4 aryl ether linkages present in lignin. Due to their non-radical 
mechanism, these enzymes are promising biocatalysts for the selective 
depolymerization of lignin polymer as well as oligomers, and hence the production of 
aromatic platform chemicals from renewable sources. Lignin, as part of lignocellulose, is 
one of the most abundant aromatic polymers present on earth. Hence, its valorization is 
regarded as a valuable alternative to the synthesis of aromatics from mineral oil. β-
Etherases and glutathione lyases belong to the superfamily of glutathione transferases 
and require 2 equivalents of the cofactor glutathione (GSH) for cleavage of each β-O-4 
aryl ether bond. 
In this thesis, an E. coli-based whole-cell biocatalyst was generated harboring 
glutathione-dependent β-etherases together with glutathione lyase for efficient supply of 
required GSH by the cells during β-O-4 aryl ether bond cleavage. By combining a 
stereoselective β-etherase and a less selective glutathione lyase, this whole-cell 
cascade enabled the kinetic resolution of 10 mM racemic lignin model substrate on a 
semi-preparative scale without the need to add expensive glutathione cofactor. Thus, 
the presented whole-cell system can be applied for the efficient preparation of 
enantiopure lignin model substrates containing β-O-4 aryl ether linkages. These 
molecules are useful substrates for mechanistic or kinetic studies of β-etherases and 
other ligninolytic enzymes. Similarly, chiral glutathione adducts formed by β-etherase 
catalysis can also be accessed using this whole-cell approach if no glutathione lyase is 
present. Moreover, the application of this intracellular GSH supply and recycling concept 
based on E. coli is not limited to β-etherases and glutathione lyases. In principle, it can 
be extended to other GSH-dependent enzymes. However, as the glutathione cofactor is 
provided within the cell, only substrates that are able to enter the cell can be converted 
with this approach. Examples could be the synthesis of enantiomerically pure aromatic 
compounds with a valuable pharmaceutical application like phenylpropanoids exhibiting 
anti Alzheimer’s disease activity 263, compounds that promote the formation of new blood 
vessels 264, or neuroprotective compounds that have only been isolated from their natural 
sources so far 265. Moreover, larger scale reactions in a fully-controlled environment 
could be explored. Furthermore, as the used organic cosolvents for substrate dissolution 
all exhibited a negative effect on the whole-cell catalyst performance, novel solvents that 
may also be less damaging to the catalyst and environment, such as solvate ionic liquids 
266, should be tested. 
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For successful industrial application of any biocatalyst, extended knowledge of the 
catalyst’s mechanism is necessary. In this thesis, the best studied β-etherases, LigE and 
LigF, underwent a detailed analysis of their active sites based on their previously solved 
crystal structures in combination with substrate docking. Mutational studies of the active-
site residues of LigE and LigF revealed amino acid residues that are important or even 
essential for substrate binding and catalysis. Moreover, mutants with improved catalytic 
activity have been identified, establishing a good starting point for further protein 
engineering of β-etherases. Protein engineering will be necessary to improve the 
enzyme’s properties, such as specific activity, thermostability, pH sensitivity and 
substrate specificity, for industrial application. Since the mutation of a remote residue, 
Pro142, located outside of LigF’s active site, resulted in a boost of enzyme activity, LigF 
appears to be a good candidate for further activity improvement by random mutagenesis. 
Additionally, the importance and function of several amino acid residues for the catalytic 
mechanism of LigF have been proposed. Nevertheless, further analysis of active-site 
residues is still necessary, especially regarding Ser111 and the possible role of 
surrounding residues which are or might be involved in proton transfer to the leaving 
group during catalysis.  
Results gathered in the mutational study of β-etherase LigE are, unfortunately, less 
meaningful as the productive substrate binding orientation could not be elucidated with 
the crystal structure of truncated LigE. This should be taken as a scientific challenge and 
further analyses, computational and experimental, should be conducted to reveal the 
substrate-bound structure of this promising enzyme. In that sense, a close cooperation 
between computational scientists and wet-lab researchers will be crucial in the future for 
efficient advancement of β-etherase-catalyzed lignin depolymerization and biocatalysis 
in general. 
In connection to this, by conversion of BPA-related compounds, the substrate scope of 
β-etherases was demonstrated in this thesis to go beyond lignin-derived ether 
substrates. This opens new possibilities for potential application of these enzymes in 
waste water treatment and the degradation of non-lignin-like polymers. However, the 
data presented here is just the beginning and further investigations are necessary to 
uncover the full biocatalytic potential of β-etherases. 
As indicated in this thesis, a collaboration of experts from various fields, including 
biochemical engineering, process engineering, bioinformatics, polymer science and 
biochemistry, will be necessary for the development of processes in which 
heteropolymeric lignin can be valorized in an efficient but environmentally sustainable 
way to replace petrol-based chemistry. The current climate situation, characterized by 
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increasing sea levels, melting icebergs, extreme droughts followed by extreme floods, 
increased wildfires, declining fresh water sources, and a rapid increase in Earth's 
average surface temperature should force not only the scientific, but also the layman 
community to do anything possible to reverse these changes and preserve the planet 
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7.3 List of abbreviation 
AA  Amino acid 
ABTS  2,2'-azino-bis-(3-ethylbenzothiazoline-6-sulfonic acid) 
ACN  Acetonitrile 
Amp  Ampicillin 
APS  Ammonium persulfate 
ATP  Adenosine triphosphate 
AV  Acetoveratrone 
BLAST  Basic Local Alignment Searching Tool 
bp  Base pairs 
B-PER  Bacterial Protein Extraction Reagent 
CFE  Cell free extract 
CV  Column volume 
DCM  Dichloromethane 
DFT  Density Functional Theory 
DMF  Dimethylformamide 
DMSO  Dimethyl sulfoxide 
DNA   Deoxyribonucleic acid 
dNTP   Deoxynucleotide triphosphate  
DyP  Dye-decolorizing peroxidase 
e.g.  exempli gratia (for example) 
ESI-MS  Electro Spray Ionization Mass Spectrometry 
et al.  et alii (and others) 
EtOAc   Ethyl acetate 
EtOH   Ethanol 
FPLC  Fast protein liquid chromatography 
Fwd  Forward 
G  Guaiacyl unit 




GSSG  Oxidized glutathione 
GST  Glutathione transferase 
H  p-hydroxyphenyl unit 
HBT  1-hydroxybenzotriazole 
HPLC  High performance chromatography 
IMAC  Immobilized metal affinity chromatography 
IPCC  Intergovernmental Panel on Climate Change 
IPTG  Isopropyl β-D-1-thiogalactopyranoside 
IR  Infrared radiation 
kan  Kanamycin 
kb  Kilobase 
kcat  Turnover number 
kDa  Kilodalton 
Kpi  Potassium phosphate buffer 
LB  Luria broth 
LC-MS  Liquid chromatography-mass spectrometry 
LED  Light emitting diode 
LiP  Lignin peroxidase 
M  Marker 
MilliQ  Ultrapure water 
MnP  Manganese peroxidase 
MST  Microscale thermophoresis 
NAD  Nicotinamide dinucleotide  
NADP  Nicotinamide dinucleotide phosphate 
NBS  N-bromsuccinimid 
NTA  Nitrilotriacetic acid 
NMR  Nuclear magnetic resonance 
OD600   Optical density at λ = 600 nm 




PDB  Protein data bank 
PMSF   Phenylmethylsulfonyl fluoride 
rac  Racemic 
rpm  Revolutions per minute 
rev  Reverse 
S  Syringyl unit 
SDS  Sodium dodecyl sulphate  
SDS-PAGE Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SOC  Super optimal broth with Catabolite repression 
SSM  Site-saturation mutagenesis 
TAE  Tris base, acetic acid and EDTA 
TB  Terrific broth 
TEMED  Tetramethylethylenediamine  
TEMPO  2,2,6,6-tetramethylpiperidine-1-oxyl 
TLC  Thin Layer Chromatography 
Tm   Melting temperature 
Tris   Tris(hydroxymethyl)aminomethane 
UV  Ultraviolet 
VA  Veratryl alcohol 
VG  Veratryl glycerone 
VP  Versatile peroxidase 
WT   Wild type 
 
7.3.1 Abbreviation of amino acids 
Alanine  Ala  A 
Arginine  Arg  R 
Asparagine Asn  N 
Aspartic acid Asp  D 




Glutamic acid Glu  E 
Glutamine Gln  Q 
Glycine  Gly  G 
Histidine  His  H 
Isoleucine Ile  I 
Leucine  Leu  L 
Lysine  Lys  K 
Methionine Met  M 
Phenylalanine Phe  F 
Proline  Pro  P 
Serine  Ser  S 
Threonine Thr  T 
Tryptophan Trp  W 
Tyrosine  Tyr  Y 





7.4 Vector maps 
 
Supplementary Figure. 7.1: Gene ligE cloned into the pET28a(+) expression vector using restriction sites 
Ndel and HindIII. 
 
Supplementary Figure 7.2: Vector maps of pETDuet1_ligE_ligF harbouring β-etherase genes ligE (MCS1) 





7.5 1H NMR Spectra 
Compound B 
 
Supplementary Figure 7.3: 1H NMR (300 MHz, CDCl3) of 3,4-dimethoxyacetophenon (B) (Spectrum 







Supplementary Figure 7.4: 1H NMR (300 MHz, CDCl3) of β-(2,6-dimethoxyphenoxy)-α-(3,4-







Supplementary Figure 7.5: 1H NMR (300 MHz, CDCl3) of β-(2,6-dimethoxyphenoxy)-α-veratrylglycerone (1) 







Supplementary Figure 7.6: 1H NMR (300 MHz, dDMSO) of 4-(2-(3,4-dimethoxyphenyl)-2-oxoethoxy)-3-







Supplementary Figure 7.7: 1H NMR (300 MHz, dDMSO) of (β-vanillinyl-α-veratrylglycerone (3) (Spectrum 





7.6 LC-MS, MS analysis 
 
Supplementary Figure 7.8: MS spectra of the substrate in the reaction, where mixture 30 was tested.  
 
 


















Supplementary Figure 7.12: LC-MS spectra of the intermediate in the reaction, where mixture 32 was tested.  
 
 




7.7 HPLC chromatogram 
 
 
Supplementary Figure 7.14: HPLC chromatogram of achiral analysis of substrate 1 with the corresponding 
intermediates and final product when in reaction with β-etherases and glutathione lyases. 
 
7.8 Kinetic measurements 
 
 



























Equation y = Vmax * x / (Km + x)
Plot reaction rate
Vmax 8.02187E-4 ± 2.66943E-5




























Equation y = Vmax * x / (Km + x)
Plot reaction rate
Vmax 0.00126 ± 1.35365E-4





































Equation y = Vmax * x / (Km + x)
Plot reaction rate
Vmax 9.94243E-5 ± 2.68305E-6































y = Vmax * x / (Km + x * (1 + x 
/ Ki));
Plot reaction rate
Vmax 8.55049E-4 ± 7.96538E-5
Km 0.43123 ± 0.0719































y = Vmax * x / (Km + x * (1 +
 x / Ki));
Plot reaction rate
Vmax 8.9694E-4 ± 1.52761E-4
Km 5.06557 ± 1.05825

































Equation y = Vmax * x / (Km + x)
Plot reaction rate
Vmax 2.14837E-4 ± 6.90842






























Equation y = Vmax * x / (Km + x)
Plot reaction rate
Vmax 8.06775E-4 ± 1.63013E-































Equation y = Vmax * x / (Km + x)
Plot reaction rate
Vmax 5.17002E-4 ± 2.59384E-5






































y = Vmax * x / (Km + x * (1 
+ x / Ki));
Plot reaction rate
Vmax 4.89782E-4 ± 7.03517E-5
Km 1.70273 ± 0.38442





























Equation y = Vmax * x / (Km + 
Plot reaction rate
Vmax 0.00133 ± 4.37191E-
































Equation y = Vmax * x / (Km + x)
Plot reaction rate
Vmax 2.14007E-4 ± 2.421E-6































Equation y = Vmax * x / (Km + x)
Plot B
Vmax 3.9053E-4 ± 1.04508E-5































Equation y = Vmax * x / (Km + x)
Plot B
Vmax 8.03057E-4 ± 3.81588E-5
































Equation y = Vmax * x / (Km + x)
Plot B
Vmax 5.45022E-4 ± 2.45428E-5






































Equation y = Vmax * x / (Km + x)
Plot B
Vmax 8.58353E-4 ± 4.14329E-5

































y = Vmax * x / (Km + x * (1 + x
 / Ki));
Plot reaction rate
Vmax 7.79667E-4 ± 8.64587E-5
Km 0.93463 ± 0.1555
































y = Vmax * x / (Km + x * (1 + x / Ki));
Plot reaction rate
Vmax 0.00498 ± 0.0038
Km 11.05428 ± 8.818
































y = Vmax * x / (Km + x * (1 + x / Ki))
;
Plot reaction rate
Vmax 6.70457E-4 ± 4.3049E-4
Km 3.93455 ± 2.87949






























y = Vmax * x / (Km + x * (1 + x
 / Ki));
Plot reaction rate
Vmax 8.81014E-4 ± 3.66227E-4
Km 2.64198 ± 1.32447

































y = Vmax * x / (Km + x * (1 + x / Ki))
;
Plot B
Vmax 0.00165 ± 9.58008E-4
Km 3.26239 ± 2.11715








   




























y = Vmax * x / (Km + x * (1 + x /
 Ki));
Plot reaction rate
Vmax 2.84211E-4 ± 3.5627E-5
Km 0.74087 ± 0.1657


































y = Vmax * x / (Km + x * (1 
+ x / Ki));
Plot reaction rate
Vmax 0.00172 ± 1.94302E-4
Km 5.81888 ± 0.75144






























y = Vmax * x / (Km + x * (1 + 
x / Ki));
Plot reaction rate
Vmax 6.12616E-4 ± 1.31655E-4
Km 1.20746 ± 0.35749






























y = Vmax * x / (Km + x * (1 +
 x / Ki));
Plot reaction rate
Vmax 5.88484E-4 ± 9.59353E-5
Km 1.53464 ± 0.33326































y = Vmax * x / (Km + x * (
1 + x / Ki));
Plot reaction rate
Vmax 8.0573E-4 ± 5.37568E-4
Km 9.06752 ± 6.59667






























y = Vmax * x / (Km + x * (1 + 
x / Ki));
Plot B
Vmax 1.02786E-4 ± 7.59276E-5
Km 1.53033 ± 1.46053





































y = Vmax * x / (Km + x * (1 + 
x / Ki));
Plot reaction rate
Vmax 9.27413E-4 ± 3.26423E-4
Km 1.67619 ± 0.75969



































y = Vmax * x / (Km + x * (1
 + x / Ki));
Plot Reaction rate A
Vmax 4.37585E-4 ± 9.02376E-5
Km 1.43463 ± 0.41009






























y = Vmax * x / (Km + x * (1 + x /
 Ki));
Plot Reaction rate A
Vmax 7.81831E-4 ± 5.23078E-4
Km 2.18625 ± 1.83057





























y = 4.97048E-4 * x / (1.90522
 + x * (1 + x / 2.07316));
Zeichnen Reaction rate A
Vmax 4.97048E-4 ± 1.59536E-4
Km 1.90522 ± 0.79981































y = Vmax * x / (Km + x * (1 
+ x / Ki));
Plot Reaction rate A
Vmax 2.05475E-4 ± 2.85417E-5
Km 0.78284 ± 0.18692

































y = Vmax * x / (Km + x * (
1 + x / Ki));
Plot Reaction rate A
Vmax 2.65882E-4 ± 4.60801E-
Km 0.96445 ± 0.26899










































y = Vmax * x / (Km + x * (1 + x
 / Ki));
Plot reaction rate
Vmax 3.62863E-4 ± 4.36244E-5
Km 881.56365 ± 157.20849






























y = Vmax * x / (Km + x * (1 
+ x / Ki));
Plot B
Vmax 0.00121 ± 4.17578E-4
Km 4.20371 ± 1.65539































y = Vmax * x / (Km + x * (1 + x /
 Ki));
Plot B
Vmax 4.26996E-4 ± 1.36454E-4
Km 3.03619 ± 1.1666
































y = Vmax * x / (Km + x * (1
 + x / Ki));
Plot reaction rate
Vmax 0.003 ± 0.00107
Km 9.37071 ± 3.58912
































y = Vmax * x / (Km + x * (1 
+ x / Ki));
Plot B
Vmax 5.97183E-4 ± 1.23612E-4
Km 1.61367 ± 0.42012


































y = Vmax * x / (Km + x * (1 + x /
 Ki));
Plot B
Vmax 6.60258E-4 ± 5.63978E-4
Km 7.04178 ± 6.53255










Supplementary Figure 7.15: Kinetic analyses of every enzyme and mutant created in this project toward 
substrate 3. 
  


























y = Vmax * x / (Km + x * (1 
+ x / Ki));
Plot B
Vmax 2.47738E-4 ± 6.15478E-5
Km 1.40316 ± 0.41785

































y = Vmax * x / (Km + x * (1 +
 x / Ki));
Plot B
Vmax 8.57189E-4 ± 8.27212E-5
Km 1.24067 ± 0.16164
































y = Vmax * x / (Km + x * (1 + x / 
Ki));
Plot reaction rate
Vmax 0.00214 ± 1.82253E-4
Km 1.13698 ± 0.13214





























Gleichung y = Vmax * x / (Km + x 
Zeichnen Reaction rate A
Vmax 6.8222E-4 ± 8.98364E
Km 0.82161 ± 0.18163



































y = Vmax * x / (Km + x * (1
 + x / Ki));
Plot Reaction rate A
Vmax 3.95303E-4 ± 6.30865E-5
Km 0.7318 ± 0.19446








7.9 LigE homologs multiple sequence alignment 
 
                                          10         20         30         40  
                                 ....|....| ....|....| ....|....| ....|....|  
Sphingobium sp. SYK-6(1)    MARNNTITLY DLQLESGCTI SPYVWRTKYA LKHKGFDIDI   
Novosphingobium fuchskuhlense   MAANNTITFY DLALSTGATI SPFVWATKYA LKHKGFDLDV   
Novosphingobium sp. NDB2Meth1   MAANNTITFY DLALSTGATI SPFVWATKYA LKHKGFDLDV   
Novosphingobium sp. AAP93   MAANNTITFY DLALSTGATI SPFVWATKYA LKHKGFDLDV   
Novosphingobium subterraneum   MAANNTITFY DLALSTGATI SPFVWATKYA LKHKGFDLDV   
Novosphingobium sp. CCH12-A3   MAANNTITFY DLALSTGATI SPFVWATKYA LKHKGFDLDV   
Novosphingobium sp. B1    MAANNTITFY DLALSTGATI SPFVWATKYA LKHKGFDLDV   
Novosphingobium sp. AAP83   MAQNNTITFY DLALSTGATI SPFVWATKYA LKHKGFDLDV   
Novosphingobium aromaticivorans   MAANNTITFY DLALSTGATI SPFVWATKYA LKHKGFDLDV   
Novosphingobium sp. B-7    MAQDNKITFY DLALSTGATI SPFVWATKYA LKHKGFDLDV   
Novosphingobium sp. AAP1    MAQDNKITFY DLALSTGATI SPFVWATKYA LKHKGFDLDV   
Altererythrobacter atlanticus(1) MAKNNTITFY DLALSTGATI SPFVWATKYA LKHKGFDLDV   
Erythrobacter sp. SG61-1L(1)   MAKNNTITFY DLALSTGATI SPFVWATKYA LKHKGFDLDV   
Novosphingobium capsulatum   MAQDNKITFY DLAISTGATI SPFVWATKYA LKHKGFDLDV   
Novosphingobium sp. SCN 66-18   MAANNTITFY DLALSTGATI SPFVWATKYA VKHKGFELDV   
Novosphingobium sp. MD-1    MAANNTITFY DLALSTGATI SPFVWATKYA VKHKGFELDV   
Altererythrobacter sp. 66-12   MARNNTITFY DLALSTGATI SPFVWATKYA LKHKGFDLDV   
Sphingomonadales bacterium 63-6(1) MAKNNTITFY DLALSTGATI SPFVWATKYA LKHKGFDLDV   
Altererythrobacter sp. Root672(1) MAQNNTITFY DLAISTGATI SPFVWATKYA LKHKGFDLDV   
Sphingomonadales bacterium 63-6(2) MAKNNRITLY DLQIAAGCTI SPFVWATKYA VAHKGFEIDI   
Erythrobacter sp. SG61-1L(2)   MAKNNTITLY DLQLEPGCTI SPFVWATKYA IAHKGFEIDI   
Novosphingobium acidiphilum   MAKDNRITFF DLQHASGATT SPFVWATKYA LKHKGFDLDV   
Novosphingobium sp. Fuku2-ISO-50 MAKDNRIRFF DLQHASGCTT SPFVWATKYA LKHKGFDLDV   
Sphingobium sp. 66-54(1)    MAKDNKITIY DLALASGATI SPFVWATKYA IAHKGFELDI   
Altererythrobacter sp. Root672(2) MAKDNTITLY DLQLASGATI SPFVWATKYA IAHKGFEMDI   
Altererythrobacter atlanticus(2) MAANNTVTLY DLQLASGATI SPFVWATKLA IAHKGLDMEI   
Novosphingobium sp. SCN 63-17   MAKDNKITFF DLTHESGCTT SPFVWATKYA VKHKGFDLDV   
Sphingobium sp. SCN 64-10   MAKDNKITIY DLALASGATI SPFVWATKYA IAHKGFELDI   
Sphingobium sp. SYK-6(2)    MAKDNKITIY DLALASGATI SPFVWATKYA IAHKGFELDI   
Novosphingobium sp. FSW06-99   MAQNNRITFF DLQHASGATT SPFVWATKYA LKHKGFDLDV   
Sphingomonas hengshuiensis   MTDRHSVTLY DLNLASGCTI SPFVWRTKYA LAHKGLAIDI   
Novosphingobium sp. PP1Y    MAKDNRITLY DLQLASGCTI SPFVWRTKYA LAHKGFDVDI   
Novosphingobium sp. ST904   MARDNRITLY DLQLASGCTI SPFVWRTRYA LAHKGFDVDL   
Novosphingobium mathurense   MARDNRITLY DLQLASGCTI SPFVWRTKYA LAHKGFDIDI   
Novosphingobium sp. KN65.2   MARDNRITLY DLQLASGCTI SPFVWRSKYA LAHKGFDIDI   
Sphingobium sp. 66-54(2)    MAKNNKITLF DLQLESGCTI SPYVWRTKYA LAHKGFDVEL   
Novosphingobium sp. MBES04   MAKDNRITLY DLQLASGCTI SPFVWRTKYA LAHKGFDMDI   
 
                                          50         60         70         80  
                                 ....|....| ....|....| ....|....| ....|....|  
Sphingobium sp. SYK-6(1)    VPGGFTGILE RTGGRSERVP VIVDDGEWVL DSWVIAEYLD   
Novosphingobium fuchskuhlense   VPGGFTGILE RTGGKTERLP AIVDDGEWVL DSWGIVEYLD   
Novosphingobium sp. NDB2Meth1   VPGGFTGILE RTGGKTERLP AIVDDGEWVL DSWGIVEYLD   
Novosphingobium sp. AAP93   VPGGFTGILE RTGGKTERLP AIVDDGEWVL DSWGIVEYLD   
Novosphingobium subterraneum   VPGGFTGILE RTGGKTERLP AIVDDGEWVL DSWGIVEYLD   
Novosphingobium sp. CCH12-A3   VPGGFTGILE RTGGKTERLP AIVDDGEWVL DSWGIVEYLD   
Novosphingobium sp. B1    VPGGFTGILE RTGGKTERLP AIVDDGEVVL DSWGIVEYLD   
Novosphingobium sp. AAP83   VPGGFTGILE RTGGKTERLP AIVDDGEFVL DSWGIVEYLD   
Novosphingobium aromaticivorans   VPGGFTGILE RTGGKTERLP AIVDDGEFVL DSWGIVEYLD   
Novosphingobium sp. B-7    VPGGFTGILE RTGGKTERLP AIVDDGTWVL DSWGIVEYLD   
Novosphingobium sp. AAP1    VPGGFTGILE RTGGKTERLP AIVDDGTWVL DSWGIVEYLD   
Altererythrobacter atlanticus(1) VPGGFTGIPE RTGGKTERLP AIVDDGKWVL DSWGIVEYLD   
Erythrobacter sp. SG61-1L(1)   VPGGFTKILE RTGGKTERLP AIVDDGTWVL DSWGIVEYLD   
Novosphingobium capsulatum   VPGGFTGILE RTGGKTERLP AIVDDGTWVL DSWGIVEYLD   
Novosphingobium sp. SCN 66-18   VPGGFTGILE RTGGKTERLP AIVDDGEWVL DSWGIVEYLD   
Novosphingobium sp. MD-1    VPGGFTGILE RTGGKTERLP AIVDDGEWVL DSWGIVEYLD   
Altererythrobacter sp. 66-12   VPGGFTKIPE RTGGKTERLP AIVDDGKWVL DSWGIVEYLD   
Sphingomonadales bacterium 63-6(1) VPGGFTGIPE RTGGNSERLP AIVDDGKWVL DSWGIVEYLD   
Altererythrobacter sp. Root672(1) VPGGFTKIPE RTGGVTERLP AIVDDGKWVL DSWGIVEYLD   




Erythrobacter sp. SG61-1L(2)   VPGGFTGIME RTGGKTERLP AIVDDGEWVL DSWLIAEYLD   
Novosphingobium acidiphilum   VDGGFTGILE RTQGRSERLP VIVDDGEWVL DSWLIAEYLD   
Novosphingobium sp. Fuku2-ISO-50 VDGGFTGILD RTGGRSERLP VIVDDGEWVL DSWLIAEYLD   
Sphingobium sp. 66-54(1)    VPGGFSGIPE RTGGKTERLP AIVDDGKWVL DSWLIAEYLD   
Altererythrobacter sp. Root672(2) VPGGFTGIPE RTGGQTERLP AIVDDGQWVL DSWLIAEYLD   
Altererythrobacter atlanticus(2) VPGGFTGIEE RTGGKTQRLP AIVDDGEWIL DSWTIAEYLD   
Novosphingobium sp. SCN 63-17   VPGGFTGILD RTGGRSERLP VICDDGEYVL DSWLIAEYLD   
Sphingobium sp. SCN 64-10   VPGGFSGIPE RTGGVTERLP AIVDDGKWVL DSWLIAEYLD   
Sphingobium sp. SYK-6(2)    VPGGFSGIPE RTGGVTERLP AIVDDGKWVL DSWLIAEYLD   
Novosphingobium sp. FSW06-99   IDGGFIGILD RTGGRSERLP VIVDDGEWIL DSWLIAEHLD   
Sphingomonas hengshuiensis   VPGGFTGILE RTGGRSERLP AIIDNGEWVL DSWLIAEYLD   
Novosphingobium sp. PP1Y    VPGGFTGIAE RTGGRSERVP VIVDDGEWVL DSWKIAEYLD   
Novosphingobium sp. ST904   VPGGFTGIAE RTGGRSERVP VIVDDGEWVL DSWKIAEYLD   
Novosphingobium mathurense   VPGGFTGIAE RTGGRSERVP VIVDDGEWVL DSWKIAEYLD   
Novosphingobium sp. KN65.2   VPGGFTGIAE RTGGRSERVP VIVDDGEWVL DSWKIAEYLD   
Sphingobium sp. 66-54(2)    VPGGFTGILE RTGGRSERVP VIVDDGEWIL DSWVIAEYLD   
Novosphingobium sp. MBES04   VPGGFTGIAE RTGGRSERAP VIVDDGKWVL DSWKIAEYLD   
 
                                          90        100        110        120  
                                 ....|....| ....|....| ....|....| ....|....|  
Sphingobium sp. SYK-6(1)    EKYPDRPMLF EGPTQKNLMK FLDNWLWSTA VGPWFRCYIL   
Novosphingobium fuchskuhlense   AKYPDRPALI PHPSVAATLK ALDHWFWNAA VGPWMFCFCA   
Novosphingobium sp. NDB2Meth1   AKYPDRPALI PHPSVAATLK ALDHWFWGAA VGPWMRCFCA   
Novosphingobium sp. AAP93   AKYPDRTALI PHPSVAATLK ALDHWFWGAA VGPWMRCFCA   
Novosphingobium subterraneum   AKYPNRPALI PHESVAVTLK ALDHWFWNAA VGPWMFCFCA   
Novosphingobium sp. CCH12-A3   AKYPDRPALI PHESVAVTLK ALDHWFWNAA VGPWMFCFCA   
Novosphingobium sp. B1    AKYPDRPALI PHESVAATLK ALDHWFWNAA VGPWMFCFCA   
Novosphingobium sp. AAP83   AKYPDRPALI PHESVAATLK ALDHWFWNTA VGPWMFCFCQ   
Novosphingobium aromaticivorans   AKYPDRPVLI PHESVAATLK ALDNWFWNAA VGPWMFCFCQ   
Novosphingobium sp. B-7    KTYPDRPLLI PHESVAATLK ALDHWFWGAA VGPWMRCFCA   
Novosphingobium sp. AAP1    KTYPDRPLLI PHESVAATLK ALDHWFWGAA VGPWMRCFCA   
Altererythrobacter atlanticus(1) ETYPDRPALI PHPSVAALTR AMDAWFWKVA TGPWMRCFCA   
Erythrobacter sp. SG61-1L(1)   AEYPTRPTLI PHESVATVTR ALDAWFWKVA TGPWMRCFCA   
Novosphingobium capsulatum   ATYPDRPLLI PHESVAATLK ALDHWFWGAA VGPWMRCFCA   
Novosphingobium sp. SCN 66-18   ATYPDRPALI PHESVAATLK ALDHWFWNAA VGPWMFCFCA   
Novosphingobium sp. MD-1    AKYPDRPALI PHESVAATLK ALDHWFWNAA VGPWMFCFCA   
Altererythrobacter sp. 66-12   ETYPDRPMLI PHPSVAAVTR ALDAWFWGAA TGPWMRCFCV   
Sphingomonadales bacterium 63-6(1) AEYPARPTLV PHESVASVTR ALDAWFWKVA TGPWMRCFCA   
Altererythrobacter sp. Root672(1) ATYPDRPLLI PHPSVAIVTR ALDAWFWQVA TGPWMRCNCV   
Sphingomonadales bacterium 63-6(2) EKYPDRPTLI PDPSLRVLTT MMESWLWQVA IGPWMSCFIK   
Erythrobacter sp. SG61-1L(2)   EKYPDRPTLI PDPSVRVLTT MMESWLWQAA IGPWMTCFIK   
Novosphingobium acidiphilum   RKYPDRPTLI GDPSVRVLAQ FLETWLWKTA VGPWARCFAV   
Novosphingobium sp. Fuku2-ISO-50 AKYPDRPTLI GDPSVKVLTQ FLEAWLWKTA VGPWARCFAV   
Sphingobium sp. 66-54(1)    ETYPDRPTLI PHPSVKALTQ AMEGWLWQTA ISPWMTCFIK   
Altererythrobacter sp. Root672(2) EKYPHRPTLI GDPSVKVCGQ MLEQWLWQTA IGPWMTCYLK   
Altererythrobacter atlanticus(2) EKYPDRPTLI GDPGIRPSAQ MNEAWLWQTA VGPWMTCYLV   
Novosphingobium sp. SCN 63-17   AKYPDRPTLI GDPSVKVLTQ FLETWLWKTV VGPWARCFAV   
Sphingobium sp. SCN 64-10   ETYPDRPTLI PHPSVKALTQ GMEAWLWSTA ISPWMTCFIK   
Sphingobium sp. SYK-6(2)    ETYPERPTLI PHASVKALTQ GMEAWLWGAA ISPWMTCFIK   
Novosphingobium sp. FSW06-99   RKYPDRPTLI GDPSVRVLTQ FLETWLWKTA VGPWARCFAV   
Sphingomonas hengshuiensis   GKYPERP~LF EGPSMKVLTK FIDQWLWRTA IGPWFRCYIL   
Novosphingobium sp. PP1Y    ERYPDRPMLF EGPSMKQLTK FLDAWLWQTA IGPWFRCYIQ   
Novosphingobium sp. ST904   EKYPDRPMLF EGPSMKELTR FLDAWLWTTA IGPWFSCYIL   
Novosphingobium mathurense   ERYPERPMLF EGPSMQQLTK FLDAWLWQTA IGPWFRCYIQ   
Novosphingobium sp. KN65.2   ERYPERPMLF EGPSMQQLTK FLDAWLWQTA IGPWFRCYIQ   
Sphingobium sp. 66-54(2)    EKYPDRPMLF EGPAQKNLMK FLDNWLWGTA IGPWFRCYIL   
Novosphingobium sp. MBES04   ETYPDRPMLF EGPSMKVLTK FLDAWLWKTI IAPWFRCYIL   
 
                                         130        140        150        160  
                                 ....|....| ....|....| ....|....| ....|....|  
Sphingobium sp. SYK-6(1)    DYHDLSLPQD RDYVRWSREQ WFLGG~QRLE DVQAGREDRL   
Novosphingobium fuchskuhlense   DYRDLSVPQD HEYVTHSREK ML~~G~RKLE DVQAGREDRL   
Novosphingobium sp. NDB2Meth1   DYRDLSVPQD HEYITHSREK ML~~G~KKLE DMQAGREQRL   
Novosphingobium sp. AAP93   DYRDLSVPQD HEYITHSREK ML~~G~KKLE DMQAGREQRL   
Novosphingobium subterraneum   DYRDLSVPAD HEYVTHSREK ML~~G~RKLE DVQAGREERL   
Novosphingobium sp. CCH12-A3   DYRDLSVPAD HEYVTHSREK ML~~G~RKLE DVQAGREERL   




Novosphingobium sp. AAP83   DYRDLSLPQD HEYVTHSREK ML~~G~RKLE DVQAGREERL   
Novosphingobium aromaticivorans   DYRDLSLPQD HEYVTHSREK ML~~G~RKLE EVQAGREERL   
Novosphingobium sp. B-7    DYRDLSVPQD HEYITHSREK ML~~G~CKLE EIQAGREDRL   
Novosphingobium sp. AAP1    DYRDLSVPQD HEYITHSREK ML~~G~RKLE EIQAGREDRL   
Altererythrobacter atlanticus(1) NYRDLANKED HEYITHSREI ML~~G~KKLE DMQAGYEERL   
Erythrobacter sp. SG61-1L(1)   NYRNLANQED HEYITHSREI ML~~G~MKLE DMQAGYEDRL   
Novosphingobium capsulatum   DYRDLSLPQD HEYITHSREK ML~~G~RKLE EIQAGREDRL   
Novosphingobium sp. SCN 66-18   DYRNLSLPQD HAYVTHSREK ML~~G~RKLE EVQAGREERL   
Novosphingobium sp. MD-1    DYRNLSVPQD HAYVTHSREK ML~~G~RKLE EVQAGREERL   
Altererythrobacter sp. 66-12   NYRDLSNPED HEYITYSREK ML~~G~KTLE EMQAGWEDRL   
Sphingomonadales bacterium 63-6(1) NYRNLANPED HEYITHSREI ML~~G~MKLE DMQAGYEDRL   
Altererythrobacter sp. Root672(1) SYRDLSNPED HEYITHSREK ML~~G~KTLE AMQEGYEDRL   
Sphingomonadales bacterium 63-6(2) SYRDRSLPQD HEYVTESRER MF~~G~RKME DIIVGREDRL   
Erythrobacter sp. SG61-1L(2)   SYRDRSLPQD HEYVTQSRER MF~~G~RKME DIIVGREDRL   
Novosphingobium acidiphilum   QYRDRSFPQD IPYIVESRRR MW~~G~APME DLVSGREDRL   
Novosphingobium sp. Fuku2-ISO-50 GYRDRCFAQD IPYIVESRRR MW~~G~APME DLAAGREDRL   
Sphingobium sp. 66-54(1)    QYRDRSLPQD HAYVTESRER MF~~G~RKIE DIIVGREDRL   
Altererythrobacter sp. Root672(2) QYRDRALPQD HGYVTESRER MF~~GGQKIE DIIIGREDRL   
Altererythrobacter atlanticus(2) AYRDRSVPED HEYVTATRET MF~~GGRKLE DIIVGREDRL   
Novosphingobium sp. SCN 63-17   QYRDRCFPHD IQYITESRLR MW~~G~KPME ELIVGREDVF   
Sphingobium sp. SCN 64-10   QYRDRSLPVD HEYVTTSRER MF~~G~RKIE DLIVGREDRL   
Sphingobium sp. SYK-6(2)    QYRDRSLPQD HEYVTTSRER MF~~G~RKIE DIIVGREDRI   
Novosphingobium sp. FSW06-99   QYRDRCFEQD IPYIVESRRR MW~~G~APME DLIVGREDRL   
Sphingomonas hengshuiensis   DYHNLSYPHD HDYIRTTRET MFLGG~QKLE DVQAGREERL   
Novosphingobium sp. PP1Y    DYHDLSLPQD QTYVRHSRET MFLGG~KTLE EVQAGREDRL   
Novosphingobium sp. ST904   DYHDLSLPQD HAYVRHSRET MFLGG~RKLE DVQAGREDRL   
Novosphingobium mathurense   DYHDLSLPQD QAYVRHSRET MFLGG~KTLE EVQAGREDRL   
Novosphingobium sp. KN65.2   DYHDLSLPQD QAYVRHSRET MFLGG~KTLE EVQAGREDRL   
Sphingobium sp. 66-54(2)    DYHDLSLPQD RDYVRWSREQ WFLGG~QKLE DVQAGREDRL   
Novosphingobium sp. MBES04   DYHDLSLPQD HAYVRESRET MFLGG~QKLE DVQAGREDRL   
 
                                         170        180        190        200  
                                 ....|....| ....|....| ....|....| ....|....|  
Sphingobium sp. SYK-6(1)    PLVPPTLEPF RRILAETKWL GGDQPNFADY SALAVFLWTA   
Novosphingobium fuchskuhlense   PKISAALEPL RAALGQSEWL GGDSPNYADY RILGGILFTA   
Novosphingobium sp. NDB2Meth1   PGISAALEPL RATLGQHEWL GGDAPNYADY RIMGGILFTS   
Novosphingobium sp. AAP93   PGISAALEPL RATLGQHEWL GGDAPNYADY RIMGGILFTS   
Novosphingobium subterraneum   PRISAALEPL RAALGQHEWL GGSSPNYADF RIMGGILFTA   
Novosphingobium sp. CCH12-A3   PRISAALEPL RAALGQHEWL GGSSPNYADF RIMGGILFTA   
Novosphingobium sp. B1    PRISAALEPL RAALGQHEWL GGSSPNYADF RIMGGILFTA   
Novosphingobium sp. AAP83   PKISAALEPL RAALAQHQWL GGSTPNYADF RIMGGILFTA   
Novosphingobium aromaticivorans   PKISAALEPL RAALAQHQWL GGSSPNYADY RIMGGILFTA   
Novosphingobium sp. B-7    AGISAALEPL RSALGQHAWL GGSSPNYADY RILGGFLFTA   
Novosphingobium sp. AAP1    AGISAALEPL RSALGQHAWL GGSSPNYADY RILGGFLFTA   
Altererythrobacter atlanticus(1) PGISADLEPL RIALREVEWL GGDGPNYADY RIMGSILFTA   
Erythrobacter sp. SG61-1L(1)   PQISADLEPL RIALRESKWL GGSQPNYADF RIMGSILFTA   
Novosphingobium capsulatum   AGISAALEPL RSALGQHAWL GGSSPNYADY RILGGFLFTA   
Novosphingobium sp. SCN 66-18   PKISAALEPL RAALAQHAWL GGATPNYADF RIMGGILFTA   
Novosphingobium sp. MD-1    PKISAALEPL RAALAQHPWL GGPTPNYADF RIMGGILFTA   
Altererythrobacter sp. 66-12   PGISAALEPL RIALREVDYL GGDAPNYADY RILGSILFTA   
Sphingomonadales bacterium 63-6(1) PKISAELEPL RIALRESKWL GGSQPNYADY RILGSILFTA   
Altererythrobacter sp. Root672(1) PAISAALEPL RIALREGDWL GGDSPNYADY RILGSILFTA   
Sphingomonadales bacterium 63-6(2) PLVPPSLQLM RNALADNPWF GGESPNYADY RMLSVFLFAA   
Erythrobacter sp. SG61-1L(2)   PLVPPALQLL RNTLADNKWF GGESPNYADH RMLSVFLFAA   
Novosphingobium acidiphilum   PLVLPELELL RGILREHKWL GGDSPNYADY RALAVFLWCS   
Novosphingobium sp. Fuku2-ISO-50 PLVLPELELL RGILRDHKWL GGDAPNYADY RALAVFLWCA   
Sphingobium sp. 66-54(1)    PLVPPTLQLM RNALAENKWF GGDTPNYADF RLLAVFLFTA   
Altererythrobacter sp. Root672(2) PQIPPKLELM RNTLREHQWF GGESPNYVDY RLLAVFLFLA   
Altererythrobacter atlanticus(2) PRISADLELM RGVLRENKWF GGDSPNYADH RMLACFLWLA   
Novosphingobium sp. SCN 63-17   PKVLPELELL RGILREHKWL GGETPNYADY RALAVFLWAA   
Sphingobium sp. SCN 64-10   PKVPPTLQLR RNVLAENKWF GGETPNYADF RLLAVFLFTA   
Sphingobium sp. SYK-6(2)    PKVPPTLQLL RNVLAENKWL GGDTPNYADF RLLAVFLFTA   
Novosphingobium sp. FSW06-99   PLVLPELELL RGILREHKWL GGDTPNYADY RALAVFLWCA   
Sphingomonas hengshuiensis   PLVPPLLEPL RQLLRDTPWL GGDTPNYADY CALAVFLWTA   
Novosphingobium sp. PP1Y    PLVPPTLEPF RKLLRDTPWL GGDAPNFADY TALAVFLWTA   
Novosphingobium sp. ST904   PLVPPTLEPF RKLLRDTPWL GGEKPNFADY TALAVFLWTA   




Novosphingobium sp. KN65.2   PLVPPTLEPF RKLLRDTPWL GGDAPNFADY TALSVFLWTA   
Sphingobium sp. 66-54(2)    PLVPPTLEPF RKILAETKWL GGETPNFADY SALAVFLWTA   
Novosphingobium sp. MBES04   PHVPPLLEPL RQLLRDTPWL GGATPNYADY TALAIFLWTG   
 
                                         210        220        230        240  
                                 ....|....| ....|....| ....|....| ....|....|  
Sphingobium sp. SYK-6(1)    SVART~PPLT EDDPLRDWLD RGFDLFDGLG RHPGMNPLFG   
Novosphingobium fuchskuhlense   SVCKT~PVLA EDDPLRGWIE RCLDLYGGLG RHPGLFPLFG   
Novosphingobium sp. NDB2Meth1   SVCKV~PVLA NDDPLRGWIE RCLDLYGGLG RHPGLFPLFG   
Novosphingobium sp. AAP93   SVCKV~PVLA NDDPLRGWIE RCLDLYGGLG RHPGLFPLFG   
Novosphingobium subterraneum   SVCKT~PVLA NDDPLRPWIE RCLDLYGGLG RHPGLFPLFG   
Novosphingobium sp. CCH12-A3   SVCKT~PVLA NDDPLRPWIE RCLDLYGGLG RHPGLFPLFG   
Novosphingobium sp. B1    SVCKT~PVLA NDDPLRPWIE RCLDLYGGLG RHPGLFPLFG   
Novosphingobium sp. AAP83   SVCKI~PVLA NDDPMRDWIE RSLDLFGGLG RHPGLFPLFG   
Novosphingobium aromaticivorans   SVCKT~PVLA NDDPLRDWIE RCLDLYGGLG RHPGLFPLFG   
Novosphingobium sp. B-7    SVCKT~PVLA NDDPLRDWLD RCLDLYGGLG RHPGLFPLFG   
Novosphingobium sp. AAP1    SVCKT~PVLA NDDPLRDWLD RCLDLYGGLG RHPGLFPLFG   
Altererythrobacter atlanticus(1) SVCKTSPVLA DDDPLRDWIE RCLDLFGGLG RHPGLFPLFG   
Erythrobacter sp. SG61-1L(1)   SVCQTSPVFA DDDPLRDWIE RCLDLYGGLG RHPGLFPLFG   
Novosphingobium capsulatum   SVCKT~PVLA SDDPLRDWLD RCLDLYGGLG RHPGLFPLFG   
Novosphingobium sp. SCN 66-18   SVCQT~PVLA EDDPLRDWIE RCLDLYGGLG RHPGLFPLFG   
Novosphingobium sp. MD-1    SVCQT~PVLA EDDPLRDWIE RCLDLYGGLG RHPGLFPLFG   
Altererythrobacter sp. 66-12   SVCKTSPVLA DDDPLRPWID NLLDMFGGLG RHPGLFPLFG   
Sphingomonadales bacterium 63-6(1) SVCQTSPVFA DDDPLRDWIE RCLDLYDGLG RHPGLFPLFG   
Altererythrobacter sp. Root672(1) SVCQNSPVLA EDDPLRPWIE RCLDLYDGLG RHPGLFPLFG   
Sphingomonadales bacterium 63-6(2) AVADT~PVLT EDDPLRDWIE RGFDLYGGLG RHPGLLPLFG   
Erythrobacter sp. SG61-1L(2)   AVADT~PVLT DDDPLRDWID RGFDLYGGLG RHPGMLPLFG   
Novosphingobium acidiphilum   SIADV~PPMT DDEPLRDWID RGFDLFGGLG RIPGMSPLFG   
Novosphingobium sp. Fuku2-ISO-50 SVADI~PPMT DDEPLRDWID RGFDLYGGLG RIPGMSPLFG   
Sphingobium sp. 66-54(1)    SVADT~PVLT DDDPLRDWIE RGFDLYGGLG RHPGLSPIFG   
Altererythrobacter sp. Root672(2) SVADI~PALP ADDPLRDWID RGFDLYGGLG RHPGMSPIFG   
Altererythrobacter atlanticus(2) SVCDT~PALA EDDPLRDWID RGFDLYGGIG RHPGLSNIFG   
Novosphingobium sp. SCN 63-17   SVADT~PPMT EDDPLRDWID RGFDLYGGLG RIPGMSPLFG   
Sphingobium sp. SCN 64-10   SVADT~PVLT DDDPLRDWIE RGFDLYGGLG RHPGLSPIFG   
Sphingobium sp. SYK-6(2)    SVADT~PVLT DDDPLRDWIE RGFDLYGGLG RHPGLSPIFG   
Novosphingobium sp. FSW06-99   SIADI~PPMT DDEPLRDWID RGFDLYGGLG RIPGMSPLFG   
Sphingomonas hengshuiensis   SVATT~PPLT DDDPLRDWLD RGFDLYDGLG RHPGMHSLFG   
Novosphingobium sp. PP1Y    SVATT~PPLT EDDPLRGWLD RGFDLYAGLG RHPGMHSLFG   
Novosphingobium sp. ST904   SVATT~PPLT GDDPLRDWLD RGFDFFGGLG RHPAMHTLFG   
Novosphingobium mathurense   SVATT~PPLT EDDPLRGWLD RGFDLHGGLG RHPGMHSLFG   
Novosphingobium sp. KN65.2   SVATT~PPLT EDDPLRGWLD RGFDLHGGLG RHPGMHGLFG   
Sphingobium sp. 66-54(2)    SVART~PPLT EDDPLRDWLD RGFDLFGGLG RHPAMHSLFG   
Novosphingobium sp. MBES04   SVCTT~PPLT EDDPLRDWLD RGFDLYGGLG RHPGMHTLFG   
 
                                         250        260        270        280  
                                 ....|....| ....|....| ....|....| ....|....|  
Sphingobium sp. SYK-6(1)    LKLREGDPEP FVRQTGPAGA GGQALNKG~P QTTKMPPRVA   
Novosphingobium fuchskuhlense   LEQREGDPDL FNR~~~~~~~ ~~AGGQGG~I ~YKRNTGPAS   
Novosphingobium sp. NDB2Meth1   LEEPEGGPAL FNR~~~~~~~ ~~AAGQGG~I ~YKRNTGPAS   
Novosphingobium sp. AAP93   LEEPEGGPAL FNR~~~~~~~ ~~AAGQGG~I ~YKRNTGPAS   
Novosphingobium subterraneum   LEQREGDPDL FNR~~~~~~~ ~~SAGQGG~I ~YKRNTGPDS   
Novosphingobium sp. CCH12-A3   LEQREGDPDL FNR~~~~~~~ ~~SAGQGG~I ~YKRNTGPDS   
Novosphingobium sp. B1    LEQREGDPDL FNR~~~~~~~ ~~AAGQGG~I ~YKRNTGPDS   
Novosphingobium sp. AAP83   LEQREGDPDL FNR~~~~~~~ ~~AAGQGG~I ~YKRNTGPAS   
Novosphingobium aromaticivorans   LEQREGDPDL FNR~~~~~~~ ~~AAGQGG~I ~YKRNTGPES   
Novosphingobium sp. B-7    LVEREGDVPA FTR~~~~~~~ ~~QGGLGG~I ~YKRNTGPAS   
Novosphingobium sp. AAP1    LVEREGDVPA FTR~~~~~~~ ~~QGGLGG~I ~YKRNTGPAS   
Altererythrobacter atlanticus(1) LPHPENGQEL FA~~~~~~~~ ~~PQGQGG~I ~HKRNTGVDS   
Erythrobacter sp. SG61-1L(1)   LKQRDGDPEL FA~~~~~~~~ ~~PQGAGG~I ~HKRNTGPAS   
Novosphingobium capsulatum   LVEREGDVPA FTR~~~~~~~ ~~QGGLGG~I ~YKRNTGPAS   
Novosphingobium sp. SCN 66-18   LKQRDGDPDL FNR~~~~~~~ ~~QAGQGG~I ~YKRNTGPES   
Novosphingobium sp. MD-1    LKQRDGDPDL FNR~~~~~~~ ~~QAGQGG~I ~YKRNTGPES   
Altererythrobacter sp. 66-12   LKQREGDPPL FM~~~~~~~~ ~~PAGMGG~I ~HKRNTGVES   
Sphingomonadales bacterium 63-6(1) LKRREGDPEL FA~~~~~~~~ ~~PQGQGG~I ~HKRNTGPAS   
Altererythrobacter sp. Root672(1) LEQRPQDPPL FM~~~~~~~~ ~~PQGQGG~I ~HKRNTGPAS   
Sphingomonadales bacterium 63-6(2) LQLREGDPEP FQK~~~~~~~ ~~GPQMGG~L ~ARRNTGPAS   




Novosphingobium acidiphilum   LQPRPGDPEP FAK~~~~~~~ ~GPTLVGG~L ~ISRNTGPTS   
Novosphingobium sp. Fuku2-ISO-50 LKLRAGDPEP FAK~~~~~~~ ~GPTLVGG~L ~VSRNTGPAS   
Sphingobium sp. 66-54(1)    LQLREGDPEP FLK~~~~~~~ ~~GAGVGGGL ~YNRNTGPQS   
Altererythrobacter sp. Root672(2) LPRRENDPEP FVR~~~~~~~ ~~DPQANG~L ~TKRNTGPQS   
Altererythrobacter atlanticus(2) LKQRAGDPDL FNR~~~~~~~ ~~NPMANG~L ~TSRNTGVKS   
Novosphingobium sp. SCN 63-17   LKMREGDPEP FAK~~~~~~~ ~GPSLVAG~L ~VKRNTGPAS   
Sphingobium sp. SCN 64-10   LQLREGDPEP FIK~~~~~~~ ~~GGAVGG~L ~ATRNTGPKS   
Sphingobium sp. SYK-6(2)    LQLREGDPEP FIK~~~~~~~ ~~GGAVGG~L ~ATRNTGPKS   
Novosphingobium sp. FSW06-99   LQVREGDPEP FAK~~~~~~~ ~GPTLVGG~L ~ISRNTGPAS   
Sphingomonas hengshuiensis   LQLREGDPAP FLK~~~~~~~ AGIGTAPA~P ~VNRGAGTTP   
Novosphingobium sp. PP1Y    LRLREGDPEP FAR~~~~~~~ DGAGIEVA~P ~VNRGTARSA   
Novosphingobium sp. ST904   LRLRPGDPEP FES~~~~~~~ GGAGIEVA~P ~VNRGAAPQV   
Novosphingobium mathurense   LQLREGDPEP FVR~~~~~~~ DGAGIEVA~P ~VNRGTARSA   
Novosphingobium sp. KN65.2   LQLREGDPEP FVR~~~~~~~ DGAGIEVA~P ~VNRGTARSA   
Sphingobium sp. 66-54(2)    LKLREGDPEP FVKQTGPAGA GGQGINKG~P QTTKMPPRGT   
Novosphingobium sp. MBES04   LKLREGDPEP FDR~~~~~~~ TGLGIEPA~P ~VNQGSAEPA   
 
                                         290        300  
                                 ....|....| ....|....| . 
Sphingobium sp. SYK-6(1)    EKAD------ ---------- -  
Novosphingobium fuchskuhlense   TQAE~~~TQR ITEGMKK--- -  
Novosphingobium sp. NDB2Meth1   TQAE~~~TQR ITEGMKK--- -  
Novosphingobium sp. AAP93   TQAE~~~TQR ITEGMKK--- -  
Novosphingobium subterraneum   TRAE~~~TQR ITEGMKK--- -  
Novosphingobium sp. CCH12-A3   TRAE~~~TQR ITEGMKK--- -  
Novosphingobium sp. B1    TRAE~~~TQR ITEGMKK--- -  
Novosphingobium sp. AAP83   TSAE~~~TQR ITEGLKR--- -  
Novosphingobium aromaticivorans   TRAE~~~TQR ITEGMKK--- -  
Novosphingobium sp. B-7    TQAE~~~TQK ITQGMKQPA- -  
Novosphingobium sp. AAP1    TQAE~~~TQK ITQGMKQPA- -  
Altererythrobacter atlanticus(1) TRAE~~~SEK ITQGMSKD-- -  
Erythrobacter sp. SG61-1L(1)   TSTE~~~TQR ITEGMKAG-- -  
Novosphingobium capsulatum   TQAE~~~TQK ITQGMKQPA- -  
Novosphingobium sp. SCN 66-18   TRAE~~~TQR ITEGMAAA-- -  
Novosphingobium sp. MD-1    TRAE~~~TQR ITEGMAAA-- -  
Altererythrobacter sp. 66-12   TRAE~~~TRR ITEGMAKN-- -  
Sphingomonadales bacterium 63-6(1) TSAE~~~TQR ITQGLAAD-- -  
Altererythrobacter sp. Root672(1) TSAE~~~TQR ITEGMAKA-- -  
Sphingomonadales bacterium 63-6(2) TSAE~~~TAM LKGSR----- -  
Erythrobacter sp. SG61-1L(2)   TQAE~~~TAM MKGKS----- -  
Novosphingobium acidiphilum   TAAE~~~TAK ITGREETAKN A  
Novosphingobium sp. Fuku2-ISO-50 TSAE~~~TAK ITGRKEAANH A  
Sphingobium sp. 66-54(1)    TAAE~~~TAR MKGEAAPAA- -  
Altererythrobacter sp. Root672(2) TASE~~~TAR LKGEAASA-- -  
Altererythrobacter atlanticus(2) TAGE~~~TAR MKGQKAGA-- -  
Novosphingobium sp. SCN 63-17   TAAE~~~TAH ITGKGEKAPA -  
Sphingobium sp. SCN 64-10   TAAE~~~TAR LKGQTAPAN- -  
Sphingobium sp. SYK-6(2)    TAAE~~~TAR LKGEKAPAA- -  
Novosphingobium sp. FSW06-99   TSAE~~~TAK ITGRAEAASD A  
Sphingomonas hengshuiensis   FPEPARAA-- ---------- -  
Novosphingobium sp. PP1Y    EMAD------ ---------- -  
Novosphingobium sp. ST904   EPAD------ ---------- -  
Novosphingobium mathurense   EMAD------ ---------- -  
Novosphingobium sp. KN65.2   EMAD------ ---------- -  
Sphingobium sp. 66-54(2)    TKTD------ ---------- -  
Novosphingobium sp. MBES04   TAS------- ---------- -  
 
Supplementary Figure 7.16: Multiple sequence alignment of LigE homologs obtained from BLAST tool 
provided by NCBI where sequence of LigE from Sphingobium sp. SYK-6 was used as a template. Proteins 
analyzed are Sphingobium sp. SYK-6(1) (WP_014075192.1), Novosphingobium fuchskuhlense 
(WP_067913477.1), Novosphingobium sp. NDB2Meth1 (WP_072379148.1), Novosphingobium sp. AAP93 
(WP_054121822.1), Novosphingobium subterraneum (WP_039335072.1), Novosphingobium sp. CCH12-
A3 (WP_062343074.1), Novosphingobium sp. B1 (WP_084280065.1), Novosphingobium sp. AAP83 
(WP_054106368.1), Novosphingobium aromaticivorans (WP_011446047.1), Novosphingobium sp. B-7 




(WP_046903062.1), Erythrobacter sp. SG61-1L(1) (WP_054530882.1), Novosphingobium capsulatum 
(WP_062781915.1), Novosphingobium sp. SCN 66-18 (ODU67585.1), Novosphingobium sp. MD-1 
(GAO55515.1), Altererythrobacter sp. 66-12 (OJU60283.1), Sphingomonadales bacterium 63-6(1) 
(OJW72302.1), Altererythrobacter sp. Root672(1) (WP_055920889.1), Sphingomonadales bacterium 63-
6(2) (OJW69813.1), Erythrobacter sp. SG61-1L(2) (WP_054530343.1), Novosphingobium acidiphilum 
(WP_028641482.1), Novosphingobium sp. Fuku2-ISO-50 (WP_067743869.1), Sphingobium sp. 66-54(1) 
(OJY67521.1), Altererythrobacter sp. Root672(2) (WP_055921561.1), Altererythrobacter atlanticus(2) 
(WP_046903179.1), Novosphingobium sp. SCN 63-17 (ODU84760.1), Sphingobium sp. SCN 64-10 
(ODT90752.1), Sphingobium sp. SYK-6(2) (WP_014077574.1), Novosphingobium sp. FSW06-99 
(WP_067615430.1), Sphingomonas hengshuiensis (WP_044331491.1), Novosphingobium sp. PP1Y 
(WP_013832481.1), Novosphingobium sp. ST904 (WP_054436034.1), Novosphingobium mathurense 
(WP_079730390.1), Novosphingobium sp. KN65.2 (WP_054947729.1), Sphingobium sp. 66-54(2) 
(OJY68654.1), Novosphingobium sp. MBES04 (WP_039391125.1). Protein sequences were aligned using 
BioEdit tool. 
 
7.10 LigF homologs multiple sequence alignment 
 
                                          10         20         30         40  
                                 ....|....| ....|....| ....|....| ....|....|  
Sphingobium sp. SYK-6    M~~~~~~~~~ ~TLKLYSFGP GANSLKPLAT LYEK~~~GLE   
Sphingobium     ~~~~~~~~~~ ~MLTLYSFGP AANSMKPLLT LYEK~~~GLE   
Sphingobium xenophagum    ~~~~~~~~~~ ~MLTLYSFGP AANSMKPLLT LYEK~~~GLE   
Sphingobium sp. Leaf26    ~~~~~~~~~~ ~MLTLYSFGP AANSMKPLLA LYEK~~~GLE   
Sphingobium sp. AP50    ~~~~~~~~~~ ~MLTLYSFGP AANSLKPLLA LYEK~~~GLE   
Sphingobium sp. YR768    ~~~~~~~~~~ ~MLTLYSFGP AANSLKPLLA LYEK~~~GLE   
Sphingobium czechense    ~~~~~~~~~~ ~MLTLYSFGP AANSLKPLLA LYEK~~~GLD   
Sphingobium sp. TCM1    ~~~~~~~~~~ ~MLTLYSFGP AANSLKPLLA LYEK~~~GLD   
Novosphingobium sp. ST904   ~~~~~~~~~~ ~MLTLYSFGP AANSLKPLLA LYEK~~~GLE   
Novosphingobium capsulatum   ~~~~~~~~~~ ~MLKLYSFGP AANSMKPLLT LFEK~~~GLP   
Novosphingobium sp. AAP93   ~~~~~~~~~~ ~MLKLYSFGP AANSMKPLLT LFEK~~~GLP   
Novosphingobium(1)    ~~~~~~~~~~ ~MLKLYSFGP AANSMKPLLT LFEK~~~GLP   
Novosphingobium sp. NDB2Meth1   ~~~~~~~~~~ ~MLKLYSFGP AANSMKPLLT LFEK~~~GLP   
Novosphingobium aromaticivorans   ~~~~~~~~~~ ~MLKLYSFGP AANSMKPLLT VFEK~~~GLD   
Sphingomonas mali     ~~~~~~~~~~ ~MLTLYSFGP AANSLKPLLA LYEK~~~GLP   
Novosphingobium sp. AAP83(1)   ~~~~~~~~~~ MTLKLYSFGP AANSMKPLLT VFEK~~~GLE   
Novosphingobium subterraneum(1)   ~~~~~~~~~~ MTLKLYSFGP AANSMKPLLT VFEK~~~GLD   
Novosphingobium sp. B1(1)   ~~~~~~~~~~ MTLKLYSFGP AANSMKPLLT VFEK~~~GLD   
Sphingomonas asaccharolytica   ~~~~~~~~~~ ~MLTLYSFGP AANSLKPLLA LYEK~~~GLP   
Novosphingobium fuchskuhlense   ~~~~~~~~~~ ~MLKLYSFGP AANSLKPLLT LYEK~~~GLP   
Sphingomonas hengshuiensis   ~~~~~~~~~~ ~MLTLYSFGP AANSLKPLLA LYEK~~~GLD   
Novosphingobium(2)    ~~~~~~~~~~ ~MLTLYSFGP GANSLKPLLA LYEK~~~GLE   
Novosphingobium sp. PP1Y    ~~~~~~~~~~ ~MLTLYSFGP GANSLKPLLA LYEK~~~GLE   
Novosphingobium sp. SCN 63-17   ~~~~~~~~~~ ~MLKLYSFGP AANSMKPLLT LYEK~~~GTP   
Sphingomonas sp. 66-10    ~~~~~~~~~~ ~MLTLYSFGP AANSLKPLLA LYEK~~~GLA   
Novosphingobium DSM 12444   MVIPLGEDNT IMLKLYSFGP AANSMKPLLT VFEK~~~GLD   
Novosphingobium sp. B1(2)   MVHPLGEDKT MTLKLYSFGP AANSMKPLLT VFEK~~~GLD   
Novosphingobium sp. AAP83(2)   MVSPFGEDTI MTLKLYSFGP AANSMKPLLT VFEK~~~GLE   
Novosphingobium sp. SCN 66-18   ~~~~~~~~~~ ~MLKLYSFGP AANSLKPLLT LYEK~~~GLP   
Novosphingobium sp. MBES04   ~~~~~~~~~~ ~MLTLYSFGP GANSLKPLLA LYEK~~~GLE   
Novosphingobium subterraneum(2)   MVLPLGEDNA MTLKLYSFGP AANSMKPLLT VFEK~~~GLD   
Novosphingobium sp. CCH12-A3   MVLPLGEDND MTLKLYSFGP AANSMKPLLT VFEK~~~GLD   
Novosphingobium sp. MD-1    ~~~~~~~~~~ ~MLKLYSFGP GANSLKPLLT LYEK~~~GLP   
Sphingobium sp. 66-54    M~~~~~~~~~ ~TLTLYSFGP GANSLKPLAT LYEK~~~GLE   
Novosphingobium lentum    ~~~~~~~~~~ ~MLTLYSFGP GANSLKPLLT LYEK~~~GLE   
Altererythrobacter sp. 66-12   ~~~~~~~~~~ ~MLTLYSFGP MANSLKPMLT LFEKFEFGRD   
Altererythrobacter atlanticus   ~~~~~~~~~~ ~MLKLYSFGP GANSLKPMLT LYEK~~~GLE   
Sphingomonadales bacterium 63-6   ~~~~~~~~~~ ~MLKLYSFGP GANSLKPMLT LHEK~~~GLD   
Erythrobacter sp. SG61-1L   ~~~~~~~~~~ ~MLKLYSFGP GANSLKPMLT LHEK~~~GLD   
Altererythrobacter sp. Root672   ~~~~~~~~~~ ~MLKLYSFGP GANSLKPMLT LFEK~~~GLE   





                                          50         60         70         80  
                                 ....|....| ....|....| ....|....| ....|....|  
Sphingobium sp. SYK-6    FEQVFVDPSK FEQHSDWFKK INPRGQVPAL WH~~~~DGKV   
Sphingobium     FTPRFVDPTR FEHHEDWFKA INPRGQVPAL DH~~~~DGHI   
Sphingobium xenophagum    FTPRFVDPTR FEHHEDWFKA INPRGQVPAL DH~~~~DGHI   
Sphingobium sp. Leaf26    FVPRFVDPTR FEHHEDWFKA INPRGQVPAL DH~~~~DGHI   
Sphingobium sp. AP50    FTPRFVDPTR FEHHEDWFKA INPRGQVPAL DH~~~~DGHI   
Sphingobium sp. YR768    FTPRFVDPTR FEHHEDWFKA INPRGQVPAL DH~~~~DGHI   
Sphingobium czechense    FTPRFVDPTR FEHHEDWFKA INPRGQVPAL DH~~~~DGHI   
Sphingobium sp. TCM1    FTPRFVDPTR FEHHEDWFKA INPRGQVPAL DH~~~~DGHI   
Novosphingobium sp. ST904   FTPRFVDPTR FEHHEDWFKK INPRGQVPAL DH~~~~DGHI   
Novosphingobium capsulatum   FQANRLDPAK FEHHSDWFKA INPRGQVPAL VD~~~~GDKV   
Novosphingobium sp. AAP93   FEKNRLDPAK FEHHTDWFKA INPRGQVPAL VD~~~~GEHV   
Novosphingobium(1)    FQANRLDPAK FEHHSDWFKA INPRGQVPAL VD~~~~GDKV   
Novosphingobium sp. NDB2Meth1   FEKNRLDPAK FEHHTDWFKA INPRGQVPAL VD~~~~GEHV   
Novosphingobium aromaticivorans   VEKHRLDPAK FEHHTDWFKA INPRGQVPAL VD~~~~GDKV   
Sphingomonas mali     FTPRFVDPRK FEHHEEWFKK INPRGQVPAL DH~~~~DGHI   
Novosphingobium sp. AAP83(1)   VEKHRLDPAK FEHHTDWFKA INPRGQVPAL VD~~~~GGKV   
Novosphingobium subterraneum(1)   VEKHRLDPAK FEHHTDWFKA INPRGQVPAL VDSGVDGDKV   
Novosphingobium sp. B1(1)   VEKHRLDPAK FEHHTDWFKA INPRGQVPAL VD~~~~GEKV   
Sphingomonas asaccharolytica   FTPRFIDPRK FEHHEEWFKK INPRGQVPAL DH~~~~DGHI   
Novosphingobium fuchskuhlense   FEKNRLDPAK FEHHTDWFKA INPRGQVPAL VD~~~~GDHV   
Sphingomonas hengshuiensis   FTPRFVDPTR FEHHEDWFKQ LNPRGQVPAL DH~~~~DGHI   
Novosphingobium(2)    FTPRFVDPTR FEHHEDWFKK INPRGQVPAL DH~~~~DGHI   
Novosphingobium sp. PP1Y    FTPRFVDPTR FEHHEEWFKK INPRGQVPAL DH~~~~DGHI   
Novosphingobium sp. SCN 63-17   FEGHRLNPAI FEHHQDWFKA INPRGQVPAL VD~~~~GDKV   
Sphingomonas sp. 66-10    FTPRFIDPRR FEHHEDWFKR INPRGQVPAL DH~~~~DGHI   
Novosphingobium DSM 12444   VEKHRLDPAK FEHHTDWFKA INPRGQVPAL VD~~~~GDKV   
Novosphingobium sp. B1(2)   VEKHRLDPAK FEHHTDWFKA INPRGQVPAL VD~~~~GEKV   
Novosphingobium sp. AAP83(2)   VEKHRLDPAK FEHHTDWFKA INPRGQVPAL VD~~~~GGKV   
Novosphingobium sp. SCN 66-18   FEGHRLNPAI FEHHSDWFKA INPRGQVPAL VD~~~~RGKV   
Novosphingobium sp. MBES04   FTPRFVDPTK FEHHEEWFKK INPRGQVPAL DH~~~~DGNV   
Novosphingobium subterraneum(2)   VEKHRLDPAK FEHHTDWFKA INPRGQVPAL VDSGVDGDKV   
Novosphingobium sp. CCH12-A3   VEKHRLDPAK FEHHTEWFKA INPRGQVPAL VDSGVDGDKV   
Novosphingobium sp. MD-1    FEGHRLNPAT FEHHSDWFKA INPRGQVPAL VD~~~~EGRI   
Sphingobium sp. 66-54    FTPRFVDPAK FEQHSDWYKK INPRGQVPAL DH~~~~DGKI   
Novosphingobium lentum    FKGVRLNPAQ FEHHEDWFKA INPNGQVPAL VD~~~~NGRV   
Altererythrobacter sp. 66-12   FTVHRLDPSK FEHHTDWFKA INPRGQVPAL KD~~~~GDRI   
Altererythrobacter atlanticus   YEQHLLNPAK FEHHSDWFKE INPRGQVPAL WD~~~~DGKV   
Sphingomonadales bacterium 63-6   YEQALLDPRK FEHHSDWFKK INPRGQVPAL ED~~~~RGHI   
Erythrobacter sp. SG61-1L   YEQVLLDPRK FEHHSDWFKK INPRGQVPAL ED~~~~RGHI   
Altererythrobacter sp. Root672   YEQHQLNPAK FEHHSDWYKA VNPRGQVPAL DD~~~~NGRI   
Gammaproteobacteria bacterium   FESRYLNPAR FEQHEDWFKQ INPNAQAPAL DH~~~~DGRI   
 
                                          90        100        110        120  
                                 ....|....| ....|....| ....|....| ....|....|  
Sphingobium sp. SYK-6    VTESTVICEY LEDVFPESGN ~SLRPADPFK RAEMRVWTKW   
Sphingobium     ITESTVICEY LEDAFPDA~P ~RLRPADPVG IAEMRVWTKW   
Sphingobium xenophagum    ITESTVICEY LEDAFPDA~P ~RLRPVDPVG IAEMRVWTKW   
Sphingobium sp. Leaf26    ITESTVICEY LEDAFPDA~P ~RLRPTDPVQ IAEMRVWTKW   
Sphingobium sp. AP50    ITESTVICEY LEDAFPDA~P ~RLRPADPVQ IAEMRVWTKW   
Sphingobium sp. YR768    ITESTVICEY LEDAFPDA~P ~RLRPVDPVQ IAEMRVWTKW   
Sphingobium czechense    ITESTVICEY LEDAFPNA~T ~RLRPTDPVQ IAEMRVWTKW   
Sphingobium sp. TCM1    ITESTVICEY LEDAFPDA~P ~RLRPTDPVQ IAEMRVWTKW   
Novosphingobium sp. ST904   ITESTVICEY LEDAFPDA~P ~KLRPTDPVQ IAEMRVWTKW   
Novosphingobium capsulatum   ITESTVICEY LEDEYPTQ~V ~SLRPADSYG RAQMRVWTKW   
Novosphingobium sp. AAP93   ITESTVICEY LEDEYPTE~V ~KLRPDTSYG RAQMRVWTKW   
Novosphingobium(1)    ITESTVICEY LEDEYPTQ~V ~SLRPADSYG RAQMRVWTKW   
Novosphingobium sp. NDB2Meth1   ITESTVICEY LEDEYPTE~V ~KLRPDTSYG RAQMRVWTKW   
Novosphingobium aromaticivorans   VTESTVICEY LEDEYPTE~V ~ALRPADSFG KAQMRIWTKW   
Sphingomonas mali     ITESTVICEY LEDAFPDA~P ~RLRPTDPIK IAEMRVWTKW   
Novosphingobium sp. AAP83(1)   ITESTVICEY LEDEYPTE~V ~KLRPADSYG RAQMRVWTKW   
Novosphingobium subterraneum(1)   ITESTVICEY LEDEYPTE~V ~SLRPADSFG RAQMRIWTKW   
Novosphingobium sp. B1(1)   VTESTVICEY LEDEYPTE~V ~SLRPADSFG RAQMRIWTKW   
Sphingomonas asaccharolytica   ITESTVICEY LEDAFPDA~P ~RLRPADPVA TAEMRVWTKW   
Novosphingobium fuchskuhlense   ITESTVICEY LEDEYPTE~V ~KLRPETSWG KAQMRVWTKW   




Novosphingobium(2)    ITESTVICEY LEDAFPEA~P ~RLRPVDPVN IAEMRVWTKW   
Novosphingobium sp. PP1Y    ITESTVICEY LEDAFPEA~P ~RLRPVDPVM IAEMRVWTKW   
Novosphingobium sp. SCN 63-17   ITESTVICEY LEDEHPGE~V ~KLRPADSYG RAQMRIWTKW   
Sphingomonas sp. 66-10    VTESTVICEY LEDAFPDA~P ~RLRPTDPLA IAEMRVWTKW   
Novosphingobium DSM 12444   VTESTVICEY LEDEYPTE~V ~ALRPADSFG KAQMRIWTKW   
Novosphingobium sp. B1(2)   VTESTVICEY LEDEYPTE~V ~SLRPADSFG RAQMRIWTKW   
Novosphingobium sp. AAP83(2)   ITESTVICEY LEDEYPTE~V ~KLRPADSYG RAQMRVWTKW   
Novosphingobium sp. SCN 66-18   VTESTVICEY LEDEHPTE~V ~ALRPADSFG KAEMRVWTKW   
Novosphingobium sp. MBES04   ITESTVICEY LEDAFPDA~P ~RLRPTDPVQ IAEMRVWTKW   
Novosphingobium subterraneum(2)   ITESTVICEY LEDEYPTE~V ~SLRPADSFG RAQMRIWTKW   
Novosphingobium sp. CCH12-A3   ITESTVICEY LEDEYPTE~V ~SLRPADSFG RAQMRIWTKW   
Novosphingobium sp. MD-1    VTESTVICEY LEDAYPTE~V ~ALRPADSFG KAEMRVWTKW   
Sphingobium sp. 66-54    VTESTVICEY LEDVFPDAGT ~SLRPADPYK RAEMRVWTKW   
Novosphingobium lentum    ITESTVICEY LEDEYPTA~V ~KLRPADSYG RAQMRVWTKW   
Altererythrobacter sp. 66-12   VTESTVICEY LEDAHPTA~V ~KLRPDDPYD RAQMRVWTKW   
Altererythrobacter atlanticus   VTESTVICEY LEDAHPTE~V ~KLRPEDPFD RAQMRIWTKW   
Sphingomonadales bacterium 63-6   ITESTVICEY LEDEWPTD~V ~KLRPDTSWE RADMRVWTKW   
Erythrobacter sp. SG61-1L   ITESTVICEY LEDEWPTD~V ~KLRPDTSWE RADMRVWTKW   
Altererythrobacter sp. Root672   VTESTVICEY LEDAHPTA~V ~KLRPDDPYD RAQMRVWTKW   
Gammaproteobacteria bacterium   ITESTVICEY LEDLFPGT~P ~RLRPEDPYQ RAQMRIWTKW   
 
                                         130        140        150        160  
                                 ....|....| ....|....| ....|....| ....|....|  
Sphingobium sp. SYK-6    VDEYFCWCVS TIGWAFGIKA IAQKMSDEEF EEHINKNVPI   
Sphingobium     VDEYFCWCVS TIGWERMIGP MARKLSDEEF EEKL~KHIPI   
Sphingobium xenophagum    VDEYFCWCVS TIGWERMIGP MARKLSDEEF EEKL~KHIPI   
Sphingobium sp. Leaf26    VDEYFCWCVS TIGWERMIGP MARKLSDAEF EEKL~KHIPI   
Sphingobium sp. AP50    VDEYFCWCVS TIGWERMIGP MARKLSDAEF EEKL~KHIPV   
Sphingobium sp. YR768    VDEYFCWCVS TIGWERMIGP MARKLSDAEF EEKL~KHIPI   
Sphingobium czechense    VDEYFCWCVS TIGWERMIGP MARKLSDAEF EEKL~KHIPI   
Sphingobium sp. TCM1    VDEYFCWCVS TIGWERMIGP MARKLSDEEF EEKL~KHIPI   
Novosphingobium sp. ST904   VDEYFCWCVS TLGWERGIGP MARALSDEEF EAKV~ARIPI   
Novosphingobium capsulatum   VDEYFCWCVS TIGWHRYVGK MVQGLSDQEF EDKV~KAIPV   
Novosphingobium sp. AAP93   VDEYFCWCVS TIGWHRYVGN MVKGLSDAEF EEKV~KAIPV   
Novosphingobium(1)    VDEYFCWCVS TIGWHRYVGK MVQGLSDQEF EDKV~KAIPV   
Novosphingobium sp. NDB2Meth1   VDEYFCWCVS TIGWHRYVGN MVKGLSDAEF EEKV~KAIPV   
Novosphingobium aromaticivorans   VDEYFCWCVS TIGWHRYVGN MVKSLSDAEF EEKV~KAIPV   
Sphingomonas mali     VDEYFCWCVS TIGWERMIGP MARALSDAEF EEQV~KRIPV   
Novosphingobium sp. AAP83(1)   VDEYFCWCVS TIGWHRYVGN MVKALSDAEF EEKV~AAIPV   
Novosphingobium subterraneum(1)   VDEYFCWCVS TIGWHRYVGN MVKGLTDAEF EEKV~KAIPV   
Novosphingobium sp. B1(1)   VDEYFCWCVS TIGWHRYVGN MVKGLTDAEF EAKV~AAIPV   
Sphingomonas asaccharolytica   VDEYFCWCVS TIGWERMIGP MARALSDSEF EEQL~ARIPV   
Novosphingobium fuchskuhlense   VDEYFCWCVS TIGWHRYVGN MVKSLSDAEF EEKV~KAIPV   
Sphingomonas hengshuiensis   VDEYFCWCVS TIGWERMIGP MARAYSDAEF EEKM~ARIPI   
Novosphingobium(2)    VDEYFCWCVS TIGWERMIGP MARALSDEEF EAKV~ARIPV   
Novosphingobium sp. PP1Y    VDEYFCWCVS TIGWERMIGP MARALSDEEF EAKV~ARIPV   
Novosphingobium sp. SCN 63-17   VDEYFCWCVS TIGWHRYVGN MVKSLSDEAF EEKV~KAIPV   
Sphingomonas sp. 66-10    VDEYFCWCVS TIGWERMIGP MARALSDEEF EEKV~KRIPV   
Novosphingobium DSM 12444   VDEYFCWCVS TIGWHRYVGN MVKSLSDAEF EEKV~KAIPV   
Novosphingobium sp. B1(2)   VDEYFCWCVS TIGWHRYVGN MVKGLTDAEF EAKV~AAIPV   
Novosphingobium sp. AAP83(2)   VDEYFCWCVS TIGWHRYVGN MVKALSDAEF EEKV~AAIPV   
Novosphingobium sp. SCN 66-18   VDEYFCWCVS TIGWHRGVSH MAQRLSDAEF EEHL~KKIPI   
Novosphingobium sp. MBES04   VDEYFCWCVS TIGWERGIGP MARALSDEEF EEKV~KRIPI   
Novosphingobium subterraneum(2)   VDEYFCWCVS TIGWHRYVGN MVKGLTDAEF EEKV~KAIPV   
Novosphingobium sp. CCH12-A3   VDEYFCWCVS TIGWHRYVGN MVKGLTDAEF EEKV~KAIPV   
Novosphingobium sp. MD-1    VDEYFCWCVS TIGWHRGVSH MAQRLSDAEF EEHL~KKIPV   
Sphingobium sp. 66-54    VDEYFCWCVS TIGWAFGIKA IAQKMSDEEF EEHIRKNVPI   
Novosphingobium lentum    VDEYFCWCVS TIGWSRMISG MARAISAEEF EEKI~KRIPI   
Altererythrobacter sp. 66-12   VDEYFCWCVS TIGWHRGVSH MAKALSDQEF EEHL~KKIPI   
Altererythrobacter atlanticus   VDEYFCWCVS TIGWHRGVRQ MAQQLSDDEF EEHL~KKIPI   
Sphingomonadales bacterium 63-6   VDEYFCWCVS TIGWHRYVGN MVKGLSDEEF EEKV~KNIPV   
Erythrobacter sp. SG61-1L   VDEYFCWCVS TIGWHRYVGN MVKGLSDEEF EEKV~KNIPV   
Altererythrobacter sp. Root672   VDEYFCWCVS TIGWHRGVRF MAQQLSDAEF EEHL~KKIPI   
Gammaproteobacteria bacterium   VDEYFCWCVS TIGWERRISG IARSVSEEEF ERLV~ARIPL   
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Sphingobium sp. SYK-6    PEQQLKWRRA RNGFPQEMLD EEFRKVGVSV ARLEETLSKQ   
Sphingobium     PEQQAKWRNA RAGFPQAVLD EEMRKIRVSI DRLEKRLAQS   
Sphingobium xenophagum    PEQQAKWRNA RAGFPQAVLD EEMRKIRVSI DRLEKRLAQS   
Sphingobium sp. Leaf26    PEQQAKWRSA RAGFPQAVLD EEMRKIRVSI DRLEQRLSQS   
Sphingobium sp. AP50    PEQQAKWRSA RAGFPQAVLD EEMRKIRVSI DRLEQRLSQS   
Sphingobium sp. YR768    PEQQAKWRSA RAGFPQAVLD EEMRKIRVSI DRLEKRLSQS   
Sphingobium czechense    PEQRAKWRSA RAGFPQAVLD EEMRKIRVSI DRLEQRLAQS   
Sphingobium sp. TCM1    PEQQAKWRSA RAGFPQAVLD EEMRKIRVSI ERLEKRLSQS   
Novosphingobium sp. ST904   PEQRTKWRTA RAGFPRDVLE EEMRKIRVSV DRVEKRLSES   
Novosphingobium capsulatum   VEQQVKWRRA REGFPQDLLD EEMRKIAFSV RRLDDHLRDH   
Novosphingobium sp. AAP93   VEQQVKWRRA REGFPQDMLD EEMRKIGYSV ERLDAHLRQH   
Novosphingobium(1)    VEQQVKWRRA REGFPQDLLD EEMRKIAFSV RRLDDHLRDH   
Novosphingobium sp. NDB2Meth1   VEQQVKWRRA REGFPQDMLD EEMRKIAYSV ERLDAHLREH   
Novosphingobium aromaticivorans   IEQQVKWRRA REGFPQDMLD EEMRKIAYSV RKLDDHLADH   
Sphingomonas mali     PEQQVKWRNA RKGFPKELLD EEMRKVRVSV DKLEKRLAES   
Novosphingobium sp. AAP83(1)   VEQQVKWRRA REGFPQDMLE EEMRKIAFSV RRLDDHLADN   
Novosphingobium subterraneum(1)   VEQQVKWRRA REGFPQDMLD EEMRKIGYSV RKLDDHLADH   
Novosphingobium sp. B1(1)   VEQQVKWRRA REGFPQDMLD EEMRKIAYSV RKLDDHLADH   
Sphingomonas asaccharolytica   AEQKVKWRNA RNGFPKEVLD EEMRKIGVSV DRLEKRLSQS   
Novosphingobium fuchskuhlense   VEQQVKWRRA REGFPQDLLD EEMRKIGYSV ERLDAHLRQH   
Sphingomonas hengshuiensis   PEQQAKWRAA RAGFPKATLD EEMRKIGVSV AKLEARLAES   
Novosphingobium(2)    PEQRTKWRTA RAGFPKDVLA EEMRKIGVSV NRLEMRLAES   
Novosphingobium sp. PP1Y    PEQRTKWRTA RTGFPKEVLD EEMRKIGVSV NRLETRLAES   
Novosphingobium sp. SCN 63-17   FEQQVKWRRA REGFPQDLLD EEMRKIAFSV TRLNDHLADH   
Sphingomonas sp. 66-10    VEQQVKWRNA RAGFPKEVLD EEMRKIRFSI DRLEKRLSES   
Novosphingobium DSM 12444   IEQQVKWRRA REGFPQDMLD EEMRKIAYSV RKLDDHLADH   
Novosphingobium sp. B1(2)   VEQQVKWRRA REGFPQDMLD EEMRKIAYSV RKLDDHLADH   
Novosphingobium sp. AAP83(2)   VEQQVKWRRA REGFPQDMLE EEMRKIAFSV RRLDDHLADN   
Novosphingobium sp. SCN 66-18   PEQQVKWRRA REGFPQDLLD EEMRKIAVSV RRLDDHLADH   
Novosphingobium sp. MBES04   PEQQAKWRSA RAGFPKEVLD EEMRKIRVSI DRLEKRLSES   
Novosphingobium subterraneum(2)   VEQQVKWRRA REGFPQDMLD EEMRKIGYSV RKLDDHLADH   
Novosphingobium sp. CCH12-A3   VEQQVKWRRA REGFPQDMLD EEMRKIGYSV RKLDDHLANH   
Novosphingobium sp. MD-1    PEQQVKWRRA REGFPQDLLD EEMRKIAVSV RRLDDHLADN   
Sphingobium sp. 66-54    PEQQLKWRRA RNGFPQEMLD EEYRKVGVSI ERLEATLSRQ   
Novosphingobium lentum    PEQQVKWRRA RDGFPQDMLD EEMRKIGVSV RRLNDHLADH   
Altererythrobacter sp. 66-12   PEQQVKWRRA REGFPQDLLD EEMRKIAVSV RKLDDHLADN   
Altererythrobacter atlanticus   PEQQVKWRRA REGFPQDLLD EEMRKIGVSV RKLDDHLADN   
Sphingomonadales bacterium 63-6   VEQQVKWRRA REGFPQEMLD EEMRKIAYSV RKLDDHLRDH   
Erythrobacter sp. SG61-1L   VEQQVKWRRA REGFPQEMLD EEMRKIAYSV RKLDDHLRDN   
Altererythrobacter sp. Root672   PEQQVKWRRA REGFPQDLLD EEMRKIGVSV RKLDDHLADN   
Gammaproteobacteria bacterium   KEQQLKWRNA RNGFDKKVLE EEMRKIDYSV KKLEARLSQS   
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Sphingobium sp. SYK-6    DYLVDTGYSL ADICNFAIAN GLQRPGGFFG DYVNQEKTPG   
Sphingobium     PWLAGDEYTL ADICNFAIAN GMQFG~~~HA DIVNGQATPH   
Sphingobium xenophagum    PWLAGDEYTL ADICNFAIAN GMQFG~~~HA DIVNGQATPH   
Sphingobium sp. Leaf26    PWLAGEDFTL ADICNFAIAN GMQFG~~~YA DIVNKDATPH   
Sphingobium sp. AP50    LWLAGEDYTL ADICNFAIAN GMQFG~~~YA DIVNKDMTPH   
Sphingobium sp. YR768    PWLAGEDYTL ADICNFAIAN GMQFG~~~YS DIVNKTATPH   
Sphingobium czechense    PWLAGDDYTL ADVCNFAIAN GMQFG~~~YA DIVNREATPH   
Sphingobium sp. TCM1    PWLAGEVYTL ADICNFAIAN GMQFG~~~YA DIVNPDATPN   
Novosphingobium sp. ST904   TWLVGEQFTL ADVCNFAIAN GMQNS~~~FA DIVNREATPH   
Novosphingobium capsulatum   EWLVPGQYTL ADICNFAIAN GMQFG~~~FA ELVNREDTPH   
Novosphingobium sp. AAP93   EWLVPGQYTL ADICNFAIAN GMQVG~~~FA ELVNKEKTPG   
Novosphingobium(1)    EWLVPEQYTL ADICNFAIAN GMQFG~~~FA ELVNREDTPH   
Novosphingobium sp. NDB2Meth1   EWLVPGQYTL ADICNFAIAN GMQVG~~~FA ELVNKEKTPG   
Novosphingobium aromaticivorans   EWLVPGQYTL ADICNFAIAN GMQFG~~~FA ELVNKQDTPH   
Sphingomonas mali     EWLAGDDYTL ADICNFAIAN GMQHG~~~FA EIVNREASPH   
Novosphingobium sp. AAP83(1)   EWLVGNMFSL ADICNFAIAN GMQFG~~~FA DLVNKEATPH   
Novosphingobium subterraneum(1)   EWLVPGQYTL ADICNFAIAN GMPFG~~~FK ELVNKEDTPH   
Novosphingobium sp. B1(1)   EWLVPGQYTL ADICNFAIAN GMQFG~~~FA ELVNKDDTPH   
Sphingomonas asaccharolytica   PWLAGDDYTL ADICNFAIAN GMQHG~~~FA EIVNREASPH   
Novosphingobium fuchskuhlense   EWLVPGQYTL ADICNFAIAN GMQLG~~~FP EFVSAEKTPG   
Sphingomonas hengshuiensis   EWLAGPDYTL ADICNFAIAN RMQHG~~~FA ELVNTAATPH   
Novosphingobium(2)    PWLAGDEFTL ADVCNFAIAN GMQNG~~~FS DIVNREATPH   




Novosphingobium sp. SCN 63-17   EWLAGDMFTL ADICNFAIAN GMNYS~~~FP ELVNEADAPH   
Sphingomonas sp. 66-10    EWLAGDQYTL ADICNFAVAN GMQHG~~~YA DIVNREATPH   
Novosphingobium DSM 12444   EWLVPGQYTL ADICNFAIAN GMQFG~~~FA ELVNKQDTPH   
Novosphingobium sp. B1(2)   EWLVPGQYTL ADICNFAIAN GMQFG~~~FA ELVNKDDTPH   
Novosphingobium sp. AAP83(2)   EWLVGNMFSL ADICNFAIAN GMQFG~~~FA DLVNKEATPH   
Novosphingobium sp. SCN 66-18   EWLAGGIYTL ADICNFAIAN GMQNG~~~FA ELVNTGDTPH   
Novosphingobium sp. MBES04   TWLAGEDYTL ADICNFAIAN GMEKG~~~FD DIVNTAATPN   
Novosphingobium subterraneum(2)   EWLVPGQYTL ADICNFAIAN GMPFG~~~FK ELVNKEDTPH   
Novosphingobium sp. CCH12-A3   EWLVPGQYTL ADICNFAIAN GMPFG~~~FK ELVNKEDTPH   
Novosphingobium sp. MD-1    EWLAGGMYTL ADICNFAIAN GMQKG~~~FA ELVNTSDTPH   
Sphingobium sp. 66-54    DYLVDSGYSL ADICNFAIAN GLQRPGGFFE GYVTEQKTPG   
Novosphingobium lentum    EWLAGEMYSL ADICNYAIAG GMQFG~~~FA ELVNQADTPH   
Altererythrobacter sp. 66-12   EWLAGGMYSL ADICNFAIAN GMQNG~~~FA ELVNTSDTPH   
Altererythrobacter atlanticus   EWLAGGMYSL ADICNFAIAN GMQFG~~~FA ELVNKEDTPH   
Sphingomonadales bacterium 63-6   EWLVPGMYTL ADICNFAIAN GMQHG~~~YP ELVNKEDTPG   
Erythrobacter sp. SG61-1L   EWLVPGMYTL ADICNFAIAN GMQHG~~~YP ELVNKEDTPG   
Altererythrobacter sp. Root672   EWLAGGMFSL ADICNFAIAN GMEVG~~~FA DQVNKQDTPH   
Gammaproteobacteria bacterium   PWLAGDSYTL ADICNFAIAH TMDSG~~~FP ELINPQATPH   
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Sphingobium sp. SYK-6    LCAWLDRINA RPAIKEMFEK S~~KREDLLK RQ~~~~~~~~   
Sphingobium     LLAWIERINA RPATQAMFAK ~~~SQTEMPP RPAMSAA      
Sphingobium xenophagum    LLAWIERINA RPATQAMFAK ~~~SQTEMPP RPAMSAA      
Sphingobium sp. Leaf26    LVAWIDRINA RPATQAMFAR ~~~SKSEMPA RPTATAA      
Sphingobium sp. AP50    LVAWIERINA RPATQAMFAK ~~~SKSEMPA RPTATAA      
Sphingobium sp. YR768    LVAWIDRINA RPATQAMFSK ~~~SKSEMPA RPTATAA      
Sphingobium czechense    LVAWIERINA RPAAQAMFAK ~~~SKSEMPP RPTATAA      
Sphingobium sp. TCM1    LVAWIDRINA RPAAQAMFAN ~~~SRSEMPP RPAAATAA     
Novosphingobium sp. ST904   LVGWIDRIND RPGCQKMFAN ~~~SKSEFGD RGRKVTV      
Novosphingobium capsulatum   LVRWIEQIKQ RPAVRTMFDS V~~ELEKLGP RD           
Novosphingobium sp. AAP93   LVRWIDQIKA RPAVKQMYAE V~~ELEKLGP RD           
Novosphingobium(1)    LVRWIEQIKQ RPAVRTMFDS V~~ELEKLGP RD           
Novosphingobium sp. NDB2Meth1   LVRWIDQIKA RPAVKQMYAE V~~ELEQLGP RD           
Novosphingobium aromaticivorans   LVRWIEQINE RPAVKQMFAQ V~~ELEKLGP RE           
Sphingomonas mali     LLAWIERINQ RPAVREMFAR ~~~SQSEMPA RAPAPAA      
Novosphingobium sp. AAP83(1)   LLRWIEQINA RPAVQAMFAQ V~~ELEKLGP RE           
Novosphingobium subterraneum(1)   LVRWIEQINE RPAVKAMFAQ V~~ELEKLGP RE           
Novosphingobium sp. B1(1)   LVRWIEQIKA RPAVQQMFAQ V~~ELEQLGR RD           
Sphingomonas asaccharolytica   LLAWIERINQ RPAVREMFAR ~~~SQSEMPS RAPAPAS~~~   
Novosphingobium fuchskuhlense   LVRWIEQIKA RPAVKQMYAE V~~ELEQLGP RD           
Sphingomonas hengshuiensis   LVAWIDRINA RPAAQAMFAQ ~~~SKSEMPA PRPAAAA      
Novosphingobium(2)    LVAWIEKIND RPACKTMFAH ~~~SKSEFAD RGRKVTA      
Novosphingobium sp. PP1Y    LVAWIEKIND RPACKAMFAN ~~~SKSEFAD RGQKVTA      
Novosphingobium sp. SCN 63-17   LVRWIAQINA RPAVQKMFAE V~~PMEKLRP QD           
Sphingomonas sp. 66-10    LVAWIERINA RPAAREMFAR ~~~SQTEMPD RRPAPAP~~~   
Novosphingobium DSM 12444   LVRWIEQINE RPAVKQMFAQ V~~ELEKLGP RE           
Novosphingobium sp. B1(2)   LVRWIEQIKA RPAVQQMFAQ V~~ELEQLGR RD           
Novosphingobium sp. AAP83(2)   LLRWIEQINA RPAVQAMFAQ V~~ELEKLGP RE           
Novosphingobium sp. SCN 66-18   LVRWIEQINQ RPAVQRMFAE V~~PMERLGP PK           
Novosphingobium sp. MBES04   LVAWIERINA RPACIEMFAK ~~~SKSEFAA RKPFAKSEEQ   
Novosphingobium subterraneum(2)   LVRWIEQINE RPAVKAMFAQ V~~ELEKLGP RE           
Novosphingobium sp. CCH12-A3   LVRWIEQINE RPAVKAMFAQ V~~ELEKLGP RE           
Novosphingobium sp. MD-1    MVRWIEQINQ RPAVQRMFAE V~~PMERLGP PKT          
Sphingobium sp. 66-54    VVAWLARINE RPAIQEMFAK A~~KREELLK RV~~~~~~~~   
Novosphingobium lentum    LLRWIEMIAA RPAAKKMVAE V~~PMERLVA DA           
Altererythrobacter sp. 66-12   LVRWIEQINA RPKVQQMFAS V~~PREQLGP PR           
Altererythrobacter atlanticus   LLRWIEQIND RPKVKAMFDA V~~PREKLGG PKD          
Sphingomonadales bacterium 63-6   LLRWIEQINE RPAAKKMFAD VPREIRHEDA KK           
Erythrobacter sp. SG61-1L   LLRWIEQINE RPAAQKMFAD VPREIRHEDA KK           
Altererythrobacter sp. Root672   LVRWIEQINA RPKVQEMFAA V~~PRERLGP PK           
Gammaproteobacteria bacterium   ILDWLARIRE RPACRTMYAN A~~PVR                  
 
Supplementary Figure 7.17: Multiple sequence alignment of LigF homologs obtained from BLAST tool 
provided by NCBI where sequence of LigF from Sphingobium sp. SYK-6 was used as a template. Proteins 




family protein), Sphingobium xenophagum (WP_019052363.1), Sphingobium sp. Leaf26 
(WP_056685155.1), Sphingobium sp. AP50 (SEI61226.1), Sphingobium sp. YR768 (SER63234.1), 
Sphingobium czechense (WP_066609183.1), Sphingobium sp. TCM1 (WP_066854755.1), 
Novosphingobium sp. ST904 (WP_054436033.1), Novosphingobium capsulatum (WP_062782323.1), 
Novosphingobium sp. AAP93 (WP_054121580.1), Novosphingobium(1) (WP_022675760.1, multispecies 
family protein), Novosphingobium sp. NDB2Meth1 (WP_072381855.1), Novosphingobium aromaticivorans 
(WP_041551020.1), Sphingomonas mali (WP_066818898.1), Novosphingobium sp. AAP83(1) 
(KPF91204.1), Novosphingobium subterraneum(1) (KHS49048.1), Novosphingobium sp. B1(1) 
(SMC30538.1), Sphingomonas asaccharolytica (WP_066804606.1), Novosphingobium fuchskuhlense 
(WP_067910024.1), Sphingomonas hengshuiensis (WP_044331490.1), Novosphingobium(2) 
(WP_054947728.1, multispecies family protein), Novosphingobium sp. PP1Y (WP_013832480.1), 
Novosphingobium sp. SCN 63-17 (ODU83729.1), Sphingomonas sp. 66-10 (OJU17901.1), 
Novosphingobium aromaticivorans DSM 12444 (ABD26530.1), Novosphingobium sp. B1(2) 
(WP_084276739.1), Novosphingobium sp. AAP83(2) (WP_082356151.1), Novosphingobium sp. SCN 66-
18 (ODU70795.1), Novosphingobium sp. MBES04 (WP_039391123.1), Novosphingobium subterraneum(2) 
(WP_082013229.1), Novosphingobium sp. CCH12-A3 (WP_082734789.1), Novosphingobium sp. MD-1 
(GAO55900.1), Sphingobium sp. 66-54 (OJY68655.1), Novosphingobium lentum (WP_068075965.1), 
Altererythrobacter sp. 66-12 (OJU59935.1), Altererythrobacter atlanticus (WP_046904735.1), 
Sphingomonadales bacterium 63-6 (OJW61742.1), Erythrobacter sp. SG61-1L (WP_054529921.1), 
Altererythrobacter sp. Root672 (WP_055919008.1), Gammaproteobacteria bacterium 
RIFCSPLOWO2_02_FULL_56_15 (OGT78215.1). Protein sequences were aligned using BioEdit tool. 
 
7.11 Calibration curves 
 






Supplementary Figure 7.19: Calibration curve of the absorbance of the vanillin. 
 
  
























Equation y = a + b*x
Plot absorbance (360nm
Weight No Weighting
Intercept 0.09787 ± 0.00374
Slope 10.08024 ± 0.04859
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